[{"text": "Recursion Pharmaceuticals (RXRX) Moves 8.9% Higher: Will This Strength Last? Zacks Equity Research Thu, Jan 23, 2025, 5:45 PM 2 min read In This Article: RXRX +0.14% ENTA +1.17% Recursion Pharmaceuticals (RXRX) shares ended the last trading session 8.9% higher at $7.49. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 5% loss over the past four weeks. The sudden rise in the stock price was observed after President Donald Trump announced a $500 billion project to develop and expand AI infrastructure, at his inauguration event on Monday. Investors likely anticipate that Recursion, being a Tech-Bio company that utilizes AI models in drug discovery, would benefit from the project. This biotechnology company is expected to post quarterly loss of $0.35 per share in its upcoming report, which represents a year-over-year change of +12.5%. Revenues are expected to be $26.7 million, up 145.2% from the year-ago quarter. Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements. For Recursion Pharmaceuticals, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on RXRX going forward to see if this recent jump can turn into more strength down the road. The stock currently carries a Zacks Rank #2 (Buy). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Recursion Pharmaceuticals belongs to the Zacks Medical - Drugs industry. Another stock from the same industry, Enanta Pharmaceuticals (ENTA), closed the last trading session 1.2% higher at $5.18. Over the past month, ENTA has returned -16.1%. Enanta Pharmaceuticals' consensus EPS estimate for the upcoming report has changed +3.5% over the past month to -$1.16. Compared to the company's year-ago EPS, this represents a change of +26.6%. Enanta Pharmaceuticals currently boasts a Zacks Rank of #3 (Hold). Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Recursion Pharmaceuticals, Inc. (RXRX) : Free Stock Analysis Report Enanta Pharmaceuticals, Inc. (ENTA) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "ENTA", "date": "2025-01-23T14:45:00+00:00", "sentiment": {"score": 0.6023134887218475, "confidence": 0.7359200119972229, "probabilities": {"positive": 0.7359200119972229, "negative": 0.13360652327537537, "neutral": 0.13047346472740173}}, "embedding": [-0.11941154301166534, -0.15304207801818848, 0.044783443212509155, -0.04981795698404312, -0.03184650093317032, -0.05197763442993164, -0.0181015282869339, 0.1968860626220703, 0.1371246874332428, 0.12458335608243942, -0.10760129988193512, 0.153395876288414, 0.022056033834815025, 0.04794256016612053, -0.1364063024520874, 0.02244579792022705, 0.00834485050290823, -0.044377055019140244, -0.07990887761116028, 0.026517732068896294, -0.06517856568098068, -0.06766226887702942, 0.06325560808181763, 0.010274874977767467, 0.12061285972595215, 0.11623480916023254, -0.013623754493892193, -0.010074608027935028, -0.11451894044876099, -0.11524748802185059, 0.002785217948257923, 0.11948439478874207, 0.11375503242015839, -0.1264895498752594, -0.07535801827907562, 0.015770142897963524, 0.013147683814167976, 0.04464179277420044, 0.16040579974651337, 0.010289719328284264, -0.05962444096803665, 0.04731280729174614, -0.10241608321666718, 0.002014963887631893, 0.02919350005686283, -0.21038809418678284, -0.007819857448339462, -0.015866268426179886, 0.08051900565624237, 0.10181497037410736, -0.10285307466983795, -0.05555947124958038, 0.03196127712726593, 0.07148834317922592, -0.045342035591602325, 0.06314314156770706, -0.11340771615505219, -0.11205574870109558, 0.021625328809022903, 0.06208755075931549, 0.11762993037700653, -0.0248213279992342, 0.03350764140486717, 0.015726711601018906, 0.1310771107673645, 0.027870524674654007, 0.07577785849571228, -0.05706083029508591, -0.0605267770588398, 0.05067819356918335, 0.13568001985549927, 0.015318283811211586, -0.05181938782334328, -0.07201633602380753, -0.08347605913877487, 0.05141974985599518, 0.15686270594596863, 0.11315372586250305, 0.06250368803739548, -0.12660592794418335, 0.0627368688583374, 0.0329337939620018, -0.0443299300968647, -0.08489280939102173, -0.0100921131670475, 0.0005589097272604704, 0.21373048424720764, 0.06253230571746826, 0.10880132019519806, 0.023787779733538628, 0.06231022626161575, -0.037648238241672516, 0.010428888723254204, -0.0072145662270486355, 0.03482704609632492, 0.07285817712545395, -0.17497491836547852, -0.016144147142767906, 0.03641563653945923, 0.009708834812045097, 0.09110214561223984, 0.11130191385746002, -0.052309855818748474, -0.13235124945640564, -0.138708233833313, -0.11226065456867218, 0.050120703876018524, -0.017407935112714767, 0.007379276677966118, 0.07409074902534485, -0.1098114550113678, 0.07647790014743805, -0.030137119814753532, 0.07916384935379028, -0.10152117162942886, 0.11563977599143982, -0.028970519080758095, -0.02041476219892502, 0.04759446531534195, 0.024249523878097534, 0.08492270857095718, 0.03681387007236481, -0.02403862029314041, -0.0071460953913629055, 0.08786066621541977, -0.025666214525699615, -0.19092372059822083, 1.0589601020487877e-32, -0.041973941028118134, 0.07990401238203049, 0.014807047322392464, -0.0019177645444869995, 0.01971285417675972, 0.054108627140522, 0.06724292039871216, 0.03637165203690529, -0.114583320915699, -0.10488620400428772, -0.23000049591064453, 0.12386971712112427, -0.06684784591197968, -0.04578561335802078, 0.01345045492053032, -0.15185916423797607, 0.01057676412165165, 0.0873047411441803, -0.04196710139513016, -0.08538712561130524, -0.04536376893520355, -0.05795769393444061, -0.07332995533943176, -0.015865864232182503, 0.017415596172213554, 0.03752744570374489, -0.05398164689540863, 0.028914302587509155, -0.030421093106269836, -0.036861956119537354, -0.006090988405048847, 0.048711396753787994, -0.017407860606908798, 0.005140127148479223, -0.07136119157075882, -0.07819963991641998, 0.011447953060269356, 0.029129065573215485, 0.15795813500881195, 0.05581556633114815, -0.034768056124448776, 0.19728343188762665, -0.16241514682769775, -0.14312973618507385, -0.02454923652112484, -0.08744555711746216, -0.08062951266765594, -0.02233186922967434, -0.057287778705358505, -0.01043684408068657, -0.04274687170982361, 0.07849334925413132, 0.0060698967427015305, -0.09502366185188293, -0.011229688301682472, 0.012843882665038109, -0.11742006242275238, -0.05791521817445755, 0.05991079658269882, 0.17052480578422546, 0.027244245633482933, 0.23840682208538055, 0.030201606452465057, 0.025681957602500916, -0.21387973427772522, 0.16091392934322357, 0.026794474571943283, 0.04359254240989685, -0.10333042591810226, 0.2717280387878418, 0.021498167887330055, 0.004952951334416866, 0.07565654069185257, -0.1638176143169403, 0.19130314886569977, -0.0919562429189682, -0.07469215989112854, -0.05317925661802292, 0.07101266086101532, 0.021939236670732498, 0.01681079901754856, -0.06861553341150284, 0.014628676697611809, 0.10921259224414825, -0.07554890215396881, -0.1178133487701416, -0.033528272062540054, 0.05564539134502411, -0.020327193662524223, 0.06477131694555283, 0.06558391451835632, -0.15153327584266663, -0.1085422933101654, 0.09811267256736755, 0.0427447073161602, -9.465033493047026e-33, -0.02826361358165741, 0.03198275342583656, -0.017810091376304626, -0.016922373324632645, -0.04883921146392822, -0.03644884377717972, 0.12028024345636368, 0.14622657001018524, 0.03993268311023712, -0.06740635633468628, 0.07554566860198975, 0.08769813179969788, -0.06073922663927078, 0.10511624813079834, -0.006072448566555977, -0.013502570800483227, 0.13830119371414185, -0.09531338512897491, -0.016249775886535645, -0.16155025362968445, 0.0004701041616499424, 0.20155367255210876, -0.13101547956466675, 0.07051566243171692, -0.012680275365710258, 0.13602088391780853, 0.027184883132576942, 0.21277481317520142, 0.07476367056369781, -0.13369734585285187, -0.058608151972293854, -0.07629408687353134, -0.1360706388950348, 0.17194753885269165, -0.010696392506361008, 0.06007510423660278, 0.016355739906430244, -0.16407452523708344, -0.005236751865595579, 0.006176110357046127, 0.18401910364627838, 0.07795082032680511, 0.05600889399647713, 0.036234550178050995, 0.08918709307909012, -0.06201845407485962, 0.02481384016573429, 0.04882252961397171, 0.1927461326122284, -0.017313692718744278, 0.014040972106158733, -0.011145851574838161, -0.05407807230949402, 0.07241012901067734, -0.08582144975662231, 0.08866827189922333, -0.07684609293937683, 0.007765749469399452, -0.06708729267120361, 0.05670769512653351, -0.020413391292095184, 0.0732322633266449, -0.001006745733320713, 0.005380827933549881, -0.07588757574558258, -0.05307001620531082, 0.01476963423192501, 0.005982939153909683, 0.06638283282518387, -0.06579229235649109, 0.05911191925406456, -0.05317454785108566, 0.09968288987874985, -0.06144598498940468, -0.04274895787239075, 0.1101890280842781, -0.051800355315208435, -0.22358499467372894, -0.0836789458990097, -0.03664647415280342, -0.0038891909644007683, -0.0012807175517082214, -0.022238878533244133, 0.014376088976860046, -0.0517999604344368, 0.13678455352783203, -0.01780908927321434, -7.0926733314991e-05, -0.018837081268429756, -0.04749196767807007, 0.003459252417087555, -0.20541122555732727, -0.11561629176139832, 0.0648057758808136, 0.06371475011110306, -9.973030046239728e-08, 0.06720646470785141, -0.11526443064212799, 0.08621947467327118, 0.014373344369232655, 0.20242035388946533, -0.014609584584832191, 0.0317392572760582, 0.015863575041294098, 0.11050369590520859, 0.09664738178253174, 0.09771008789539337, 0.0083505529910326, -0.14777730405330658, 0.07220059633255005, -0.10536807775497437, 0.05304254591464996, -0.060525111854076385, -0.0051619079895317554, -0.01570938155055046, -0.20885106921195984, -0.09749192744493484, 0.050974614918231964, 0.051273636519908905, -0.002391345798969269, 0.04298936203122139, -0.08343540132045746, -0.042079247534275055, -0.01916951686143875, -0.08460450917482376, 0.02522049844264984, 0.06048440560698509, 0.005554836243391037, 0.12211354076862335, 0.09862926602363586, -0.005726229399442673, -0.12607339024543762, 0.054089516401290894, 0.15023235976696014, 0.01897358149290085, 0.006084589287638664, -0.0037232208997011185, 0.03275348246097565, -0.06119494140148163, 0.028417643159627914, -0.05620676279067993, -0.11673780530691147, -0.18399487435817719, -0.08320072293281555, 0.11016994714736938, -0.3154861330986023, 0.11703956127166748, -0.0047089699655771255, -0.016324549913406372, -0.05450963228940964, 0.05755161866545677, 0.06870783865451813, -0.22936572134494781, -0.0348818339407444, -0.123087078332901, -0.04116201773285866, -0.006107937544584274, -0.20989954471588135, 0.02824407070875168, 0.08777908980846405], "changes": {"1wk": -7.220218377648491}}, {"text": "Veteran Allergist and Immunologist Carolyn M. Kwiat, M.D. Joins ENT and Allergy Associates, LLP Bay Ridge West Office ENT & Allergy Associates Thu, Jan 9, 2025, 5:28 PM 2 min read Dr. Kwiat will begin seeing both Adult and Pediatric patients in ENTA's Bay Ridge West office, effective May 1, 2025. Allergist and Immunologist Carolyn M. Kwiat, M.D. Dr. Carolyn Kwiat will begin seeing both Adult and Pediatric patients in ENTA's Bay Ridge West office, effective May 1, 2025. Tarrytown, New York, Jan. 09, 2025 (GLOBE NEWSWIRE) -- ENT and Allergy Associates, LLP (ENTA) is proud to announce the addition of Carolyn M. Kwiat, M.D., to its Bay Ridge West office, located at 9020 Fifth Avenue, Third Floor, Brooklyn, NY 11209. Dr. Kwiat is a highly respected allergist and immunologist with a wealth of experience in the field and will begin seeing both Adult and Pediatric patients in Bay Ridge West, effective May 1, 2025. The Bay Ridge West office of ENTA is equipped with the latest technology and staffed by a team of talented and experienced physicians, nurses, and support staff. Dr. Kwiat will join the following otolaryngologists: Wesley L. Davison, M.D., Ramez Habib, M.D., F.A.C.S., and Christopher Song, M.D., F.A.C.S., along with Audiologists Regina Matskina, Au.D., CCC-A, and Benjamin G. Schultz, Au.D. Dr. Kwiat joins ENTA after serving as an Assistant Professor in the Division of Clinical Immunology in the Department of Medicine and Department of Pediatrics, a part of the Mount Sinai Health System. She received her bachelor\u2019s degree from Boston University, Master of Public Health from the University of Connecticut, and Doctor of Medicine from the University of Connecticut School of Medicine. She completed her Internal Medicine Residency at the Zucker School of Medicine at Hofstra/Northwell, and her Allergy and Immunology Fellowship at the National Jewish Health/University of Colorado in Denver. Outside of her medical practice, Carolyn enjoys spending time with her family at Broadway shows, taking weekend getaways to the mountains, snowboarding, hiking, and unwinding with a great book. Prashant Ponda, M.D., ENTA\u2019s Director of Allergy, stated, \"It is always exciting to bring in established physicians with great reputations, and Dr. Kwiat exemplifies this. We are thrilled to welcome her into the ENTA family, and eager for the patients in the Bay Ridge West area to get to know her.\u201d To learn more about ENTA, find a local office or book an appointment, visit www.entandallergy.com or call 1-855-ENTA-DOC. Attachment Allergist and Immunologist Carolyn M. Kwiat, M.D. CONTACT: Jason Campbell ENT and Allergy Associates, LLP 914-984-2531 jcampbell@entandallergy.com View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "ENTA", "date": "2025-01-09T14:28:00+00:00", "sentiment": {"score": 0.07422267086803913, "confidence": 0.08633942157030106, "probabilities": {"positive": 0.08633942157030106, "negative": 0.012116750702261925, "neutral": 0.9015437960624695}}, "embedding": [-0.0466105118393898, -0.07121709734201431, 0.07681780308485031, -0.07466399669647217, -0.07115397602319717, -0.017075618728995323, -0.017972899600863457, 0.11618457734584808, 0.005479680374264717, 0.0689164325594902, -0.053111281245946884, -0.0487004891037941, 0.03400557488203049, 0.10831107199192047, -0.03459151089191437, 0.143808051943779, 0.0941944345831871, -0.01288587599992752, -0.0418272390961647, -0.04342139512300491, -0.013397902250289917, 0.07838303595781326, 0.09690555930137634, -0.02866479940712452, -0.049082498997449875, 0.041809648275375366, -0.07665503025054932, -0.06771238148212433, -0.16253548860549927, -0.01896328292787075, -0.1219366192817688, 0.011758100241422653, -0.0512116402387619, -0.005513235926628113, 0.033645812422037125, -0.0044541023671627045, -0.09314773231744766, 0.13777825236320496, -0.033724963665008545, 0.10443814098834991, 0.043065350502729416, 0.04046913608908653, -0.1465475857257843, -0.026196427643299103, -0.10902710258960724, -0.12609252333641052, -0.11590534448623657, -0.048551782965660095, 0.034672994166612625, 0.10847391188144684, 0.02732926420867443, -0.05798301100730896, 0.002408037893474102, 0.13941961526870728, -0.04583218693733215, -0.004721098579466343, -0.053132593631744385, -0.04205923527479172, 0.05500873550772667, -0.03780317306518555, -0.047140419483184814, -0.08995985239744186, -0.03798922896385193, 0.013571004383265972, 0.027170760557055473, -0.005269018467515707, 0.06680059432983398, 0.00873554963618517, 0.023292947560548782, -0.11034146696329117, 0.016311898827552795, 0.01626160554587841, -0.04014822840690613, 0.20281994342803955, 0.1342380791902542, 0.07921537756919861, 0.14732566475868225, -0.013502450659871101, 0.059699125587940216, -0.018356211483478546, 0.0726216658949852, 0.1875338852405548, 0.0782778412103653, -0.060507483780384064, -0.0024057698901742697, -0.032754164189100266, -0.09630326181650162, 0.07686949521303177, -0.04030802473425865, -0.03241152688860893, 0.1526455283164978, -0.08032207936048508, -0.00934517290443182, 0.009895509108901024, 0.10635364055633545, -0.023971470072865486, -0.0818222165107727, 0.006454234942793846, -0.020826958119869232, -0.03694041445851326, -0.10172750055789948, -0.11858240514993668, -0.04554770514369011, -0.02409067004919052, -0.004356358665972948, -0.07702872902154922, 0.05404654145240784, -0.14010147750377655, -0.04733632504940033, -0.044540885835886, -0.08172757178544998, 0.03125162422657013, 0.14437708258628845, 0.05587686970829964, -0.0007680924609303474, 0.09736241400241852, 0.015251405537128448, -0.00535767525434494, 0.0661800280213356, -0.04152596741914749, 0.06567378342151642, -0.0876251757144928, 0.012317619286477566, 0.03529287129640579, 0.12160791456699371, 0.07446460425853729, -0.08206947147846222, 9.893158086508104e-33, 0.03449508175253868, 0.016323572024703026, 0.13225243985652924, 0.05174050107598305, 0.00010263978037983179, 0.11339907348155975, 0.00976494513452053, -0.005557614844292402, -0.06408645212650299, -0.0713382363319397, -0.2009078860282898, 0.09198108315467834, 0.058407485485076904, -7.758731953799725e-05, -0.1633470058441162, 0.11411510407924652, -0.06925554573535919, 0.04693705588579178, -0.14310240745544434, 0.033397842198610306, 0.014541185460984707, 0.10429546236991882, -0.050789713859558105, 0.06402851641178131, -0.09967444837093353, 0.06287464499473572, -0.022169897332787514, 0.03539536893367767, 0.06723584234714508, -0.017773889005184174, -0.06412317603826523, -0.03469136357307434, 0.011620909906923771, 0.015455838292837143, -0.04245960712432861, 0.04843799024820328, -0.019838795065879822, 0.01692967303097248, 0.051391925662755966, -0.13034012913703918, -0.03991934657096863, 0.07860058546066284, -0.06832003593444824, 0.011718573048710823, 0.025802873075008392, -0.09308595210313797, -0.021410975605249405, 0.015067271888256073, 0.10263937711715698, -0.05603591352701187, 0.10975198447704315, -0.028047002851963043, -0.11162173748016357, -0.06254832446575165, -0.00680609280243516, 0.10165295749902725, 0.045614637434482574, -0.0012234309688210487, -0.0063134729862213135, 0.07132847607135773, 0.09098891913890839, 0.031855084002017975, -0.0446348711848259, 0.024058550596237183, -0.0367138497531414, -0.03496529161930084, -0.052409254014492035, -0.045883484184741974, -0.008148040622472763, -0.08548516035079956, 0.001613102969713509, -0.09170704334974289, 0.025882771238684654, 0.025080960243940353, 0.0014489851891994476, -0.06617199629545212, 0.06373372673988342, 0.17689308524131775, -0.11711044609546661, 0.023812539875507355, -0.02261262759566307, 0.07223664969205856, 0.034925829619169235, 0.11305348575115204, -0.0007769539952278137, -0.17623968422412872, -0.04685888811945915, -0.0729658231139183, -0.0410122275352478, 0.009158744476735592, 0.09883501380681992, 0.05843839421868324, -0.06927565485239029, 0.13002662360668182, -0.06656477600336075, -1.2175417102828038e-32, -0.004995562136173248, -0.044237565249204636, 0.04053935408592224, -0.0954248458147049, -0.030803631991147995, 0.13505913317203522, 0.13885703682899475, 0.07129808515310287, 0.0691971555352211, -0.12237223237752914, 0.11425518989562988, -0.02163393795490265, -0.030691441148519516, -0.03296434506773949, -0.02962629124522209, 0.03889857232570648, -0.049391064792871475, 0.12404805421829224, -0.16471153497695923, -0.03261279687285423, -0.02612205222249031, 0.049563996493816376, -0.05462714284658432, 0.015726786106824875, 0.017979390919208527, 0.052091535180807114, 0.11012402176856995, 0.0703720897436142, 0.020032376050949097, -0.026132920756936073, -0.07564855366945267, 0.02234296314418316, -0.10180729627609253, -0.03820233792066574, 0.04602101445198059, -0.007761862128973007, 0.010475791990756989, -0.09381654113531113, -0.14682725071907043, -0.08308261632919312, 0.0200117826461792, -0.01777503453195095, 0.03791738674044609, -0.00707051157951355, 0.08450975269079208, 0.09653349220752716, 0.10866701602935791, -0.11019925773143768, -0.048042573034763336, 0.030585002154111862, 0.0032167143654078245, 0.023080410435795784, -0.0030892682261765003, 0.046827271580696106, -0.031521305441856384, 0.0497848317027092, 0.10605664551258087, -0.023923184722661972, 0.03306853026151657, -0.07961338013410568, 0.007049333304166794, -0.05751865357160568, -0.034010179340839386, -0.028107598423957825, 0.06485264003276825, 0.05859049782156944, 0.0438438281416893, -0.06288252770900726, 0.049308616667985916, -0.025209207087755203, -0.12795591354370117, -0.08587955683469772, -0.15865084528923035, -0.23066353797912598, -0.013697464019060135, 0.04227706789970398, -0.08113812655210495, -0.07475580275058746, -0.055257491767406464, -4.432396963238716e-05, -0.09265446662902832, -0.031913381069898605, -0.012338187545537949, 0.09296149015426636, 0.03178290277719498, 0.008973409421741962, 0.041936665773391724, -0.0799129456281662, -0.005023060366511345, 0.09865812212228775, -0.08354544639587402, -0.06240298971533775, -0.09999945759773254, 0.0698668584227562, 0.08026589453220367, -1.0094748859046376e-07, 0.15064814686775208, 0.013075634837150574, -0.03307246044278145, 0.0060285963118076324, -0.06441502273082733, -0.08969743549823761, -0.09782890975475311, 0.11288264393806458, -0.03807877004146576, 0.13262829184532166, 0.08469913899898529, 0.12582114338874817, 0.026057085022330284, -0.05438618361949921, 0.11241482198238373, 0.005558650940656662, -0.02391989529132843, 0.03541941940784454, -0.035303205251693726, -0.06769035756587982, -0.10025762766599655, 0.016404075548052788, 0.0374632254242897, 0.05532225966453552, -0.001437412342056632, -0.06029778718948364, 0.020154081284999847, 0.12104502320289612, 0.12365119159221649, -0.07285761833190918, -0.020028915256261826, -0.06285388767719269, -0.04431399330496788, -0.0646815076470375, -0.06880774348974228, -0.09286366403102875, -0.06390025466680527, 0.017230432480573654, 0.0931006520986557, 0.17876875400543213, -0.04475750774145126, -0.01169203594326973, -0.032183919101953506, 0.04899773746728897, 0.0014949981123209, -0.12367132306098938, 0.046336181461811066, 0.013944584876298904, 0.08172576129436493, -0.09412527084350586, -0.08778397738933563, -0.11851029843091965, 0.03754128888249397, -0.12166434526443481, -0.11934977769851685, 0.1252143383026123, -0.018966320902109146, -0.09714270383119583, 0.029026567935943604, 0.06844726949930191, -0.06266218423843384, -0.04667167365550995, -0.012404091656208038, 0.0894480049610138], "changes": {"1wk": -5.304518130303759}}, {"text": "Enanta Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference Business Wire Wed, Jan 8, 2025, 3:00 PM 1 min read In This Article: ENTA +1.17% WATERTOWN, Mass., January 08, 2025 --( BUSINESS WIRE )-- Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for virology and immunology indications, today announced that Jay R. Luly, Ph.D., President and Chief Executive Officer, will present at the 43 rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2024 at 8:15 a.m. PT in San Francisco, CA. A live webcast of the event will be accessible by visiting the \"Events and Presentations\" section on the \"Investors\" page of Enanta\u2019s website at www.enanta.com . A replay of the webcast will be available following the presentation and will be archived for at least 30 days. About Enanta Pharmaceuticals, Inc. Enanta is using its robust, chemistry-driven approach and drug discovery capabilities to become a leader in the discovery and development of small molecule drugs with an emphasis on indications in virology and immunology. Enanta\u2019s clinical programs are currently focused on respiratory syncytial virus (RSV) and its earlier-stage immunology pipeline aims to develop treatments for inflammatory diseases by targeting key drivers of the type 2 immune response, including KIT and STAT6 inhibition. Glecaprevir, a protease inhibitor discovered by Enanta, is part of one of the leading treatment regimens for curing chronic hepatitis c virus (HCV) infection and is sold by AbbVie in numerous countries under the tradenames MAVYRET \u00ae (U.S.) and MAVIRET \u00ae (ex-U.S.) (glecaprevir/pibrentasvir). A portion of Enanta\u2019s royalties from HCV products developed under its collaboration with AbbVie contribute ongoing funding to Enanta\u2019s operations. Please visit www.enanta.com for more information. View source version on businesswire.com: https://www.businesswire.com/news/home/20250108518953/en/ Contacts Media and Investors Contact: Jennifer Viera 617-744-3848 jviera@enanta.com View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "ENTA", "date": "2025-01-08T12:00:00+00:00", "sentiment": {"score": 0.2512432304210961, "confidence": 0.25804781913757324, "probabilities": {"positive": 0.25804781913757324, "negative": 0.006804588716477156, "neutral": 0.7351476550102234}}, "embedding": [-0.05991209298372269, -0.12280967086553574, -0.10627530515193939, -0.1098601371049881, 0.03970402106642723, 0.03271158039569855, -0.07124263048171997, 0.19108402729034424, 0.020220767706632614, 0.14748674631118774, -0.03906607627868652, 0.034611597657203674, 0.038783516734838486, 0.11751972883939743, 0.02356504276394844, 0.05971989780664444, -0.010524932295084, 0.02795395255088806, -0.1019400954246521, 0.013055127114057541, 0.023596543818712234, 0.08817297965288162, 0.01622253842651844, 0.011594454757869244, -0.08459308743476868, 0.0758950486779213, -0.07381297647953033, 0.04365309327840805, -0.127707377076149, -0.08668158948421478, -0.047998249530792236, 0.06509900838136673, 0.033852141350507736, -0.07368266582489014, 0.010878972709178925, 0.009382804855704308, -0.11386653780937195, 0.07782372087240219, -0.016643725335597992, -0.1390821933746338, -0.05020155757665634, -0.004313107579946518, -0.11683037132024765, -0.004465453326702118, 0.04427102953195572, -0.17050565779209137, -0.0335853137075901, 0.06402704119682312, -0.00041754497215151787, 0.07703904062509537, -0.0398271307349205, -0.07667866349220276, -0.005753934383392334, 0.0678425207734108, -0.03563488647341728, -0.01662166602909565, -0.18718987703323364, -0.1583920419216156, 0.01573055610060692, -0.03098442777991295, 0.006956387311220169, -0.032065633684396744, -0.01037079468369484, -0.007052326574921608, 0.05243711173534393, -0.06712815910577774, 0.1604151725769043, 0.07302658259868622, -0.04619590938091278, -0.02776060625910759, -0.007280619814991951, -0.059466440230607986, -0.0774492621421814, 0.20497746765613556, -0.025208652019500732, 0.128631591796875, 0.1638762503862381, 0.038010962307453156, 0.09308910369873047, -0.004722584970295429, 0.12543454766273499, 0.06635482609272003, 0.0837990939617157, 0.12053769826889038, -0.005136845167726278, 0.026797711849212646, -0.004633284639567137, 0.0838465467095375, 0.10154019296169281, -0.018060842528939247, 0.09860499948263168, -0.03484340012073517, 0.0036007496528327465, -0.007605531252920628, 0.02128426358103752, 0.01243849378079176, -0.11568313837051392, 0.06994740664958954, 0.03591255843639374, 0.012737568467855453, -0.03127184510231018, -0.045909278094768524, -0.08517804741859436, -0.06109432131052017, -0.016312245279550552, -0.004613439552485943, 0.13022762537002563, 0.030745450407266617, 0.0454343780875206, -0.006162270437926054, -0.11188386380672455, 0.003292154986411333, 0.058836162090301514, -0.01621011085808277, 0.01310158334672451, 0.23687468469142914, 0.02504499815404415, 0.09742811322212219, 0.12061148881912231, -0.07995585352182388, 0.10071519017219543, 0.0502408891916275, 0.09110866487026215, -0.09744367003440857, 0.007789035327732563, 0.05039013549685478, -0.050901591777801514, 5.9055616609922746e-33, 0.029553230851888657, -0.0287772286683321, 0.14635059237480164, 0.12373632937669754, 0.1345636397600174, 0.0373426154255867, 0.013587025925517082, 0.014261533506214619, -0.16825494170188904, -0.11884574592113495, -0.16939367353916168, 0.07213588058948517, 0.05431504547595978, 0.07439380884170532, -0.14079149067401886, -0.004808927420526743, -0.04911937192082405, 0.0031984392553567886, -0.07298528403043747, -0.014747516252100468, -0.044070325791835785, -0.000423334538936615, 0.03854191303253174, 0.07763808965682983, -0.07568435370922089, 0.052053794264793396, -0.02326854318380356, 0.057890959084033966, 0.09181801229715347, 0.00034447479993104935, -0.08270139992237091, 0.11145903170108795, -0.03804519772529602, -0.020213305950164795, 0.0082921851426363, -0.08201542496681213, -0.05199073255062103, -0.09250792860984802, 0.035120293498039246, 0.029485413804650307, 0.06845726072788239, 0.1047157496213913, -0.17749261856079102, -0.02741304226219654, 0.022989148274064064, -0.058603234589099884, -0.06490609049797058, 0.07578422129154205, -0.01495514065027237, 0.017683569341897964, 0.11307026445865631, 0.012847313657402992, -0.034423962235450745, -0.16637828946113586, 0.03515835106372833, 0.05508176609873772, -0.0597442165017128, 0.015729721635580063, 0.11070448160171509, 0.09814037382602692, -0.024378929287195206, 0.07922326773405075, -0.0035172905772924423, 0.11980216205120087, -0.05773105472326279, 0.03657139092683792, -0.08039379119873047, -0.07220890372991562, -0.048436813056468964, 0.08283532410860062, -0.004133520647883415, 0.048131875693798065, 0.08022414147853851, -0.014635920524597168, 0.15613844990730286, -0.11177614331245422, 0.023666344583034515, 0.08506114035844803, -0.048234254121780396, 0.005197098478674889, -0.06438261270523071, 0.02072915993630886, -0.053527988493442535, 0.18917250633239746, -0.07859968394041061, -0.15919610857963562, -0.04216231033205986, -0.009215231984853745, -0.08152839541435242, -0.028783896937966347, 0.07396337389945984, -0.019151516258716583, -0.02315566875040531, 0.064435213804245, -0.022051502019166946, -6.448679724006512e-33, 0.05374499410390854, -0.04414523392915726, 0.009815763682126999, -0.03837186098098755, -0.004084643442183733, 0.1501273363828659, 0.11437764018774033, -0.06512103974819183, 0.17393288016319275, -0.08034951984882355, 0.08991847932338715, 0.008824234828352928, -0.008566257543861866, -0.021425163373351097, -0.01666826568543911, 0.004168039653450251, 0.035910118371248245, -0.09556752443313599, -0.15454763174057007, 0.00972264539450407, 0.044088736176490784, 0.10914908349514008, -0.016378197818994522, -0.05531804636120796, 0.05111496523022652, 0.0037592421285808086, 0.08878621459007263, 0.09895716607570648, 0.005529707297682762, -0.038039255887269974, -0.0628589391708374, 0.05067095905542374, -0.23382516205310822, 0.028287310153245926, -0.047695353627204895, 0.07922381907701492, 0.12489738315343857, -0.1790207475423813, -0.023482197895646095, -0.13090692460536957, -0.023237962275743484, 0.03885902091860771, -0.10503752529621124, 0.056831855326890945, 0.02168119139969349, 0.10807134211063385, 0.024443244561553, 0.05798104777932167, 0.03588244318962097, -0.01346657332032919, 0.02056100033223629, -0.05184926092624664, -0.04465146362781525, -0.016990412026643753, 0.023234695196151733, -0.003958860412240028, -0.019629299640655518, -0.0735449343919754, -0.02588258683681488, 0.10669243335723877, 0.05833561718463898, 0.032359637320041656, -0.06101048365235329, -0.0738145262002945, 0.00796450674533844, 0.08417908847332001, 0.11614476144313812, 0.08605597913265228, 0.07607223093509674, -0.14302341639995575, -0.011840885505080223, -0.06621803343296051, 0.03667396679520607, -0.056427039206027985, -0.03867403417825699, 0.03428754210472107, -0.0302997138351202, -0.22435742616653442, -0.08665414154529572, -0.06397784501314163, -0.059540264308452606, -0.07124597579240799, -0.0513155423104763, 0.019273312762379646, 0.060188744217157364, 0.046453751623630524, 0.03250977769494057, 0.033674053847789764, 0.021108807995915413, 0.12290609627962112, -0.09021119773387909, -0.08560338616371155, -0.03161802887916565, 0.18029828369617462, 0.06331263482570648, -9.982701243416159e-08, 0.15201786160469055, -0.10649752616882324, -0.008571473881602287, -0.08688320219516754, -0.05764763802289963, 0.05050242692232132, -0.03783426061272621, 0.03535183519124985, 0.14314521849155426, 0.11426019668579102, 0.05415792018175125, 0.13051737844944, -0.00557706831023097, 0.04539579153060913, -0.005657107103615999, 0.08461879938840866, -0.043537553399801254, 0.04318850859999657, -0.10602768510580063, -0.06704968214035034, -0.06889279186725616, -0.011565916240215302, -0.07166738063097, -0.026064855977892876, 0.0477733314037323, -0.19844292104244232, -0.04827522486448288, -0.006159359589219093, 0.0074230581521987915, -0.17564427852630615, -0.1175304651260376, -0.05276273563504219, 0.09803624451160431, 0.00036793947219848633, -0.09879065304994583, -0.10788748413324356, 0.03945149853825569, -0.04147307202219963, 0.0712415874004364, 0.05385296791791916, 0.062341731041669846, 0.010520242154598236, -0.0415545292198658, -0.056277357041835785, -0.06402101367712021, -0.03293956071138382, -0.07792672514915466, 0.038155071437358856, -0.026503661647439003, -0.08474753797054291, -0.06865549832582474, 0.01893908530473709, 0.05138514190912247, -0.06312800943851471, -0.07017403841018677, 0.1628715991973877, -0.04999842494726181, -0.12169454991817474, 0.10646025091409683, -0.11074420809745789, -0.037747547030448914, -0.04612639546394348, 0.06473289430141449, 0.02782767079770565], "changes": {"1wk": -6.201544656725289}}, {"text": "Parallel ENT & Allergy adds Allergy & Asthma Associates of Michigan as a Parallel supported practice PR Newswire Tue, Jan 7, 2025, 6:58 PM 3 min read ROYAL OAK, Mich. , Jan. 7, 2025 /PRNewswire/ -- Parallel ENT & Allergy has added Allergy & Asthma Associates of Michigan as a Parallel supported practice. Parallel will provide non-clinical, practice management services to provide\u00a0the highest-quality patient care. With the addition of Allergy &\u00a0Asthma Associates of Michigan , Parallel is now supporting 100 providers and 459 total employees across 25 locations in five states. Parallel ENT & Allergy has added Michigan ENT & Allergy Specialists as a Parallel supported practice. (PRNewsfoto/Parallel ENT & Allergy) Founded in 1990, Allergy & Asthma Associates of Michigan specializes in the diagnosis and management of asthma, allergy, sinus and immune conditions including allergic rhinitis, sinusitis, atopic dermatitis, food allergies, drug allergies, anaphylaxis, conjunctivitis, immunodeficiency disorders\u00a0and many other allergic conditions. The practice offers multiple services including allergy skin,\u00a0patch testing, pulmonary function testing, allergen immunotherapy and adjunctive biological injection therapy.\u00a0The practice has three office locations in Royal Oak , Sterling Heights and Livonia, Michigan . The board-certified physicians are on staff at Corewell Health William Beaumont\u00a0University\u00a0Hospitals in Royal Oak and Troy Michigan . \"Allergy & Asthma Associates of Michigan provides best-in-class asthma, allergy and immunology care to the greater Detroit region. Parallel is thrilled to support the practice with shared services including human resources, IT, finance, revenue cycle management, digital and reputation management services. Together, we are confident we can continue to grow and deliver best-in-class patient care,\" said Neil Hockstein , M.D. at ENT and Allergy of Delaware and a member of the Board at Parallel ENT & Allergy. \"Joining the Parallel ENT & Allergy practice network is a great partnership opportunity for Allergy & Asthma Associates of Michigan . Parallel has the right expertise and a great culture to support non-clinical operations. With Parallel at our side, we have even more resources, capital and Shared Services support to continue to deliver the best possible care and overall experience for patients,\" said practice leader Amrish Patel , M.D. Parallel ENT & Allergy is backed by\u00a0Trinity Hunt Partners, a growth-oriented private equity firm with deep healthcare experience. Physician Growth Partners served as the exclusive transaction advisor to Allergy &\u00a0Asthma Associates of Michigan . About Parallel ENT & Allergy Parallel ENT & Allergy is a physician-centric practice management organization for ENT and allergy practices. Parallel provides strategic, operational, and administrative support, so physicians can spend less time worrying about the business of medicine and more time caring for their patients. To learn more about Parallel ENT & Allergy, or to inquire about becoming a supported practice, visit https://parallelenta.com . Story Continues About Trinity Hunt Partners Trinity Hunt Partners is a growth-oriented private equity firm with over $2 billion of assets under management focused on building leading business, healthcare, and consumer services companies. Trinity Hunt's mission is to provide the talent and strategic, operational, and financial capabilities needed to build entrepreneurial services companies into market leaders. Trinity Hunt was ranked eighth amongst all firms in North America on HEC-Dow Jones' most recent Top Small-Cap Buyout Firms List (2023), which ranks firms based on their performance for investors across funds raised over a 10-year period [1] . For more information, visit www.trinityhunt.com . [1]Revealed: The top 20 global small-cap private equity firms ; Trinity Hunt Partners was ranked 8th amongst all firms in North America on the most recent HEC-Dow Jones Top Small-Cap Buyout Firms List (2023), which ranked firms based on their performance across funds raised over a 10-year period between 2010 and 2019. In total, performance data was analyzed across 632 PE firms through data sourced from Prequin, a third-party database neither managed by nor affiliated with Trinity Hunt Partners, as well as data sourced directly to HEC/Dow Jones. Neither HEC nor Dow Jones is affiliated with Trinity Hunt Partners, nor do they invest in any investment vehicle sponsored by Trinity Hunt Partners. Press Contact: Suz Murphy VP Digital Patient Experience & Marketing Parallel ENT & Allergy smurphy@parallelenta.com 630.667.7587 Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/parallel-ent--allergy-adds-allergy--asthma-associates-of-michigan-as-a-parallel-supported-practice-302338555.html SOURCE Parallel ENT & Allergy View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "ENTA", "date": "2025-01-07T15:58:00+00:00", "sentiment": {"score": 0.546812916174531, "confidence": 0.5564488172531128, "probabilities": {"positive": 0.5564488172531128, "negative": 0.00963590107858181, "neutral": 0.43391522765159607}}, "embedding": [-0.131578728556633, -0.18877854943275452, 0.08521835505962372, -0.12481728941202164, 0.002669617533683777, -0.02438291907310486, -0.0492682158946991, 0.19017204642295837, -0.12681202590465546, 0.04334314167499542, 0.012397633865475655, 0.0173567533493042, 0.09800335764884949, 0.0966748595237732, 0.09099790453910828, 0.09510913491249084, 0.004715051501989365, 0.14075687527656555, -0.06206495687365532, -0.11411817371845245, 0.02015238255262375, 0.044580813497304916, -0.05234089493751526, 0.031208179891109467, -0.1241520419716835, 0.05259396508336067, -0.15037232637405396, -0.14991629123687744, -0.2494593858718872, -0.07283806055784225, -0.007496866397559643, -0.10686604678630829, -0.08107738196849823, 0.01888221502304077, 0.026249343529343605, -0.06609661877155304, -0.16285379230976105, 0.16654638946056366, -0.09892944991588593, -0.03945178538560867, -0.1257021725177765, 0.08461377024650574, -0.1591579169034958, -0.035319626331329346, -0.12760229408740997, -0.08413277566432953, -0.03374577313661575, -0.013701546005904675, 0.036943428218364716, 0.12180609256029129, -0.017297405749559402, -0.120634064078331, 0.015275293961167336, 0.03921694681048393, 0.05469365417957306, 0.10100099444389343, -0.11272826790809631, -0.05605051666498184, -0.2545066177845001, 0.0406339168548584, -0.03808848187327385, -0.1399196982383728, -0.11763337254524231, 0.03229176253080368, 0.08905471861362457, 0.0439554899930954, 0.10808493196964264, 0.17210298776626587, -0.08522698283195496, -0.21416470408439636, 0.053508151322603226, -0.12373629957437515, 0.028751522302627563, 0.2651972770690918, 0.27720069885253906, 0.14104580879211426, 0.2078344225883484, 0.11736322939395905, 0.10303331166505814, -0.15615300834178925, 0.06378407031297684, 0.21782729029655457, 0.1443944126367569, -0.047698553651571274, 0.04137135669589043, -0.05986933782696724, -0.15632364153862, 0.1590355932712555, -0.03780485689640045, -0.06801068782806396, 0.1596750020980835, -0.03674731403589249, -0.08874724805355072, 0.02882450632750988, 0.2644738554954529, 0.07905398309230804, -0.1874818056821823, 0.06571164727210999, -0.04888347163796425, -0.025109274312853813, -0.044199783354997635, -0.1405700147151947, 0.042743030935525894, -0.02147224172949791, 0.14986220002174377, -0.10398998111486435, 0.1389368772506714, -0.22338196635246277, 0.00131138414144516, 0.020383495837450027, 0.0861813947558403, 0.06634029746055603, 0.13195368647575378, 0.014524528756737709, -0.08707498759031296, 0.11504632234573364, 0.06143638491630554, -0.005275666248053312, 0.21859899163246155, -0.008532509207725525, 0.0028209106530994177, 0.015900984406471252, 0.021469926461577415, -0.012269370257854462, 0.14903338253498077, 0.14028778672218323, -0.027607282623648643, 7.30289971380556e-33, -0.05541227012872696, 0.1278926134109497, 0.130545973777771, -0.03531939163804054, -0.031243007630109787, 0.06968627870082855, 0.0799107775092125, 0.06450919806957245, -0.039116840809583664, 0.038134872913360596, -0.22414755821228027, 0.11221306025981903, 0.0042158509604632854, 0.15644606947898865, -0.24600985646247864, -0.11369311809539795, -0.018158942461013794, 0.10123825818300247, -0.07182741910219193, 0.10543043911457062, -0.18075187504291534, 0.03224571421742439, -0.2035410851240158, 0.16706980764865875, -0.20389732718467712, 0.06009979918599129, 0.003801736980676651, -0.014931962825357914, 0.11347930878400803, -0.0487833246588707, 0.0005873627960681915, 0.06728661060333252, -0.0960279181599617, 0.08719566464424133, 0.03252973407506943, -0.039005033671855927, 0.03469758853316307, -0.013849206268787384, -0.06405745446681976, -0.04450910538434982, -0.16002604365348816, 0.08391618728637695, -0.04064551368355751, -0.1321364790201187, 0.10401467978954315, -0.08726775646209717, -0.1446804702281952, -0.06366930156946182, 0.07334553450345993, -0.03685007244348526, 0.09093450754880905, -0.0603531152009964, -0.024485642090439796, -0.08596527576446533, 0.11385190486907959, 0.21245276927947998, 0.08763761818408966, 0.11870001256465912, 0.17117489874362946, 0.2998911142349243, -0.16078299283981323, -0.03022431768476963, -0.07813973724842072, 0.05412657558917999, -0.0274308193475008, 0.04153239727020264, -0.15059794485569, -0.17446890473365784, 0.010034437291324139, 0.14054788649082184, -0.018922075629234314, -0.03898245096206665, -0.023696471005678177, 0.0927395299077034, -0.011313351802527905, -0.12211419641971588, -0.0399310328066349, 0.22572772204875946, -0.13944707810878754, 0.014053565450012684, -0.1021546870470047, 0.131858229637146, -0.022326989099383354, 0.09482535719871521, 0.045705921947956085, -0.02264345996081829, -0.017511120066046715, 0.004288939759135246, -0.03361375629901886, 0.004886644426733255, 0.14238139986991882, 0.12703150510787964, 0.01242988184094429, 0.21791866421699524, 0.011606873944401741, -5.7709389051483214e-33, -0.14994865655899048, -0.03495989367365837, -0.021972745656967163, 0.024381466209888458, -0.017868153750896454, 0.15520095825195312, 0.1258614957332611, 0.025621475651860237, 0.008080653846263885, -0.05478695407509804, 0.14366713166236877, -0.01057865284383297, -0.04442271590232849, -0.012686497531831264, -0.104915551841259, 0.1501268595457077, 0.011083721183240414, 0.055674754083156586, -0.148416206240654, 0.07877703756093979, 0.03532404452562332, 0.1567298173904419, 0.02959619089961052, 0.08509071171283722, -0.023541750386357307, 0.04324384778738022, -0.008240874856710434, 0.09228362888097763, 0.20062753558158875, -0.09359649568796158, -0.0449337475001812, -0.02958277054131031, -0.16046489775180817, 0.07709448039531708, 0.016087686643004417, -0.07471656054258347, -0.038927964866161346, 0.007620322052389383, -0.14542599022388458, -0.08645372837781906, 0.014451263472437859, -0.14068427681922913, -0.04025417938828468, 0.09604711085557938, 0.01785861700773239, 0.11633814126253128, -0.049169622361660004, -0.21715319156646729, -0.18438725173473358, 0.1004699170589447, -0.05964295566082001, -0.09822946041822433, 0.09213373064994812, 0.08838528394699097, 0.05230730399489403, -0.09212418645620346, 0.23866352438926697, -0.1398855298757553, -0.08023299276828766, -0.006440548226237297, 0.10107478499412537, -0.047219157218933105, -0.04919788986444473, 0.05202268809080124, 0.104714535176754, 0.08396971970796585, 0.09091357886791229, -0.09384240955114365, 0.02892335131764412, 0.02829522266983986, -0.24436579644680023, -0.018981214612722397, -0.1087389886379242, -0.27968117594718933, 0.0264132022857666, 0.05192659795284271, 0.05395654961466789, -0.1373642385005951, -0.07891134917736053, 0.06533295661211014, -0.10942652821540833, -0.08958694338798523, -0.013364119455218315, 0.0976267158985138, -0.015349452383816242, 0.003934619948267937, 0.1577625870704651, -0.018379250541329384, 0.12525391578674316, 0.033830199390649796, -0.10083532333374023, 0.14189958572387695, -0.10193827748298645, 0.06361941993236542, 0.04392661899328232, -1.0008422179907939e-07, 0.09570351243019104, -0.12922325730323792, -0.03069245256483555, -0.004635577090084553, -0.06578139215707779, -0.09533455967903137, -0.0939207375049591, 0.06801372766494751, -0.15484744310379028, 0.23337434232234955, 0.0706108808517456, 0.10240858793258667, -0.038630835711956024, -0.020610300824046135, 0.13298240303993225, -0.0796416774392128, -0.024041054770350456, 0.09901104122400284, -0.05678332597017288, 0.07747267186641693, -0.13268126547336578, 0.15302544832229614, -0.10476262122392654, 0.04976687580347061, 0.021505082026124, 0.008359568193554878, 0.09441553056240082, 0.07603271305561066, 0.20996814966201782, -0.14245766401290894, -0.11844149231910706, -0.13920900225639343, -0.08694864809513092, -0.0464562326669693, -0.20261171460151672, -0.10764015465974808, 0.17571833729743958, 0.08284270763397217, 0.1375492811203003, 0.04295865073800087, -0.047592829912900925, -0.061934325844049454, 0.12904644012451172, 0.029750343412160873, 0.03807755559682846, -0.12935885787010193, -0.10558512806892395, -0.024451488628983498, 0.12501861155033112, -0.10929764807224274, -0.12181800603866577, -0.027175510302186012, 0.17727576196193695, -0.08058276772499084, -0.2154141068458557, 0.05340748280286789, -0.05713238567113876, -0.12220552563667297, 0.11926649510860443, 0.0812339186668396, -0.0514945387840271, -0.16854220628738403, -0.08077085018157959, 0.10439004004001617], "changes": {"1wk": -10.204076577395496}}, {"text": "Enanta Pharmaceuticals (ENTA) Moves 7.2% Higher: Will This Strength Last? Zacks Equity Research Mon, Dec 23, 2024, 5:43 PM 2 min de lecture Dans cet article: ENTA +1.17% NBIX -1.13% Enanta Pharmaceuticals (ENTA) shares rallied 7.2% in the last trading session to close at $6.28. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 37.1% loss over the past four weeks. The company\u2019s lead candidate, zelicapavir, an oral, N-protein inhibitor, is being evaluated in two ongoing mid-stage studies to treat pediatric and adult patients with respiratory syncytial virus infection. The company also has a developmental portfolio of small-molecule drugs for viral infections. The growing optimism regarding the development of zelicapavir and other pipeline candidates might have driven the share price rally. This biotechnology company is expected to post quarterly loss of $1.15 per share in its upcoming report, which represents a year-over-year change of +27.2%. Revenues are expected to be $17.51 million, down 2.7% from the year-ago quarter. While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. For Enanta Pharmaceuticals, the consensus EPS estimate for the quarter has been revised 7.3% higher over the last 30 days to the current level. And a positive trend in earnings estimate revision usually translates into price appreciation. So, make sure to keep an eye on ENTA going forward to see if this recent jump can turn into more strength down the road. The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Enanta Pharmaceuticals is a member of the Zacks Medical - Drugs industry. One other stock in the same industry, Neurocrine Biosciences (NBIX), finished the last trading session 0.3% higher at $135.42. NBIX has returned 8% over the past month. For Neurocrine , the consensus EPS estimate for the upcoming report has changed -0.6% over the past month to $1.59. This represents a change of +10.4% from what the company reported a year ago. Neurocrine currently has a Zacks Rank of #3 (Hold). Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Enanta Pharmaceuticals, Inc. (ENTA) : Free Stock Analysis Report Neurocrine Biosciences, Inc. (NBIX) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research Afficher les commentaires CGU et Politique de confidentialit\u00e9 Privacy Dashboard Articles recommand\u00e9s", "symbol": "ENTA", "date": "2024-12-23T14:43:00+00:00", "sentiment": {"score": -0.7615147158503532, "confidence": 0.8493536114692688, "probabilities": {"positive": 0.08783889561891556, "negative": 0.8493536114692688, "neutral": 0.06280750036239624}}, "embedding": [-0.030590036883950233, -0.10480114817619324, -0.0548185370862484, -0.07466715574264526, -0.05297418683767319, -0.04454321414232254, -0.002276365179568529, 0.22836482524871826, 0.12194901704788208, 0.13528946042060852, -0.04538251832127571, 0.07189927250146866, -0.012495974078774452, 0.09914639592170715, -0.09209128469228745, 0.04050194472074509, 0.027190912514925003, -0.03510736674070358, -0.1174875944852829, 0.05601948872208595, -0.07625266164541245, 0.04218977317214012, 0.06266633421182632, -0.012785069644451141, 0.07093751430511475, 0.11982996761798859, -0.11727571487426758, 0.03596717119216919, -0.14524750411510468, -0.10185185074806213, -0.07044458389282227, 0.06277245283126831, 0.05013314262032509, -0.09613554179668427, 0.0023151349741965532, -0.07280253618955612, -0.16805559396743774, 0.04201652109622955, 0.10085766762495041, -0.008418325334787369, 0.014330681413412094, 0.03209805116057396, -0.21945098042488098, 0.00022925063967704773, -0.01940304972231388, -0.23168443143367767, -0.07077451050281525, 0.011661143973469734, 0.11316236108541489, 0.10353749990463257, -0.1652684062719345, -0.15772798657417297, -0.014113618060946465, 0.11570575088262558, -0.08696465939283371, 0.05435364693403244, -0.172554612159729, -0.13587138056755066, 0.013414302840828896, 0.04538625478744507, 0.1440211832523346, 0.04939524456858635, 0.039788853377103806, -0.02576029673218727, 0.19133472442626953, -0.0789085254073143, 0.10693877935409546, -0.006499219685792923, -0.10161279141902924, 0.01857754774391651, 0.12251367419958115, -0.046536173671483994, -0.08176924288272858, 0.08612911403179169, -0.19210991263389587, 0.10967019945383072, 0.19662685692310333, 0.06331604719161987, 0.08050015568733215, -0.09204878658056259, 0.13215629756450653, -0.003614897606894374, -0.013892256654798985, 0.029281195253133774, 0.05633339658379555, 0.032900311052799225, 0.13133522868156433, 0.18189504742622375, 0.09110629558563232, 0.007939774543046951, 0.058657627552747726, -0.015363644808530807, 0.05514858663082123, -0.015654396265745163, 0.03022226132452488, 0.06767641752958298, -0.2129250466823578, 0.03899671882390976, -0.03662601485848427, 0.0403110571205616, 0.09857089817523956, 0.03587180748581886, -0.08993291109800339, -0.10528011620044708, -0.07345180213451385, -0.0856490209698677, 0.2162502408027649, -0.028847355395555496, -0.007060471456497908, 0.12176546454429626, -0.1969425082206726, 0.04309121146798134, -0.06185789406299591, 0.054905541241168976, -0.12685230374336243, 0.19651971757411957, 0.015346440486609936, 0.04248226806521416, 0.05323724448680878, 0.041350312530994415, 0.13026884198188782, -0.04086149483919144, 0.09461632370948792, -0.03785630315542221, 0.0265042707324028, 0.10564400255680084, -0.10018792748451233, 9.442685876069956e-33, 0.0018579347524791956, 0.02253863587975502, 0.032499149441719055, 0.04322279989719391, 0.04815242439508438, 0.10097219049930573, 0.09762889891862869, 0.011338195763528347, -0.19239747524261475, -0.15786196291446686, -0.27250364422798157, 0.11705955862998962, -0.003089718520641327, 0.042243946343660355, -0.09975108504295349, -0.06937316060066223, -0.01034086849540472, 0.04515344649553299, 0.0374022014439106, -0.043750278651714325, -0.006893157958984375, -0.0008018352091312408, -0.11582253873348236, 0.07740580290555954, -0.06004101037979126, -0.05099545046687126, -0.19223371148109436, 0.04969504475593567, -0.028481315821409225, -0.010314436629414558, 0.019288700073957443, 0.0365787111222744, -0.07213834673166275, -0.07748056203126907, -0.02143312618136406, -0.11276222765445709, 0.0002880385145545006, 0.012301728129386902, 0.15497475862503052, 0.004041173029690981, -0.003685631789267063, 0.21066483855247498, -0.145624577999115, -0.12009292840957642, -0.028575316071510315, 0.01525021344423294, -0.11120190471410751, 0.014321238733828068, -0.013613974675536156, -0.05187900364398956, -0.0011466816067695618, -0.0135117769241333, -0.04290933161973953, -0.11771659553050995, -0.03521985560655594, 0.04964218661189079, -0.02338847517967224, -0.005936184898018837, 0.02846721187233925, 0.11312013864517212, -0.041200559586286545, 0.15119923651218414, 0.05955643206834793, -0.021414898335933685, -0.1848505139350891, 0.08372862637042999, -0.02716786414384842, -0.023951932787895203, -0.10745876282453537, 0.16290464997291565, -0.04923144727945328, -0.02302413433790207, 0.09285447001457214, -0.06413350999355316, 0.11937117576599121, -0.14323370158672333, -0.08472598344087601, -0.009218680672347546, 0.009514153003692627, 0.027777336537837982, 0.0465954951941967, -0.10524734854698181, -0.012817085720598698, 0.11908388137817383, -0.052212949842214584, -0.09195463359355927, -0.05973215773701668, 0.010859761387109756, -0.024949707090854645, 0.05460507422685623, 0.11445887386798859, -0.013788066804409027, -0.11013534665107727, 0.04885394126176834, 0.04820059984922409, -9.160313765903211e-33, -0.054915428161621094, 0.09034749865531921, -0.0127343088388443, -0.011044370010495186, -0.01832672953605652, 0.12331213057041168, 0.0775069147348404, 0.024536961689591408, 0.07770588994026184, -0.01217641681432724, 0.11619357764720917, 0.06328890472650528, 0.0017673205584287643, -0.0061534736305475235, -0.013770104385912418, 0.01546141691505909, 0.050077732652425766, -0.10248933732509613, 0.05255802720785141, -0.17460578680038452, -0.04635276645421982, 0.1561148762702942, -0.07925867289304733, 0.11382706463336945, 0.04468333721160889, 0.11804609000682831, 0.09138205647468567, 0.11038974672555923, 0.01768440753221512, -0.08947575092315674, -0.09561380743980408, -0.05339185148477554, -0.17462000250816345, 0.17054462432861328, -0.019185906276106834, 0.10025885701179504, 0.05158020928502083, -0.235248863697052, -0.04002853110432625, -0.06286299228668213, 0.077784463763237, 0.1020738035440445, 0.08241883665323257, 0.03960561379790306, 0.045820239931344986, 0.012718931771814823, 0.06900369375944138, -0.02277011051774025, 0.15084776282310486, 0.0426061749458313, 0.0798686146736145, 0.0038406988605856895, -0.11115837097167969, 0.08264447748661041, -0.08317217975854874, 0.09164339303970337, -0.0031004510819911957, -0.0025729937478899956, -0.1296619027853012, 0.04555603861808777, 0.06490257382392883, 0.12414799630641937, -0.0616067573428154, -0.0658944621682167, -0.07953837513923645, 0.023035190999507904, 0.055079713463783264, 0.05253014713525772, 0.0963725745677948, -0.19672724604606628, 0.004974700510501862, -0.09747277200222015, 0.11392638832330704, -0.12365192919969559, -0.034671638160943985, 0.12019231170415878, -0.021117236465215683, -0.22773891687393188, 0.005806035362184048, -0.07471679151058197, -0.05444683879613876, 0.04876137897372246, -0.04789499193429947, 0.021221289411187172, -0.07490504533052444, 0.15158715844154358, 0.0016967484261840582, 0.032063573598861694, -0.08644377440214157, 0.0033885911107063293, -0.030319444835186005, -0.18585652112960815, -0.07877287268638611, 0.06593655049800873, 0.08767814934253693, -1.0002906236650233e-07, 0.13109935820102692, -0.15374788641929626, 0.09042902290821075, 0.05145035684108734, 0.0958276093006134, -0.04816590994596481, 0.06109773367643356, 0.03489453345537186, 0.207479327917099, 0.21579080820083618, 0.1216038390994072, 0.11992643773555756, -0.2049333155155182, 0.12497707456350327, -0.09151619672775269, 0.06990239769220352, -0.08002880215644836, 0.03862687945365906, -0.04754920303821564, -0.1555332988500595, -0.07211053371429443, 0.0865224152803421, 0.03176087141036987, -0.015968618914484978, 0.009943444281816483, -0.1408643126487732, -0.09063741564750671, 0.03927294909954071, 0.018661653622984886, -0.06940352916717529, -0.03384346887469292, -0.05876022204756737, 0.15907800197601318, 0.04073406383395195, -0.04052894562482834, -0.10256944596767426, 0.02918168157339096, 0.024692177772521973, 0.027515921741724014, 0.15054446458816528, 0.04015602171421051, -0.03580328822135925, -0.044800110161304474, -0.017183614894747734, -0.04835401475429535, -0.05388598144054413, -0.11645613610744476, 0.004248311743140221, 0.029466742649674416, -0.25154808163642883, 0.096324123442173, -0.06757476925849915, -0.004819142632186413, -0.0025773742236196995, -0.08506101369857788, 0.08535044640302658, -0.21735873818397522, -0.025083158165216446, -0.01259671337902546, -0.060134779661893845, -0.019375018775463104, -0.2237512469291687, 0.03224347531795502, 0.1148611456155777], "changes": {"1wk": -8.163265153353677, "1mo": -18.6813199152203}}, {"text": "PREMIUM Enanta Pharmaceuticals to Appeal Court Ruling on Patent Infringement Case Against Pfizer MT Newswires Tue, Dec 24, 2024, 3:56 PM 1 min read In This Article: ENTA +1.17% PFE -1.21% Enanta Pharmaceuticals (ENTA) said Tuesday that it will appeal a Massachusetts District Court ruling PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? Sign in Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "ENTA", "date": "2024-12-24T12:56:06+00:00", "sentiment": {"score": 0.039575244300067425, "confidence": 0.05372326448559761, "probabilities": {"positive": 0.05372326448559761, "negative": 0.014148020185530186, "neutral": 0.9321287870407104}}, "embedding": [-0.14832726120948792, -0.0799018070101738, 0.06184781342744827, -0.17923864722251892, 0.08389414101839066, -0.0634489506483078, 0.01846408098936081, 0.15978984534740448, -0.1325865536928177, 0.20526573061943054, 0.13767853379249573, 0.0777353048324585, -0.0952044278383255, 0.0073499055579304695, 0.1371231973171234, 0.14415383338928223, 0.12695267796516418, -0.08097342401742935, 0.0661497414112091, 0.06880202144384384, 0.07172227650880814, 0.02951614372432232, -0.07050725817680359, 0.08052454888820648, -0.07429644465446472, 0.14148911833763123, -0.08208569139242172, 0.11824320256710052, -0.04678564518690109, -0.162624791264534, -0.147416353225708, 0.08743737637996674, 0.09733925759792328, -0.11167943477630615, 0.2063111960887909, -0.12792803347110748, -0.13427375257015228, -0.02189484052360058, 0.07420498877763748, -0.12337565422058105, 0.19521896541118622, -0.1527176797389984, -0.16584178805351257, -0.008274517022073269, 0.07263664901256561, -0.24354740977287292, -0.019303767010569572, 0.04883283004164696, 0.04941723495721817, 0.1462637335062027, -0.08681166917085648, -0.17252059280872345, 0.07044097781181335, -0.13030754029750824, -0.014152300544083118, -0.1912834197282791, 0.002868804382160306, -0.041803743690252304, -0.026024064049124718, -0.0767696425318718, 0.11912329494953156, -0.16467662155628204, -0.1904023289680481, 0.0937831848859787, 0.09116125106811523, -0.02279972843825817, 0.11223943531513214, -0.05507305637001991, -0.10192250460386276, -0.0651840791106224, 0.18014702200889587, 0.02422470971941948, 0.020908260717988014, 0.2585870921611786, -0.13821573555469513, 0.18487979471683502, 0.16313770413398743, 0.09421410411596298, 0.03252792730927467, -0.07063906639814377, 0.21499185264110565, -0.2375430166721344, -0.07948445528745651, -0.0893700048327446, 0.14962424337863922, -0.1031348705291748, 0.006175157148391008, 0.05985838174819946, 0.1360081285238266, -0.03708292171359062, 0.2065412849187851, -0.10526776313781738, 0.008241204544901848, 0.04117971658706665, 0.022278377786278725, -0.0521327443420887, -0.43480366468429565, -0.029279861599206924, -0.1478962004184723, 0.07709872722625732, 0.01654304563999176, 0.1250534951686859, -0.217226043343544, 0.00393535615876317, -0.0018311853054910898, -0.047839999198913574, 0.11863671988248825, 0.11738511174917221, 0.0797521099448204, 0.12168464064598083, -0.16112491488456726, -0.017187682911753654, 0.2689008116722107, 0.11100181937217712, -0.0584786981344223, 0.18124699592590332, 0.09600576758384705, 0.12911635637283325, 0.1471305638551712, -0.19659210741519928, 0.06780478358268738, 0.18271885812282562, 0.003861654084175825, 0.00820915400981903, 0.02012791484594345, 0.03271288052201271, -0.1204742044210434, 1.2408174535182451e-32, -0.03979680314660072, -0.01699945330619812, 0.11757014691829681, -0.13699038326740265, 0.0830269530415535, 0.08276477456092834, 0.0877034142613411, -0.11423400044441223, -0.28682348132133484, -0.2581077814102173, -0.29764384031295776, 0.16182264685630798, 0.029149556532502174, 0.050160910934209824, -0.16764482855796814, -0.03177320584654808, -0.09653640538454056, 0.13787373900413513, 0.1511549949645996, 0.10984258353710175, 0.0006270353915169835, -0.15018601715564728, -0.2007092386484146, 0.08780442178249359, -0.2906495928764343, 0.015464882366359234, 0.022758448496460915, -0.014435690827667713, 0.18161095678806305, 0.032428108155727386, -0.00786038301885128, 0.16510291397571564, 0.07214903831481934, 0.045334313064813614, 0.09506458789110184, -0.04036347568035126, 0.10110815614461899, 0.046577028930187225, 0.059814322739839554, -0.12095219641923904, -0.05986116826534271, 0.05833052471280098, -0.06816644966602325, -0.07183241844177246, -0.10220076143741608, -0.0839182510972023, -0.21822772920131683, -0.04525041580200195, 0.10588666051626205, 0.011013884097337723, 0.14774854481220245, 0.015961114317178726, -0.17262418568134308, -0.050208788365125656, -0.012393849901854992, -0.05208474397659302, -0.10847576707601547, 0.06406041234731674, 0.22475814819335938, 0.07590527087450027, 0.10830478370189667, 0.15222421288490295, 0.06336203962564468, -0.032482411712408066, -0.17462675273418427, 0.07744928449392319, -0.11108165234327316, -0.14167901873588562, -0.11760076135396957, 0.08411815017461777, 0.15677063167095184, -0.015802791342139244, 0.07698734849691391, 0.11082150787115097, -0.11059200018644333, -0.22025613486766815, -0.18298426270484924, 0.16253718733787537, -0.005272718612104654, -0.008565166033804417, 0.022282537072896957, -0.11980181187391281, 0.06407289952039719, 0.1419447362422943, -0.003355342196300626, -0.0837264209985733, -0.044694337993860245, -0.0064691901206970215, -0.015400183387100697, -0.019610026851296425, 0.053159795701503754, -0.04138290137052536, -0.16955098509788513, 0.17282745242118835, 0.07720606029033661, -1.2183625726816624e-32, -0.04200119152665138, -0.18314291536808014, -0.060258153825998306, 0.009500914253294468, -0.21181464195251465, -0.0011579716810956597, -0.05563373863697052, 0.11447653919458389, 0.22349023818969727, 0.07755426317453384, 0.11464357376098633, -0.0022683979477733374, 0.01146747823804617, -0.06236632540822029, 0.10957512259483337, -0.05297796428203583, 0.08683805167675018, -0.10143264383077621, -0.06937732547521591, -0.1238575130701065, 0.1716490536928177, 0.101979561150074, -0.07178175449371338, 0.24185781180858612, -0.016750723123550415, 0.04603330418467522, 0.08326748758554459, 0.010629559867084026, 0.04101168364286423, -0.14115194976329803, -0.15859748423099518, -0.030037514865398407, -0.31066641211509705, 0.1545787751674652, -0.009341958910226822, -0.048295143991708755, 0.31364625692367554, -0.06626392155885696, -0.05689925700426102, -0.02258329838514328, 0.014412656426429749, 0.0600571408867836, -0.08123953640460968, 0.03360316902399063, 0.08348051458597183, -0.09274635463953018, 0.10366971790790558, -0.05968932434916496, 0.03805837780237198, -0.07230915874242783, 0.05850204452872276, -0.018487030640244484, 0.17107748985290527, 0.05850163474678993, -0.1011519730091095, -0.08191562443971634, 0.06607063859701157, -0.05522219464182854, -0.038085900247097015, 0.14248180389404297, 0.21863089501857758, 0.1810377687215805, -0.2738461494445801, -0.19534294307231903, -0.021245764568448067, 0.1368992030620575, 0.07907954603433609, 0.012262117117643356, 0.1404256671667099, -0.07077325880527496, -0.05657818540930748, -0.14745689928531647, -0.10146835446357727, -0.10392557084560394, 0.13644012808799744, 0.2637578547000885, 0.06392351537942886, -0.021240567788481712, -0.1550057977437973, -0.10726010799407959, 0.06960741430521011, -0.11695416271686554, -0.04272880405187607, 0.16771268844604492, -0.03504692390561104, -0.034451358020305634, 0.10111954063177109, -0.1518448144197464, -0.08923935890197754, 0.062111496925354004, -0.13817769289016724, -0.11851278692483902, -0.000698175048455596, 0.22568026185035706, 0.018620086833834648, -9.960917424223226e-08, -0.004657546058297157, -0.1336052566766739, 0.006362134590744972, 0.23005762696266174, -0.12583164870738983, 0.007054064888507128, 0.003278120653703809, 0.0042238919995725155, 0.07391354441642761, -0.09401284903287888, 0.07693569362163544, 0.0619746558368206, -0.002186655066907406, 0.09911715984344482, 0.035926733165979385, 0.03643369674682617, 0.09221035987138748, 0.09007656574249268, -0.019044935703277588, -0.06167355552315712, -0.12588898837566376, 0.012772263959050179, 0.021084338426589966, -0.12666182219982147, -0.0539059191942215, 0.017702383920550346, 0.007231849245727062, -0.09595455229282379, 0.07159961014986038, 0.00030660926131531596, -0.17369931936264038, -0.119893379509449, 0.032967884093523026, 0.07159759849309921, -0.06027727946639061, -0.07658252865076065, -0.050921209156513214, -0.030697496607899666, -0.045944709330797195, -0.006301655899733305, 0.01950717344880104, -0.08195788413286209, -0.013910125009715557, -0.011297780089080334, 0.03810184821486473, -0.022383712232112885, -0.10292617231607437, -0.1105644702911377, 0.04686800763010979, 0.014960494823753834, 0.08970818668603897, -0.04904241859912872, 0.13661296665668488, -0.07329103350639343, -0.06170457974076271, 0.09289903193712234, -0.02381119132041931, -0.12127991765737534, 0.02758091688156128, -0.009960436262190342, 0.29483237862586975, -0.06320702284574509, 0.10920408368110657, 0.22850315272808075], "changes": {"1wk": -4.098360719811497, "1mo": -15.081968699626746}}, {"text": "PREMIUM HC Wainwright Adjusts Price Target on Enanta Pharmaceuticals to $18 From $27, Maintains Buy Rating MT Newswires Tue, Dec 24, 2024, 3:41 PM In This Article: ENTA +1.17% Enanta Pharmaceuticals (ENTA) has an average rating of overweight and mean price target of $15.75, a PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? Sign in Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "ENTA", "date": "2024-12-24T12:41:54+00:00", "sentiment": {"score": 0.07417156919836998, "confidence": 0.08600933104753494, "probabilities": {"positive": 0.08600933104753494, "negative": 0.011837761849164963, "neutral": 0.9021528959274292}}, "embedding": [-0.06351493299007416, -0.10238687694072723, -0.08891189843416214, 0.043493933975696564, 0.031605809926986694, 0.0077901543118059635, 0.051061615347862244, 0.2265862375497818, -0.05038871616125107, 0.19418512284755707, 0.11017418652772903, -0.130876824259758, -0.009467757306993008, 0.06925129145383835, 0.15968455374240875, 0.06558672338724136, 0.2099974900484085, -0.15093456208705902, -0.0698402002453804, 0.07149220257997513, -0.13083171844482422, 0.10914912819862366, -0.11763449013233185, 0.2523302137851715, 0.1659684032201767, -0.016992943361401558, -0.08730311691761017, -0.09397806972265244, -0.12443149834871292, -0.07714798301458359, -0.12735328078269958, 0.0014113226206973195, 0.1016770601272583, -0.1094861552119255, 0.06753286719322205, -0.1466204971075058, -0.16898952424526215, 0.046306271106004715, -0.014789814129471779, -0.04272468760609627, 0.06232260912656784, 0.131927028298378, -0.3401412069797516, -0.03886304423213005, -0.018837815150618553, -0.3839312195777893, 0.00800465140491724, 0.20652958750724792, 0.1444229632616043, 0.2795430123806, -0.03235204145312309, -0.08984272181987762, 0.09665647149085999, -0.12413188815116882, -0.05752479285001755, -0.10379523783922195, -0.12453879415988922, -0.11531751602888107, 0.04351598769426346, -0.011227497830986977, 0.0736381933093071, -0.08653364330530167, -0.15900743007659912, 0.016978582367300987, 0.1382637768983841, -0.12024211883544922, 0.12195899337530136, -0.09948302805423737, -0.08914359658956528, -0.01589515432715416, 0.12321657687425613, -0.051112741231918335, 0.1820279359817505, 0.05344473198056221, -0.025079643353819847, 0.05168228968977928, 0.210476353764534, -0.09385105222463608, -0.014772833324968815, 0.06943866610527039, 0.10984403640031815, -0.11846008151769638, -0.07400135695934296, 0.03178556263446808, 0.16077737510204315, -0.0653131753206253, 0.22185170650482178, 0.1947757750749588, 0.14849114418029785, -0.007288812659680843, 0.065693199634552, -0.11506524682044983, -0.051164571195840836, -0.06563861668109894, -0.07352680712938309, 0.08559969812631607, -0.3613123893737793, 0.03548551723361015, -0.1666279435157776, -0.021112773567438126, 0.11395896226167679, 0.06603100150823593, -0.18856041133403778, -0.007269554305821657, -0.162185937166214, -0.13911207020282745, 0.20132911205291748, 0.17726780474185944, -0.05321785807609558, 0.1389109194278717, -0.17844824492931366, -0.10938555002212524, 0.1223597601056099, 0.09897960722446442, -0.11883135139942169, 0.18365372717380524, 0.04324191063642502, -0.042961813509464264, 0.1304011046886444, -0.06367866694927216, 0.11799293756484985, -0.05378658324480057, 0.1423141360282898, 0.06697724759578705, -0.11207219213247299, -0.03582697734236717, -0.09008170664310455, 1.1127451399442491e-32, 0.03984086588025093, 0.03654307872056961, 0.04976799339056015, -0.20908236503601074, -0.0626952275633812, 0.11928540468215942, 0.023828720673918724, 0.01238993275910616, -0.284792959690094, -0.1891288459300995, -0.16814807057380676, 0.24252469837665558, 0.021358517929911613, 0.12155125290155411, -0.13985709846019745, -0.09179458022117615, -0.10446687042713165, 0.1154966801404953, 0.0860571339726448, 0.034580450505018234, -0.24173663556575775, -0.0526096373796463, -0.2132025808095932, -0.05512355640530586, -0.2130260169506073, 0.1107846051454544, -0.019782748073339462, 0.020089004188776016, 0.12010537832975388, 0.04115338623523712, -0.04267420992255211, 0.12162837386131287, 0.02259436435997486, 0.03542672470211983, 0.016434188932180405, -0.0547512024641037, -0.039714086800813675, 0.09327320009469986, 0.019878964871168137, -0.039533987641334534, 0.08554393798112869, 0.34293797612190247, -0.10579544305801392, -0.16951338946819305, -0.05180465430021286, 0.047814931720495224, -0.036702848970890045, -0.08127296715974808, -0.09118995815515518, -0.05765543133020401, -0.04106307029724121, 0.07750832289457321, -0.1362491101026535, -0.10147373378276825, 0.015631917864084244, -0.1174737960100174, 0.05391201749444008, -0.05864843353629112, 0.13536371290683746, 0.039997123181819916, -0.02047443948686123, 0.027181340381503105, 0.09958779811859131, -0.11645645648241043, -0.12267548590898514, 0.032118938863277435, -0.1812126636505127, -0.11895709484815598, -0.18025127053260803, 0.15321922302246094, 0.09269826114177704, 0.042967960238456726, 0.13608422875404358, 0.01772955432534218, -0.03845110908150673, -0.16640187799930573, -0.11810742318630219, 0.048594702035188675, 0.06961316615343094, 0.11892165243625641, -0.09753008186817169, -0.09531997889280319, 0.12765437364578247, 0.09197892248630524, 0.07648363709449768, -0.14200854301452637, -0.15296027064323425, 0.11276330798864365, -0.06349079310894012, 0.12315197288990021, 0.1894821673631668, 0.018603086471557617, -0.18603363633155823, 0.023190170526504517, 0.17587679624557495, -1.0527109536746256e-32, -0.07658080011606216, 0.06053002178668976, 0.08419441431760788, -0.04064130783081055, -0.13050299882888794, 0.06247209012508392, -0.028217587620019913, 0.15551303327083588, 0.3199213743209839, 0.22156217694282532, 0.060621604323387146, 0.15941831469535828, -0.09179471433162689, 0.12103088200092316, 0.1439359486103058, -0.06216426193714142, 0.10192609578371048, -0.10295017063617706, 0.04323960468173027, -0.3415866196155548, 0.04391132667660713, 0.09569627791643143, -0.055266428738832474, 0.2421320676803589, 0.13816781342029572, 0.09153031557798386, 0.12314701080322266, 0.12168917804956436, 0.017384745180606842, -0.123393215239048, -0.18981604278087616, -0.11543071269989014, -0.16551624238491058, 0.16758926212787628, -0.11464628577232361, 0.12080952525138855, 0.19121262431144714, -0.11383663862943649, -0.0014781500212848186, -0.03480452671647072, -0.04856102168560028, 0.0765625461935997, 0.045930955559015274, -0.05770571157336235, 0.10673246532678604, -0.15720820426940918, 0.05754772573709488, 0.014156917110085487, 0.05335889756679535, -0.011669887229800224, 0.1305411458015442, -0.07902315258979797, -0.020885450765490532, 0.071140818297863, -0.23971734941005707, -0.10699313879013062, 0.05295292288064957, 0.117478147149086, 0.02021314576268196, -0.05249112471938133, 0.16036318242549896, 0.2563147246837616, -0.24312540888786316, -0.12446118891239166, -0.19515319168567657, 0.04368595778942108, 0.1474897861480713, -0.08837936073541641, 0.026069851592183113, -0.09798388183116913, -0.07456079870462418, -0.25561755895614624, 0.1736140102148056, -0.0683969035744667, -0.04401252418756485, 0.0637541189789772, 0.02713480219244957, -0.1052885577082634, 0.07671339064836502, -0.14264167845249176, -0.033150650560855865, -0.097834013402462, -0.01437351480126381, 0.1253025084733963, 0.056634917855262756, -0.04791129007935524, -0.019296087324619293, 0.03169579803943634, -0.17050442099571228, 0.19802547991275787, -0.10965566337108612, -0.0680561289191246, 0.08250240981578827, 0.17572081089019775, 0.037373192608356476, -9.941493317455752e-08, -0.009692919440567493, -0.21303394436836243, -0.05182545259594917, 0.19199328124523163, -0.10226373374462128, 0.09149563312530518, 0.08150643110275269, 0.09344025701284409, 0.21096442639827728, 0.10902193933725357, 0.21455910801887512, 0.0075209843926131725, 0.04071682691574097, 0.16243866086006165, -0.12595872581005096, -0.046577997505664825, 0.046834319829940796, 0.13005217909812927, 0.012578540481626987, -0.127263143658638, -0.013772798702120781, 0.14270593225955963, 0.03324278071522713, -0.034149426966905594, -0.07610119134187698, -0.004822585731744766, -0.07383903115987778, 0.055480681359767914, 0.054381147027015686, -0.04961327090859413, -0.14103610813617706, -0.13056668639183044, 0.1004042997956276, 0.147003173828125, -0.029218172654509544, -0.020298607647418976, -0.058369237929582596, 0.022401705384254456, -0.07774551212787628, 0.06363856792449951, 0.11480838060379028, -0.09222027659416199, -0.20334838330745697, -0.07136927545070648, 0.10350000113248825, 0.01793806441128254, -0.16562889516353607, -0.023594969883561134, 0.013282334432005882, -0.2181834876537323, 0.1136646643280983, -0.0008431467576883733, 0.14464673399925232, -0.003963592927902937, 0.013895963318645954, -0.07686205953359604, -0.06676866859197617, -0.15808741748332977, 0.007618220988661051, 0.08259540051221848, 0.16311334073543549, -0.21436162292957306, -0.010779117234051228, 0.18017692863941193], "changes": {"1wk": -4.098360719811497, "1mo": -15.081968699626746}}, {"text": "Enanta Pharmaceuticals to Appeal Ruling Related to \u2018953 Patent Infringement Lawsuit Business Wire Tue, Dec 24, 2024, 3:00 PM 4 min read In This Article: ENTA +1.17% WATERTOWN, Mass., December 24, 2024 --( BUSINESS WIRE )-- Enanta Pharmaceuticals, Inc . (NASDAQ: ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for virology and immunology indications, today announced that the United States District Court of Massachusetts (\"the Court\") has issued a ruling on a summary judgment motion filed by Pfizer, Inc. in connection with Enanta\u2019s patent infringement lawsuit seeking damages for infringement of U.S. Patent No. 11,358,953 (\"the \u2019953 Patent\") in the manufacture, use and sale of Pfizer\u2019s COVID-19 antiviral, Paxlovid\u2122 (nirmatrelvir tablets; ritonavir tablets). The Court issued a summary judgment decision granting Pfizer\u2019s motion that the \u2018953 Patent is invalid. In its decision, the Court also denied Enanta\u2019s partial motion for summary judgment of infringement as moot in light of its allowance of summary judgment on invalidity. Enanta plans to appeal the decision to the Court of Appeals for the Federal Circuit. \"The U.S. patent system and its protection of important innovations have enabled the robust development of new medicines and spurred growth in the biotechnology industry. We are proud of the impact our strong history of drug discovery work with protease inhibitors has had on antiviral treatments and the thousands of patients that have been treated with therapies using our patented inventions,\" said Jay R. Luly, Ph.D., President and Chief Executive Officer of Enanta Pharmaceuticals, Inc. \"We are disappointed with the Court\u2019s ruling. We believe strongly in the merits of our case, and, through the appeal process, we will continue to defend our inventions from unlawful infringement.\" Enanta maintains its commitment to avoid attempting to impede the production, sale or distribution of Paxlovid. About Enanta Pharmaceuticals, Inc. Enanta is using its robust, chemistry-driven approach and drug discovery capabilities to become a leader in the discovery and development of small molecule drugs with an emphasis on indications in virology and immunology. Enanta\u2019s clinical programs are currently focused on respiratory syncytial virus (RSV) and its earlier-stage immunology pipeline aims to develop treatments for inflammatory diseases by targeting key drivers of the type 2 immune response, including KIT and STAT6 inhibition. Glecaprevir, a protease inhibitor discovered by Enanta, is part of one of the leading treatment regimens for curing chronic hepatitis c virus (HCV) infection and is sold by AbbVie in numerous countries under the tradenames MAVYRET\u00ae (U.S.) and MAVIRET\u00ae (ex-U.S.) (glecaprevir/pibrentasvir). A portion of Enanta\u2019s royalties from HCV products developed under its collaboration with AbbVie contribute ongoing funding to Enanta\u2019s operations. Please visit www.enanta.com for more information. Story Continues Forward-Looking Statements This press release contains forward-looking statements, including statements with respect to Enanta\u2019s suit against Pfizer, Inc. in the United States District Court for the District of Massachusetts seeking damages for patent infringement. Statements that are not historical facts are based on management\u2019s current expectations, estimates, forecasts and projections about Enanta\u2019s business and the industry in which it operates and management\u2019s beliefs and assumptions. The statements contained in this release are not guarantees of future performance and involve certain risks, uncertainties and assumptions, which are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed in such forward-looking statements. Important factors and risks that may affect actual results include: Enanta is competing to develop intellectual property in areas of small-molecule drug development that are highly competitive; issued patents, including the patent at issue in the Pfizer litigation, could be found invalid or unenforceable if challenged in court and could be costly to defend and be a distraction for Enanta\u2019s senior management and scientific personnel; intellectual property litigation may lead to unfavorable publicity that harms Enanta\u2019s reputation and causes the market price of its common stock to decline; and other risk factors described or referred to in \"Risk Factors\" in Enanta\u2019s Form 10-K for the fiscal year ended September 30, 2024 and other periodic reports filed more recently with the Securities and Exchange Commission. Enanta cautions investors not to place undue reliance on the forward-looking statements contained in this release. These statements speak only as of the date of this release, and Enanta undertakes no obligation to update or revise these statements, except as may be required by law. View source version on businesswire.com: https://www.businesswire.com/news/home/20241224565771/en/ Contacts Media and Investors: Jennifer Viera 617-744-3848 jviera@enanta.com View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "ENTA", "date": "2024-12-24T12:00:00+00:00", "sentiment": {"score": -0.34482531249523163, "confidence": 0.4918290078639984, "probabilities": {"positive": 0.14700369536876678, "negative": 0.4918290078639984, "neutral": 0.3611673414707184}}, "embedding": [-0.17615514993667603, -0.02804800309240818, -0.022851046174764633, -0.3082606792449951, -0.04150170832872391, 0.005981193855404854, 0.07544416189193726, 0.24693343043327332, 0.018816303461790085, 0.20877495408058167, 0.011342909187078476, 0.14023354649543762, -0.0420726053416729, 0.0796496719121933, -0.028760597109794617, 0.0292515829205513, 0.043664444237947464, 0.0439620241522789, -0.11856871843338013, 0.09611524641513824, 0.1525256335735321, 0.12920641899108887, -0.0006366331363096833, 0.017795119434595108, -0.16216135025024414, 0.12772154808044434, -0.06677541881799698, 0.03377082943916321, -0.09597642719745636, -0.11703840643167496, -0.04466082900762558, 0.18237930536270142, -0.04369810223579407, -0.09410613030195236, 0.07648903131484985, -0.08655322343111038, -0.21553528308868408, -0.014482603408396244, 0.04050110653042793, -0.09817807376384735, 0.0872153788805008, -0.08573998510837555, -0.17730626463890076, 0.07059800624847412, 0.0716913491487503, -0.14228592813014984, -0.04003420099616051, 0.06295346468687057, 0.06662050634622574, 0.1305878460407257, -0.13064157962799072, -0.10074938833713531, 0.05892110615968704, 0.06535390019416809, -0.09284605085849762, -0.13754326105117798, -0.06860100477933884, -0.050748661160469055, -0.03103402629494667, -0.04409952089190483, 0.14564621448516846, -0.04632547125220299, 0.02775588445365429, -0.01841868832707405, 0.11941130459308624, -0.04672699421644211, 0.16630113124847412, -0.09681320935487747, -0.03954198583960533, 0.014061293564736843, 0.24675902724266052, 0.017140904441475868, -0.09241904318332672, 0.24885711073875427, -0.20626454055309296, 0.09882326424121857, 0.18974357843399048, 0.13802798092365265, 0.04432818666100502, -0.06637154519557953, 0.16646744310855865, -0.06488853693008423, 0.01391017809510231, -0.06096922606229782, 0.0020860182121396065, -0.08216799795627594, -0.019847340881824493, 0.15292295813560486, 0.2183958739042282, -0.043407194316387177, 0.08226346969604492, -0.08283770829439163, 0.034073203802108765, -0.027074303478002548, 0.13040681183338165, -0.06374509632587433, -0.23000618815422058, 0.010428274050354958, 0.04154593497514725, 0.046803250908851624, 0.01752372458577156, -0.015374996699392796, -0.15225353837013245, -0.012587189674377441, 0.019145874306559563, -0.021442299708724022, 0.09869661182165146, -0.09672415256500244, 0.04689343273639679, 0.07292269170284271, -0.21282659471035004, -0.020855369046330452, 0.1624136120080948, 0.09220236539840698, -0.008012697100639343, 0.15681171417236328, 0.018527016043663025, 0.18298843502998352, 0.17980214953422546, -0.16213011741638184, 0.08686845004558563, 0.09519924223423004, -0.017019890248775482, -0.07647830247879028, -0.01726672425866127, 0.043900635093450546, -0.07349561154842377, 2.7454239943530704e-33, -0.08226848393678665, -0.0983777791261673, 0.06947845965623856, 0.054934851825237274, 0.030535660684108734, 0.05324438214302063, 0.12538523972034454, 0.018509577959775925, -0.3033251166343689, -0.1795024275779724, -0.23495492339134216, -0.0070569925010204315, 0.027222633361816406, 0.06531362980604172, -0.05618835613131523, 0.031096046790480614, -0.03015531226992607, 0.03870588541030884, 0.07204528152942657, 0.009733268059790134, 0.02949257381260395, -0.005389664322137833, -0.04908960312604904, 0.13385255634784698, -0.24573281407356262, 0.007171809673309326, -0.12804874777793884, -0.007274552248418331, 0.010412376374006271, -0.05438443273305893, 0.07865878939628601, 0.13915248215198517, 0.12745462357997894, 0.016064845025539398, 0.048439666628837585, -0.04870133846998215, -0.01183047704398632, -0.022029224783182144, 0.08949431777000427, 0.016416218131780624, -0.04588858783245087, 0.1023361086845398, -0.050685107707977295, -0.08392554521560669, 0.007388422731310129, -0.017183611169457436, -0.21207021176815033, 0.03098219633102417, -0.024421095848083496, -0.011283257976174355, 0.09629952907562256, 0.05721522867679596, -0.009650254622101784, -0.12696903944015503, -0.001982186920940876, -0.05973108112812042, -0.11580829322338104, 0.06735509634017944, 0.10445818305015564, 0.07836079597473145, -0.08956526219844818, 0.13626234233379364, 0.040403395891189575, 0.10459623485803604, -0.10423527657985687, 0.10041237622499466, 0.021373359486460686, -0.08659299463033676, -0.05271313339471817, 0.0781569629907608, -0.048784464597702026, -0.03540821373462677, 0.08689266443252563, -0.013299133628606796, 0.07119777053594589, -0.22279396653175354, -0.0020488882437348366, 0.05355506390333176, -0.0726049542427063, -0.10734452307224274, -0.0652439221739769, 0.03171009197831154, -0.07174994051456451, 0.1782425343990326, -0.06833617389202118, -0.12548460066318512, -0.05833474546670914, 0.058107294142246246, -0.022172804921865463, -0.03697732836008072, 0.09061852097511292, -0.07026427984237671, -0.10073404014110565, 0.1305314004421234, 0.07832220941781998, -4.61533575545187e-33, -0.0374039001762867, -0.1542840451002121, -0.06875602900981903, 0.01968962326645851, -0.054611336439847946, 0.1000479906797409, 0.010082768276333809, -0.07084139436483383, 0.031213518232107162, -0.05492525175213814, 0.04938693344593048, -0.02975170686841011, -0.053662873804569244, -0.020931879058480263, -0.03380493074655533, 0.04417378827929497, 0.07299840450286865, -0.09024772047996521, -0.07187502086162567, -0.07544168084859848, 0.172568216919899, 0.13070715963840485, -0.12875202298164368, 0.06088351458311081, -0.05175001919269562, 0.1022653877735138, 0.117586649954319, -0.06635042279958725, 0.05282043293118477, -0.05697280913591385, -0.12147499620914459, 0.010514374822378159, -0.33074742555618286, 0.1506030559539795, 0.036517057567834854, -0.03246484696865082, 0.24300388991832733, -0.14259275794029236, -0.04087887331843376, -0.20384886860847473, 0.025721941143274307, 0.1276034414768219, -0.028221357613801956, 0.1071762964129448, 0.02393394336104393, -0.10758078098297119, 0.05383668094873428, -0.04332319274544716, 0.06002737581729889, -0.010746074840426445, 0.056293513625860214, -0.03247039020061493, 0.12122061848640442, -0.032871756702661514, -0.0614204965531826, -0.05220391973853111, 0.0264241062104702, -0.09082695841789246, -0.0015235686441883445, 0.13476456701755524, 0.15750277042388916, 0.06968263536691666, -0.11778388917446136, -0.08173768222332001, -0.014468993991613388, 0.12284906208515167, 0.051789961755275726, 0.09598857164382935, 0.1707969605922699, -0.21566684544086456, -0.10089120268821716, -0.06191794574260712, 0.05216062441468239, -0.12582525610923767, 0.09087075293064117, 0.147069051861763, 0.032444216310977936, -0.12037760019302368, -0.1646181046962738, -0.08425720036029816, 0.0523587241768837, -0.09708086401224136, -0.03531653806567192, 0.05674813687801361, -0.024031005799770355, 0.04748979210853577, 0.0669989287853241, -0.036766938865184784, 0.03498399257659912, 0.05903362110257149, -0.06490665674209595, -0.10287299752235413, -0.007154807448387146, 0.13653215765953064, 0.023412717506289482, -1.0031870090188022e-07, 0.10463374853134155, -0.0815226286649704, -0.03263422101736069, 0.0684594213962555, -0.10093766450881958, -0.021481934934854507, 0.02199428156018257, 0.062098946422338486, 0.07397806644439697, 0.05251758173108101, 0.09855197370052338, 0.09474585205316544, -0.053572699427604675, 0.10432730615139008, 0.005052674561738968, 0.026812979951500893, -0.07740287482738495, 0.07653268426656723, -0.07344919443130493, 0.014727034606039524, -0.1577344685792923, 0.020583737641572952, -0.1603689193725586, -0.0717940405011177, -0.007541042286902666, -0.06908798217773438, 0.05774562805891037, -0.10698975622653961, -0.017084667459130287, 0.037108734250068665, -0.09003283083438873, -0.06853197515010834, 0.12378976494073868, 0.10716384649276733, -0.10650447756052017, -0.1991349160671234, 0.07164495438337326, 0.004240190610289574, 0.02865113690495491, -0.05849117785692215, -0.02543690986931324, 0.03004497103393078, -0.03596315532922745, -0.000666007399559021, 0.024008123204112053, -0.11340298503637314, -0.10369458794593811, -0.06817460060119629, 0.006206882651895285, 0.013258369639515877, 0.020177997648715973, 0.03346628695726395, 0.04133647307753563, -0.12742868065834045, -0.08004330098628998, 0.15449944138526917, -0.004456330090761185, -0.12690818309783936, 0.045160092413425446, -0.0787774920463562, 0.1484975516796112, -0.07704320549964905, 0.20823724567890167, 0.15279334783554077], "changes": {"1wk": -4.098360719811497, "1mo": -15.081968699626746}}, {"text": "Enanta Pharmaceuticals (ENTA) Reports Q4 Loss, Misses Revenue Estimates Zacks Equity Research Tue, Nov 26, 2024, 1:10 AM 3 min read In This Article: ENTA +1.17% Enanta Pharmaceuticals (ENTA) came out with a quarterly loss of $1.36 per share versus the Zacks Consensus Estimate of a loss of $1.16. This compares to loss of $1.33 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -17.24%. A quarter ago, it was expected that this biotechnology company would post a loss of $1.49 per share when it actually produced a loss of $1.07, delivering a surprise of 28.19%. Over the last four quarters, the company has surpassed consensus EPS estimates just once. Enanta Pharmaceuticals , which belongs to the Zacks Medical - Drugs industry, posted revenues of $14.61 million for the quarter ended September 2024, missing the Zacks Consensus Estimate by 20.68%. This compares to year-ago revenues of $18.93 million. The company has topped consensus revenue estimates two times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Enanta Pharmaceuticals shares have lost about 0.7% since the beginning of the year versus the S&P 500's gain of 25.2%. What's Next for Enanta Pharmaceuticals? While Enanta Pharmaceuticals has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for Enanta Pharmaceuticals: mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is -$1.24 on $17.19 million in revenues for the coming quarter and -$5.02 on $80.53 million in revenues for the current fiscal year. Story Continues Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - Drugs is currently in the top 27% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1. One other stock from the broader Zacks Medical sector, IceCure Medical Ltd. (ICCM), is yet to report results for the quarter ended September 2024. The results are expected to be released on November 26. This company is expected to post quarterly loss of $0.07 per share in its upcoming report, which represents a year-over-year change of +22.2%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. IceCure Medical Ltd.'s revenues are expected to be $0.7 million, up 112.1% from the year-ago quarter. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Enanta Pharmaceuticals, Inc. (ENTA) : Free Stock Analysis Report IceCure Medical Ltd. (ICCM) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "ENTA", "date": "2024-11-25T22:10:04+00:00", "sentiment": {"score": -0.6368590816855431, "confidence": 0.7099485993385315, "probabilities": {"positive": 0.07308951765298843, "negative": 0.7099485993385315, "neutral": 0.21696187555789948}}, "embedding": [-0.078811414539814, -0.025345083326101303, 0.02668832615017891, 0.002157701877877116, -0.03623233735561371, -0.015291052870452404, -0.008133139461278915, 0.17579403519630432, 0.1668206751346588, 0.1835336685180664, -0.07355047762393951, 0.05829034000635147, 0.010985564440488815, 0.020363930612802505, -0.06976734101772308, -0.012997476384043694, 0.03590415418148041, -0.03298219293355942, -0.12151194363832474, 0.04560648277401924, -0.03607228398323059, 0.023539703339338303, 0.055823445320129395, 0.1311909258365631, 0.12624381482601166, 0.08800112456083298, -0.10482847690582275, 0.08545991033315659, -0.22141863405704498, -0.16509707272052765, -0.07920306921005249, 0.13343748450279236, 0.0887766182422638, -0.11159677803516388, -0.022438954561948776, -0.0957731232047081, -0.08859242498874664, 0.1304686963558197, 0.1876964569091797, -0.08357581496238708, -0.08298761397600174, 0.04448835551738739, -0.23282161355018616, 0.0017893379554152489, -0.0270518995821476, -0.32142674922943115, -0.023725707083940506, -0.009997940622270107, 0.06598494946956635, 0.12977245450019836, -0.13985176384449005, -0.08877392113208771, 0.06774681806564331, 0.025204883888363838, -0.07386147975921631, -0.008886799216270447, -0.10537482053041458, -0.10335904359817505, 0.015204302966594696, 0.10262901335954666, 0.12983965873718262, -0.021635858342051506, -0.018547924235463142, 0.03795628622174263, 0.16908472776412964, -0.0808991938829422, 0.16808822751045227, 0.04193488880991936, -0.17282362282276154, 0.05844254046678543, 0.12777237594127655, -0.0757780522108078, -0.06929978728294373, 0.03253592550754547, -0.1691836416721344, 0.03812217712402344, 0.17948609590530396, 0.09957228600978851, 0.023631509393453598, -0.022483039647340775, 0.17982906103134155, -0.02887578308582306, -0.10593020915985107, -0.0431218147277832, 0.06783349812030792, 0.019169092178344727, 0.18246182799339294, 0.13227303326129913, 0.1162458285689354, 0.03511230647563934, -0.04340643435716629, -0.059842925518751144, 0.04521729424595833, -0.07580146193504333, 0.12861239910125732, 0.05870598927140236, -0.20644591748714447, -0.0473337396979332, 0.011054623872041702, 0.056290045380592346, 0.11732195317745209, 0.13010790944099426, -0.1255524456501007, -0.1693347990512848, 0.008041108027100563, -0.11849693208932877, 0.24028103053569794, -0.02685120515525341, 0.014683977700769901, 0.11257143318653107, -0.14667095243930817, 0.01564140059053898, -0.0937172919511795, 0.07272488623857498, -0.07657904177904129, 0.10640977323055267, 0.03548282012343407, 0.13131563365459442, 0.09218452870845795, 0.07852543890476227, 0.08141965419054031, 0.06757278740406036, 0.0716177225112915, 0.019246714189648628, 0.010944349691271782, 0.10888230800628662, -0.13653403520584106, 6.862615365969195e-33, 0.09303420037031174, 0.05282847210764885, 0.06436090171337128, -0.02564738504588604, 0.0300731360912323, 0.09671875834465027, 0.03521003574132919, 0.001280900090932846, -0.1472693383693695, -0.17205700278282166, -0.2549479007720947, 0.15227989852428436, -0.04795096069574356, -0.043219029903411865, -0.016827382147312164, -0.06754771620035172, -0.063695028424263, 0.0922718346118927, 0.030391065403819084, -0.02794402837753296, -0.12722952663898468, -0.05001521110534668, -0.11405810713768005, 0.032980576157569885, -0.07978634536266327, 0.03736882656812668, -0.1291031688451767, 0.03930678591132164, -0.11070657521486282, 0.0066459872759878635, 0.016686901450157166, 0.12099626660346985, 0.01972859352827072, -0.11605077236890793, -0.03273220732808113, -0.13223066926002502, 0.014436707831919193, 0.05713360011577606, 0.17686080932617188, 0.04741181433200836, -0.03031986393034458, 0.22057658433914185, -0.15709473192691803, -0.20237413048744202, -0.1015666276216507, 0.019655747339129448, -0.07361038029193878, 0.04167041555047035, 0.004850964527577162, 0.0013913288712501526, 0.015525770373642445, 0.014122345484793186, -0.04086040332913399, -0.135689839720726, 0.03999161347746849, 0.02982417307794094, -0.039167821407318115, -0.1685006320476532, 0.05698723345994949, 0.17126983404159546, 0.009586073458194733, 0.2178637683391571, 0.06445711851119995, -0.06265488266944885, -0.233427956700325, 0.16269806027412415, 0.0054084910079836845, 0.04207679629325867, -0.14369219541549683, 0.18273727595806122, -0.07547343522310257, -0.060362137854099274, 0.10274013876914978, -0.05205819010734558, 0.16382703185081482, -0.13539372384548187, -0.0950501561164856, -0.024281883612275124, 0.046708524227142334, 0.07858261466026306, 0.06927818059921265, -0.10216329991817474, -0.00698513351380825, 0.07214680314064026, 0.030435914173722267, -0.04115346074104309, 0.049353957176208496, 0.08705207705497742, 0.035121094435453415, 0.03849215433001518, 0.06476739048957825, -0.1380598545074463, -0.09143611043691635, 0.08937079459428787, 0.05762021988630295, -6.852205628808694e-33, -0.015726804733276367, 0.08100638538599014, -0.032117217779159546, -0.03160242736339569, -0.11480411142110825, 0.014226831495761871, 0.1074909195303917, 0.11829988658428192, 0.08527077734470367, 0.018291469663381577, 0.07109547406435013, 0.05736566334962845, -0.09879186749458313, 0.07319021224975586, -0.03534594923257828, -0.030290886759757996, 0.14000792801380157, -0.2192750871181488, 0.04534834623336792, -0.20193438231945038, 0.044415850192308426, 0.15486079454421997, -0.08939488232135773, 0.1028633639216423, 0.06659712642431259, 0.11922167241573334, 0.05873812735080719, 0.1951136589050293, -0.04272327944636345, -0.13490372896194458, -0.08007748425006866, -0.15671038627624512, -0.19111424684524536, 0.14720460772514343, -0.03960646316409111, -0.009052771143615246, -0.008676685392856598, -0.2099248468875885, -0.06406880170106888, -0.04984288290143013, 0.08203285932540894, 0.08664868772029877, 0.05399661138653755, 0.051387082785367966, 0.03751135244965553, -0.06278109550476074, 0.051470354199409485, 0.010875585488975048, 0.16702084243297577, 0.042252033948898315, 0.11614956706762314, 0.024288935586810112, -0.1323368400335312, 0.09360344707965851, -0.13631433248519897, -0.0017772074788808823, -0.08704904466867447, 0.009153394028544426, -0.14065203070640564, 0.06273266673088074, 0.029882092028856277, 0.15490803122520447, -0.05793195217847824, 0.007731014862656593, -0.056059934198856354, 0.029269281774759293, 0.03960532322525978, -0.03160782530903816, 0.05946015566587448, -0.16841961443424225, 0.00765623664483428, -0.15179958939552307, 0.09766372293233871, -0.0959271788597107, 0.022685309872031212, 0.2548682987689972, -0.11038029938936234, -0.26155123114585876, -0.06289505958557129, -0.03506355732679367, 0.039395466446876526, 0.021288977935910225, -0.021983403712511063, 0.05913374945521355, -0.15002188086509705, 0.16031497716903687, -0.0012330319732427597, -0.011618000455200672, -0.04226125404238701, 0.008313672617077827, -0.057821907103061676, -0.20871731638908386, -0.10363438725471497, 0.15323996543884277, 0.1343049705028534, -9.962295166587865e-08, 0.07331600785255432, -0.1239246353507042, 0.09778136759996414, 0.038735173642635345, 0.05552377179265022, -0.0666477382183075, 0.08460170030593872, 0.028971221297979355, 0.2585402727127075, 0.08190381526947021, 0.09651091694831848, 0.09858238697052002, -0.17629234492778778, 0.16925285756587982, -0.1090964674949646, 0.07984696328639984, -0.04733176529407501, 0.07611046731472015, -0.011701412498950958, -0.17621487379074097, -0.13348388671875, 0.056036949157714844, 0.046277791261672974, -0.11314146965742111, 0.03470256179571152, -0.13325759768486023, -0.11806803941726685, 0.0029482748359441757, 0.01544157788157463, -0.03432151675224304, 0.04968065023422241, -0.17221172153949738, 0.1444019079208374, 0.10238049924373627, -0.07978581637144089, -0.1187400296330452, 0.021214857697486877, 0.01997392438352108, 0.04301073029637337, 0.07136451452970505, 0.011741941794753075, -0.04359644651412964, -0.04757547378540039, 0.008265838027000427, -0.06320741772651672, -0.07206141948699951, -0.0893307626247406, 0.05042296648025513, -0.02673834189772606, -0.30897778272628784, 0.15724685788154602, -0.040654122829437256, 0.09345594048500061, 0.015582411549985409, 0.05759177729487419, 0.037106677889823914, -0.20640620589256287, -0.03242877870798111, -0.0999525934457779, -0.07164962589740753, 0.08232234418392181, -0.18618258833885193, 0.0329970084130764, 0.1359362155199051], "changes": {"1wk": -4.8834686224222486, "1mo": -32.29745005911511}}, {"text": "PREMIUM Sector Update: Health Care Stocks Mixed Tuesday Afternoon MT Newswires Tue, Dec 24, 2024, 8:47 PM 1 min read In This Article: ENTA +1.17% PFE -1.21% Health care stocks were mixed in Tuesday afternoon trading, with the NYSE Health Care Index easing 0 PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? Sign in Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "ENTA", "date": "2024-12-24T17:47:44+00:00", "sentiment": {"score": 0.055315051227808, "confidence": 0.08238217234611511, "probabilities": {"positive": 0.08238217234611511, "negative": 0.027067121118307114, "neutral": 0.8905506730079651}}, "embedding": [-0.009109376929700375, -0.12580262124538422, 0.04228202626109123, 0.1439255326986313, 0.1314338743686676, -0.043389566242694855, 0.02621820569038391, -0.07392723858356476, -0.07288800925016403, -0.025129562243819237, 0.05219234526157379, 0.13144929707050323, -0.14856289327144623, -0.05938129127025604, 0.07631977647542953, -0.026759037747979164, -0.033504776656627655, -0.09212587773799896, -0.0884646475315094, 0.20222756266593933, -0.1681322455406189, -0.01717655174434185, -0.009920630604028702, 0.029996264725923538, 0.10386694222688675, 0.11410239338874817, -0.025242801755666733, -0.004866751376539469, 0.02656504325568676, -0.06316809356212616, -0.052335839718580246, -0.0008881586836650968, 0.03373546898365021, 0.007604673504829407, -0.13316184282302856, -0.05658315122127533, 0.010907124727964401, 0.10793593525886536, 0.11224942654371262, -0.0175919346511364, 0.12142244726419449, -0.11815780401229858, -0.15240271389484406, 0.060221243649721146, 0.0014379093190655112, -0.10076311975717545, -0.13867484033107758, -0.04540723189711571, 0.13425414264202118, 0.0032196047250181437, -0.030993150547146797, -0.10561320185661316, -0.046693217009305954, -0.014662478119134903, -0.01155751384794712, -0.09935183078050613, -0.1350068747997284, -0.13976655900478363, -0.045363448560237885, -0.033684100955724716, -0.0154782859608531, -0.042317818850278854, 0.03918646275997162, 0.17531362175941467, 0.05843229964375496, -0.0005175051628611982, 0.10707906633615494, 0.10421007871627808, -0.08025604486465454, -0.19378423690795898, 0.0487065352499485, -0.04222653806209564, 0.04167583957314491, 0.09496510028839111, -0.003130503697320819, 0.1523635983467102, 0.09104841947555542, -0.01079419907182455, 0.0561213381588459, -0.07584632933139801, 0.0742114707827568, -0.083516426384449, -0.0425369068980217, 0.043492529541254044, 0.12660793960094452, -0.04959077388048172, -0.07650428265333176, -0.07800520956516266, -0.053566429764032364, -0.17381082475185394, 0.12011250853538513, 0.06468095630407333, 0.06060732528567314, -0.014088672585785389, 0.13353268802165985, -0.011647630482912064, -0.21504124999046326, -0.028907962143421173, -0.11480903625488281, 0.03890315443277359, 0.0023291518446058035, 0.06876854598522186, -0.07800660282373428, 0.11065512150526047, -0.10987051576375961, -0.15162266790866852, -0.0018217744072899222, 0.04621465504169464, 0.03702731430530548, 0.09804221242666245, -0.06259641796350479, 0.0643487274646759, 0.09793511033058167, -0.07177787274122238, -0.16371282935142517, 0.12641417980194092, -0.05516906455159187, -0.04928030073642731, 0.13435907661914825, 0.00691900635138154, -0.01721242256462574, 0.07880198955535889, -0.11688964068889618, 0.0225279089063406, 0.012835939414799213, 0.1925039440393448, 0.015125882811844349, 1.1636776938606465e-32, 0.03501266986131668, -0.02768775261938572, 0.15770705044269562, -0.05571833625435829, 0.04973558336496353, 0.14551053941249847, 0.09503325074911118, -0.22068756818771362, -0.04641690105199814, -0.0603640191257, -0.18339896202087402, 0.25551822781562805, 0.034154731780290604, -0.018213100731372833, -0.18094944953918457, -0.20798978209495544, -0.18576963245868683, 0.12106088548898697, 0.052450090646743774, 0.09132915735244751, -0.11668356508016586, -0.0396532341837883, -0.13906098902225494, -0.07619389146566391, -0.1359723061323166, -0.023836901411414146, 0.0034103142097592354, -0.015658142045140266, 0.09072425961494446, 0.0617380365729332, -0.06394345313310623, 0.12018044292926788, -0.05002349615097046, -0.03881433978676796, 0.036298371851444244, 0.0013510931748896837, 0.056021321564912796, 0.05657511577010155, 0.013703807257115841, -0.15093299746513367, -0.04439607635140419, 0.05353908613324165, -0.05736958608031273, -0.14525820314884186, -0.018350282683968544, 0.06825651973485947, -0.010566423647105694, -0.05026905611157417, 0.07648520171642303, -0.06320354342460632, -0.1344810426235199, 0.039570316672325134, -0.16794943809509277, -0.09358810633420944, -0.0094322944059968, -0.02109718695282936, 0.05101143196225166, 0.008902175351977348, -0.005495450925081968, 0.04442751035094261, 0.17845742404460907, 0.10163193941116333, 0.06171952188014984, -0.13646577298641205, -0.12354552000761032, 0.15465907752513885, -0.10007312893867493, 0.05244157463312149, -0.09495395421981812, 0.12192174792289734, 0.12595750391483307, 0.06453719735145569, 0.024474671110510826, -0.037024933844804764, -0.04500632360577583, -0.03012143075466156, -0.1825827956199646, 0.11071182787418365, 0.0464506670832634, 0.038164351135492325, 0.13074208796024323, -0.012636469677090645, 0.08252835273742676, 0.09866411983966827, 0.05471925809979439, 0.06294924765825272, -0.03724024072289467, 0.13576167821884155, -0.036965109407901764, -0.040232960134744644, -0.060556668788194656, 0.07166001945734024, 0.16524387896060944, 0.06563375890254974, 0.03766812011599541, -1.5616618774826713e-32, -0.13313303887844086, 0.05626385658979416, -0.12697425484657288, -0.05429656431078911, -0.047457076609134674, 0.002382870763540268, 0.12022179365158081, 0.03749645873904228, 0.22037720680236816, 0.2695607542991638, 0.23210509121418, 0.06794768571853638, -0.06656629592180252, -0.04868840053677559, 0.052873216569423676, 0.017658386379480362, -0.07986053079366684, 0.004731572698801756, 0.030512677505612373, 0.001067005330696702, 0.051504429429769516, 0.032349057495594025, -0.04646744951605797, 0.37699130177497864, 0.16704683005809784, 0.08643962442874908, -0.014579999260604382, 0.16784609854221344, 0.1080617681145668, -0.1250852346420288, -0.12163450568914413, -0.126702219247818, -0.09780599921941757, 0.046584077179431915, -0.13088151812553406, -0.17670732736587524, 0.07344189286231995, -0.091351218521595, -0.013329260051250458, -0.08307584375143051, 0.031115109100937843, -0.1092287227511406, -0.023077305406332016, 0.16568362712860107, 0.08848070353269577, 0.011928371153771877, 0.04271462559700012, -0.04392671957612038, -0.01885087601840496, -0.036814600229263306, -0.03837842866778374, 0.1567140519618988, -0.08435119688510895, 0.18774162232875824, -0.15788619220256805, 0.025400517508387566, -0.04897380247712135, 0.043024465441703796, -0.25037550926208496, -0.11476757377386093, 0.05938117578625679, 0.15305621922016144, -0.21003465354442596, -0.09878579527139664, -0.05202163755893707, -0.011552013456821442, 0.09072356671094894, -0.1856163889169693, 0.029855696484446526, -0.10138712078332901, -0.056706469506025314, -0.14093956351280212, -0.12135638296604156, -0.2710045278072357, 0.08050153404474258, 0.1277884542942047, 0.06847745925188065, -0.028455456718802452, -0.07899894565343857, 0.18432116508483887, 0.016555877402424812, -0.06777884811162949, -0.08548286557197571, 0.021764356642961502, -0.12840045988559723, 0.014801111072301865, 0.00885939970612526, -0.1019231304526329, -0.15677957236766815, 0.07459001243114471, -0.19397501647472382, -0.10252683609724045, -0.12398504465818405, 0.10538043826818466, 0.001428391202352941, -1.0017938478767974e-07, 0.15116383135318756, -0.12119120359420776, 0.030338343232870102, 0.03929058462381363, -0.02182287909090519, -0.17588423192501068, -0.12584243714809418, -0.08472632616758347, 0.0679967850446701, 0.24013860523700714, 0.10530486702919006, 0.0866309404373169, -0.08943166583776474, -0.0929264947772026, -0.011723553761839867, -0.11171555519104004, -0.18048888444900513, 0.15591572225093842, 0.006120158359408379, -0.08689870685338974, 0.09022781997919083, 0.02888030745089054, 0.12181785702705383, -0.03205503895878792, -0.006205257028341293, 0.12433501332998276, -0.03022773750126362, -0.0957491397857666, 0.11647583544254303, 0.01039928663522005, -0.051064763218164444, -0.08407551050186157, 9.070242958841845e-05, 0.017880288884043694, -0.06852086633443832, 0.026196807622909546, 0.062425658106803894, 0.012666401453316212, 0.05436883866786957, 0.03865472227334976, 0.08767790347337723, -0.13080786168575287, 0.017095502465963364, 0.0069682723842561245, 0.048344045877456665, 0.05670458823442459, -0.11147322505712509, -0.02928953804075718, 0.1947517693042755, -0.1398712396621704, 0.050414279103279114, -0.0899566188454628, 0.1434721052646637, -0.018899796530604362, -0.05510721728205681, 0.13143594563007355, -0.12693484127521515, -0.07508541643619537, -0.11717692762613297, 0.14996685087680817, 0.11476445943117142, -0.26374945044517517, -0.01580430381000042, 0.15101590752601624], "changes": {"1wk": -5.737703444335553, "1mo": -9.180327074337429}}, {"text": "PREMIUM Top Midday Decliners MT Newswires Tue, Dec 24, 2024, 8:38 PM 1 min read In This Article: ENTA +1.17% LEGN -2.07% DSX-WS Diana Shipping (DSX) has extended the time charter contract for its m/v Amphitrite dry bulk vessel, PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? Sign in Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "ENTA", "date": "2024-12-24T17:38:12+00:00", "sentiment": {"score": 0.11267094407230616, "confidence": 0.12252873927354813, "probabilities": {"positive": 0.12252873927354813, "negative": 0.00985779520124197, "neutral": 0.8676134347915649}}, "embedding": [-0.15640667080879211, -0.006245607975870371, 0.15133433043956757, 0.11316363513469696, 0.03712359443306923, -0.08385531604290009, 0.01630415767431259, 0.06753988564014435, -0.13934510946273804, 0.015618161298334599, -0.044638168066740036, 0.08145967125892639, -0.06719918549060822, 0.07094363868236542, 0.08414493501186371, -0.044460512697696686, 0.17432571947574615, -0.10003183782100677, -0.03972040116786957, 0.12285642325878143, 0.014647269621491432, 0.02348599210381508, -0.07494066655635834, 0.04894989728927612, 0.08116868138313293, 0.0636504665017128, -0.08285651355981827, 0.06435389071702957, 0.009774509817361832, -0.13489152491092682, -0.15755334496498108, 0.044358380138874054, 0.07085242867469788, 0.029878754168748856, 0.04974597692489624, -0.05670281872153282, 0.10926394909620285, -0.03574877977371216, -0.018414577469229698, -0.016344981268048286, 0.10166333615779877, -0.13557933270931244, -0.1291908323764801, 0.04494388774037361, -0.07619824260473251, -0.18498872220516205, 0.030426157638430595, 0.015574019402265549, -0.07070980221033096, 0.216981440782547, 0.058897215873003006, -0.05687788501381874, 0.06583934277296066, -0.08732377737760544, -0.06302465498447418, 0.055656593292951584, -0.15927819907665253, -0.046636659651994705, -0.006763215642422438, -0.15092389285564423, 0.00010983496758854017, -0.004182119388133287, -0.19798782467842102, 0.052904654294252396, 0.06731647998094559, 0.0661049634218216, -0.028611155226826668, 0.16673177480697632, -0.09142858535051346, -0.1809055507183075, -0.019204040989279747, 0.0002587656199466437, -0.03738734871149063, 0.10960833728313446, 0.03502120077610016, 0.13711056113243103, 0.29375141859054565, -0.17198094725608826, 0.0777977854013443, -0.022287869825959206, 0.027330616489052773, -0.03437478840351105, -0.06917818635702133, 0.006051491480320692, 0.02902548387646675, -0.07482664287090302, 0.06983525305986404, 0.1055438220500946, -0.020079510286450386, -0.20401909947395325, 0.078240305185318, -0.07364099472761154, -0.023493429645895958, 0.06784231960773468, -0.13576234877109528, 0.01594443991780281, -0.19087982177734375, 0.06799926608800888, -0.035264238715171814, 0.08693371713161469, 0.04849936440587044, 0.14713884890079498, -0.09794895350933075, 0.05915818735957146, -0.09300022572278976, -0.19866551458835602, -0.056650374084711075, 0.09238402545452118, -0.05096602067351341, -0.031084569171071053, -0.08735323697328568, 0.036337003111839294, 0.078145332634449, -0.12477140128612518, -0.06138056144118309, 0.0722024217247963, -0.24385428428649902, 0.09064388275146484, 0.10307466238737106, -0.21048258244991302, -0.012399492785334587, 0.07417526096105576, -0.01530122198164463, -0.03473644703626633, 0.05847291648387909, 0.09028331190347672, 0.12732256948947906, 1.550865549617544e-32, -0.00909161102026701, -0.003105423878878355, 0.015091142617166042, -0.11909650266170502, 0.14319290220737457, 0.030459607020020485, 0.03294548764824867, 0.04040992632508278, -0.07945041358470917, 0.005734845995903015, -0.19314375519752502, 0.1934089958667755, -0.02118956483900547, 0.0011573585215955973, -0.1979231983423233, -0.1491982787847519, 0.09918325394392014, 0.06594733893871307, 0.03406129777431488, -0.013214305974543095, 0.008145113475620747, -0.08527760952711105, -0.028771229088306427, -0.04217498004436493, -0.037366099655628204, -0.0532752126455307, 0.047570209950208664, 0.0019709900952875614, 0.26418814063072205, 0.1265702098608017, -0.03508653864264488, -0.07923983782529831, 0.11414839327335358, 0.037610866129398346, 0.11594311892986298, 0.1477450430393219, -0.07737233489751816, -0.023444972932338715, -0.08967301994562149, -0.18855395913124084, -0.08611844480037689, 0.004185577854514122, -0.16897988319396973, 0.01753413863480091, -0.18230824172496796, 0.057339973747730255, 0.09308695048093796, -0.14927084743976593, 0.03652721643447876, 0.011852781288325787, -0.04461751878261566, 0.05610525980591774, -0.1934714913368225, 0.04334360733628273, 0.024132292717695236, 0.025296783074736595, 0.07882114499807358, -0.08897939324378967, 0.04944385215640068, -0.05600961297750473, 0.08285252749919891, 0.06282969564199448, 0.07241390645503998, -0.15314586460590363, -0.008066486567258835, 0.12540841102600098, 0.06467565149068832, -0.036620140075683594, -0.11015884578227997, 0.08310072124004364, 0.14042016863822937, 0.06749277561903, 0.005515174008905888, -0.024765122681856155, 0.09399784356355667, 0.06466536968946457, 0.1371043473482132, -0.012578408233821392, 0.15590018033981323, 0.007822137326002121, -0.03464971482753754, -0.03837932273745537, 0.09574007987976074, 0.06437317281961441, 0.10834852606058121, -0.03368101269006729, 0.09666981548070908, -0.022588547319173813, 0.03975401073694229, 0.015563146211206913, -0.18961690366268158, 0.024259692057967186, -0.012470302172005177, 0.0714406967163086, 0.027905620634555817, -1.3090923694659114e-32, -0.005556129384785891, 0.0034964641090482473, -0.08704833686351776, 0.07146862149238586, -0.12002866715192795, -0.064182810485363, 0.02789684571325779, 0.23959486186504364, 0.2027079313993454, 0.12897616624832153, 0.04404634237289429, -0.0351647287607193, 0.027280675247311592, -0.01415081974118948, 0.08882305026054382, -0.08593513071537018, 0.127741277217865, -0.053380317986011505, -0.0838262289762497, -0.0919317975640297, 0.027664512395858765, 0.12646129727363586, -0.11131136864423752, 0.10997403413057327, 0.16509060561656952, 0.027763348072767258, 0.10221932083368301, 0.13158507645130157, -0.086545929312706, -0.04534878954291344, -0.1249622032046318, 0.022304611280560493, -0.06083138659596443, -0.04454578459262848, -0.13572220504283905, 0.08407194912433624, 0.21633762121200562, 0.17135515809059143, -0.047491226345300674, -0.01757601648569107, -0.026600772514939308, -0.06218114122748375, 0.028033403679728508, 0.00860400591045618, 0.00776720279827714, 0.01570875756442547, -0.018718786537647247, -0.03972144424915314, 0.09342040866613388, 0.08657875657081604, -0.05566294863820076, -0.06223736330866814, 0.07241253554821014, 0.1663600504398346, -0.0025394593831151724, 0.0915045440196991, -0.004446578212082386, -0.056579213589429855, -0.0071767717599868774, 0.008800405077636242, 0.05580711364746094, 0.13097336888313293, -0.1053331047296524, -0.06010862812399864, 0.037036146968603134, -0.0062952181324362755, 0.16292177140712738, -0.1675884872674942, -0.0605795718729496, -0.01711496151983738, 0.017553769052028656, -0.06081543490290642, -0.16679896414279938, -0.09505083411931992, -0.05444759503006935, -0.008133153431117535, -0.16728441417217255, 0.09084222465753555, -0.022863924503326416, 0.02136390097439289, -0.010410419665277004, -0.028250539675354958, -0.07131724804639816, 0.05796613171696663, -0.011746600270271301, -0.10272116214036942, 0.13109885156154633, -0.0713949203491211, -0.061165180057287216, 0.06035400927066803, -0.12817327678203583, -0.12912796437740326, -0.1675633043050766, 0.1625077724456787, -0.04822147637605667, -9.939044787188323e-08, 0.027253126725554466, -0.01629864238202572, -0.09779611974954605, 0.036214351654052734, 0.06297483295202255, -0.03645811602473259, 0.10076650232076645, 0.10282711684703827, 0.13888230919837952, 0.1324285864830017, 0.1940383017063141, -0.11517681926488876, -0.09801259636878967, -0.045946963131427765, -0.018334342166781425, -0.06410757452249527, 0.059402044862508774, -0.07320600003004074, -0.08984114229679108, -0.2523947060108185, 0.14243489503860474, 0.05290333926677704, 0.2464594691991806, -0.09829093515872955, 0.049033451825380325, 0.04334743693470955, 0.03800518438220024, 0.052612390369176865, 0.09807975590229034, -0.06827197223901749, -0.09312532842159271, 0.07593800127506256, -0.11092488467693329, -0.03801993653178215, -0.053709641098976135, 0.006577841471880674, -0.05332981050014496, 0.10295312851667404, -0.046098094433546066, 0.1429700255393982, -0.0170383770018816, -0.09514594078063965, -0.048392582684755325, 0.06123357266187668, 0.12150255590677261, 0.002754568587988615, -0.1591721624135971, -0.05656813085079193, 0.05997608229517937, -0.1441696584224701, 0.02572098933160305, -0.1258215308189392, 0.19720618426799774, 0.05870826169848442, 0.017360040917992592, 0.08900003880262375, 0.020586378872394562, -0.07692442089319229, -0.12360526621341705, 0.1635170727968216, 0.00010526478581596166, -0.1461426466703415, -0.02257220819592476, 0.003860450815409422], "changes": {"1wk": -5.737703444335553, "1mo": -9.180327074337429}}, {"text": "PREMIUM Enanta Pharma Reports Positive Phase 2 Results for Zelicapavir as Treatment of Respiratory Syncytial Virus MT Newswires Mon, Dec 9, 2024, 6:32 PM In This Article: ENTA +1.17% Enanta Pharmaceuticals (ENTA) reported Monday positive topline results from a phase 2 study evaluati PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? Sign in Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "ENTA", "date": "2024-12-09T15:32:14+00:00", "sentiment": {"score": 0.12023811507970095, "confidence": 0.12926718592643738, "probabilities": {"positive": 0.12926718592643738, "negative": 0.009029070846736431, "neutral": 0.8617038130760193}}, "embedding": [-0.10921816527843475, 0.05802697688341141, -0.04172921180725098, -0.03448164463043213, 0.10529261082410812, -0.057454176247119904, -0.09008818119764328, 0.14552494883537292, -0.08470489084720612, 0.1386875957250595, 0.1066664308309555, -0.009197073057293892, 0.14679501950740814, 0.13254915177822113, 0.17031103372573853, 0.0036939242854714394, 0.07397662848234177, -0.08314398676156998, 0.037759844213724136, 0.03830111771821976, 0.04346403852105141, 0.17621582746505737, 0.04682169109582901, -0.0595591738820076, -0.031968649476766586, 0.0893690288066864, -0.27780383825302124, 0.15017029643058777, 0.06338300555944443, -0.08049311488866806, -0.09068796783685684, 0.10603063553571701, -0.0065782018937170506, -0.05817510560154915, -0.004567772150039673, -0.07740969210863113, -0.16919949650764465, 0.022471603006124496, -0.11797340959310532, -0.07608459889888763, 0.07562925666570663, 0.005313935689628124, -0.2586897015571594, 0.04535318538546562, 0.0518512986600399, -0.19850531220436096, -0.06036017835140228, 0.037971533834934235, 0.03232937678694725, 0.056628741323947906, -0.03252813220024109, -0.14274582266807556, 0.010853570885956287, 0.027964351698756218, -0.15776893496513367, 0.05290119722485542, -0.18037718534469604, -0.14817337691783905, -0.06821320205926895, 0.0325501374900341, 0.08080771565437317, 0.020073531195521355, -0.13089801371097565, -0.05266302078962326, 0.08645205944776535, -0.09604979306459427, 0.1289551854133606, 0.05897014960646629, -0.06085151433944702, -0.0527154803276062, -0.06528610736131668, -0.009276299737393856, 0.06314173340797424, 0.180625781416893, -0.04888806492090225, 0.20721499621868134, 0.18860022723674774, -0.09958469867706299, 0.10325489938259125, 0.0019776190165430307, 0.18484099209308624, -0.18515978753566742, 0.06034624204039574, 0.16133569180965424, 0.13977740705013275, -0.08649282902479172, 0.06778474152088165, 0.013036269694566727, 0.015650521963834763, -0.07485456764698029, 0.12134440988302231, -0.017149370163679123, 0.18250130116939545, 0.05028920993208885, 0.08467686176300049, 0.13442346453666687, -0.25492021441459656, 0.03690136596560478, -0.08757176250219345, 0.05206484720110893, 0.025510389357805252, -0.19668562710285187, -0.11361829191446304, -0.1638021469116211, -0.11039742082357407, -0.08128608763217926, 0.32790401577949524, 0.019669439643621445, -0.01917335018515587, 0.1301630288362503, -0.08024942874908447, -0.02758425660431385, 0.21365271508693695, -0.06029420346021652, 0.03556797653436661, 0.45002880692481995, -0.0036070907954126596, 0.18606455624103546, 0.05689152702689171, -0.0838964506983757, 0.2421846240758896, -0.1852288544178009, 0.20138925313949585, -0.19272305071353912, 0.08667397499084473, 0.03085833042860031, 0.08407695591449738, 1.5261588624151673e-32, -0.04835805669426918, 0.04211767390370369, 0.16264010965824127, 0.11347949504852295, 0.16218072175979614, 0.1304253488779068, 0.038663316518068314, -0.07136120647192001, -0.15818525850772858, -0.20429609715938568, -0.30908817052841187, 0.1258726269006729, 0.009765991009771824, 0.16643856465816498, -0.2589734196662903, -0.05672576650977135, -0.11703860014677048, 0.16045533120632172, -0.03952348604798317, 0.12016074359416962, 0.1309405118227005, -0.1153855100274086, 0.06632892042398453, -0.10518600791692734, -0.038157232105731964, 0.05385702848434448, -0.11067681759595871, -0.06281787902116776, 0.0929383710026741, 0.023516928777098656, 0.026403000578284264, 0.10779014229774475, -0.12913304567337036, 0.046072281897068024, -0.034064438194036484, -0.009567013941705227, -0.015733281150460243, -0.013529449701309204, -0.05570988357067108, -0.03804577887058258, 0.1340688169002533, 0.22015628218650818, -0.10069539397954941, -0.039298512041568756, 0.027133820578455925, -0.07302835583686829, -0.11134784668684006, 0.036556318402290344, 0.09177647531032562, -0.027022354304790497, -0.007789326831698418, 0.045027006417512894, -0.28938961029052734, -0.1686546802520752, -0.047540437430143356, 0.1375696212053299, 0.14876815676689148, 0.12234620004892349, 0.024459967389702797, -0.02248709835112095, -0.027399221435189247, -0.023121919482946396, 0.056705962866544724, -0.17476031184196472, -0.18543332815170288, 0.0013851987896487117, -0.08882854878902435, -0.243052139878273, -0.1350713074207306, 0.1892016977071762, 0.05016251653432846, -0.004103331360965967, -0.05167752876877785, -0.022541100159287453, 0.04279686138033867, -0.18556922674179077, -0.0034250274766236544, 0.051867980509996414, 0.06371999531984329, -0.05822279304265976, -0.027575591579079628, -0.08387686312198639, 0.10660210996866226, 0.1733195185661316, 0.004849228076636791, -0.1742222160100937, -0.16688717901706696, 0.08660056442022324, -0.04609166085720062, 0.00812588632106781, 0.12473373115062714, 0.15908722579479218, 0.03624295815825462, 0.061293575912714005, -0.05890214443206787, -1.4256076633930042e-32, -0.1235736533999443, 0.11656434088945389, -0.06050747632980347, -0.011134722270071507, -0.07686738669872284, 0.24603582918643951, 0.024668915197253227, 0.055411532521247864, 0.22233112156391144, 0.11570966243743896, 0.26295581459999084, 0.04939113184809685, 0.06435336172580719, 0.04103948175907135, 0.06986316293478012, 0.0493977926671505, 0.19498880207538605, -0.23348468542099, -0.06179802119731903, -0.14214903116226196, 0.057727228850126266, 0.057846929877996445, 0.07349486649036407, 0.11539676785469055, 0.11737874150276184, -0.047467462718486786, 0.2564370632171631, 0.05209650099277496, 0.07388933002948761, -0.1538422703742981, -0.12195072323083878, -0.1097964495420456, -0.25768616795539856, 0.16156397759914398, -0.022924387827515602, 0.02210632711648941, 0.2376406192779541, -0.25245481729507446, -0.18016348779201508, -0.07143624871969223, 0.041085973381996155, 0.011098558083176613, -0.13510949909687042, -0.00157744821626693, -0.0168190635740757, -0.04703551530838013, 0.12238037586212158, -0.009266450069844723, 0.04177451506257057, -0.018007677048444748, 0.17106899619102478, -0.037126582115888596, -0.18983633816242218, 0.10875669866800308, -0.05533064156770706, -0.0028076469898223877, -0.0764475017786026, -0.06569831818342209, -0.20358474552631378, 0.11667334288358688, 0.09907647967338562, 0.15806418657302856, -0.3215409815311432, -0.21577857434749603, 0.017544692382216454, 0.12052581459283829, 0.22104309499263763, 0.0773712694644928, 0.09810381382703781, -0.237421914935112, -0.07779809087514877, -0.11121783405542374, -0.17204974591732025, -0.13250897824764252, -0.04250288009643555, 0.10022985935211182, -0.07982098311185837, -0.2087232619524002, 0.034071240574121475, -0.17497102916240692, -0.09301156550645828, -0.02679813653230667, -0.11147936433553696, -0.04777182266116142, 0.020083455368876457, -0.04364258795976639, 0.038546156138181686, 0.08650507032871246, 0.08057524263858795, 0.16435712575912476, -0.08728250861167908, -0.04881824925541878, -0.14764001965522766, 0.2522021532058716, 0.08826761692762375, -9.986048610244325e-08, 0.11352046579122543, -0.1432318538427353, 0.15422315895557404, 0.10913606733083725, -0.18676622211933136, -0.026285942643880844, -0.028232453390955925, 0.11008723080158234, 0.1577903926372528, 0.16841743886470795, 0.016629142686724663, 0.0974443182349205, 0.04012338072061539, 0.09611143916845322, 0.18339641392230988, 0.09435324370861053, -0.015875859186053276, 0.19371429085731506, -0.13291017711162567, -0.23019631206989288, 0.020248133689165115, 0.04392673075199127, -0.07360729575157166, -0.1259775608778, -0.08276104182004929, -0.1269262731075287, -0.07014506310224533, 0.01597963087260723, 0.05580361559987068, -0.2857292592525482, -0.252533882856369, -0.06574762612581253, 0.012886048294603825, -0.10984768718481064, -0.2804684042930603, -0.0062287249602377415, 0.184160053730011, -0.0461198054254055, 0.04774649441242218, 0.07903329282999039, 0.20260483026504517, -0.02025572769343853, 0.023942768573760986, -0.038608260452747345, -0.07901549339294434, 0.023784061893820763, -0.05932031199336052, -0.1316467970609665, 0.09763754904270172, -0.1948978453874588, 0.052476171404123306, -0.033682163804769516, 0.11678796261548996, 0.014273582026362419, -0.19559346139431, 0.09244012832641602, -0.12166494876146317, -0.1682596206665039, 0.18470297753810883, 0.005448917858302593, 0.12108228355646133, -0.1598505824804306, 0.0289841927587986, 0.07714547216892242], "changes": {"1wk": -29.418341846174883, "1mo": -42.28187819231558}}, {"text": "Enanta Pharmaceuticals\u2019 Reduced Reporting: Potential Impact on Investor Appeal and Stock Volatility TipRanks Fri, Nov 29, 2024, 9:00 AM 1 min read In This Article: ENTA +1.17% https://www.tipranks.com/news/the-fly/dentsply-sirona-to-reposition-byte-business-within-aligner-portfolio Enanta Pharmaceuticals ( ENTA ) has disclosed a new risk, in the Share Price & Shareholder Rights category. Don't Miss our Black Friday Offers: Unlock your investing potential with TipRanks Premium - Now At 40% OFF! Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter Enanta Pharmaceuticals, as a smaller reporting company under the Exchange Act, may opt to utilize reduced reporting and disclosure obligations, potentially impacting investor appeal and the market activity of its common stock. These exemptions include limited executive compensation disclosures and a requirement of only two years of audited financial statements, which may lead to heightened stock price volatility. The company will maintain this status provided its public float remains below $250 million or its annual revenues are under $100 million with specific conditions. Consequently, Enanta\u2019s decision to adhere to these reduced requirements could deter some investors, affecting stock attractiveness and trading dynamics. Overall, Wall Street has a Moderate Buy consensus rating on ENTA stock based on 3 Buys and 2 Holds. To learn more about Enanta Pharmaceuticals\u2019 risk factors, click here . Trending Articles M&A News: Blackrock to Buy HPS for $12B to Fortify Alternative Investments Business Google Urges Appeals Court to Overturn App Store Change Ruling Symbotic Craters 36% on Financial Misstatements and 10-K Filing Delay View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "ENTA", "date": "2024-11-29T06:00:24+00:00", "sentiment": {"score": 0.03779332712292671, "confidence": 0.06957914680242538, "probabilities": {"positive": 0.06957914680242538, "negative": 0.03178581967949867, "neutral": 0.8986350297927856}}, "embedding": [-0.0907534509897232, -0.07216325402259827, -0.016688227653503418, 0.003989530727267265, -0.028104353696107864, 0.052680354565382004, 0.0716252401471138, 0.13081154227256775, -0.012245328165590763, 0.09121377766132355, 0.04668573662638664, 0.04915213957428932, -0.014154860749840736, 0.029352033510804176, 0.0566517598927021, -0.019282039254903793, 0.10442645847797394, -0.03671874850988388, -0.15046802163124084, 0.1267682909965515, -0.0388384684920311, -0.12280324846506119, -0.06111091747879982, 0.15461605787277222, 0.007747229654341936, 0.03529003635048866, -0.0483754426240921, 0.0717567428946495, -0.17278827726840973, -0.17709191143512726, -0.05595400556921959, 0.09080103039741516, 0.10653961449861526, -0.07690916955471039, -0.014415036886930466, -0.01901291310787201, -0.07716133445501328, 0.08145708590745926, 0.11075717210769653, -0.0950508862733841, 0.010940732434391975, -0.06203561648726463, -0.15595611929893494, -0.032563019543886185, 0.06881994754076004, -0.21998584270477295, 0.0924973413348198, -0.005394995212554932, 0.02855255827307701, 0.07220080494880676, -0.1310008317232132, -0.06581484526395798, 0.04155349358916283, -0.03949018940329552, -0.13447163999080658, -0.09813257306814194, -0.08028488606214523, -0.014383898116648197, 0.0449734590947628, 0.02152658812701702, 0.11516182124614716, -0.0627058818936348, 0.01566380262374878, 0.0417451485991478, 0.12083227932453156, -0.004692416172474623, 0.05360583961009979, 0.003112840699031949, -0.10641621053218842, 0.0554356724023819, 0.1614357978105545, -0.045293211936950684, -0.07680859416723251, -0.006119052413851023, -0.1466994732618332, 0.08425775915384293, 0.08164825290441513, 0.007811564486473799, 0.0456123985350132, 0.009667065925896168, 0.13542158901691437, 0.007294748444110155, -0.05582829564809799, -0.014472323469817638, 0.0018526928033679724, -0.08007701486349106, 0.11244529485702515, 0.024873223155736923, 0.1096142828464508, 0.023816736415028572, 0.14882852137088776, -0.076327383518219, 0.04326274245977402, -0.007219042629003525, 0.0950942263007164, -0.023740222677588463, -0.2655574083328247, -0.008977513760328293, -0.0992797315120697, 0.03971024602651596, 0.12289172410964966, 0.09235872328281403, -0.15790309011936188, -0.06406866014003754, -0.037573155015707016, -0.12848347425460815, 0.14685340225696564, -0.025073492899537086, -0.052721116691827774, 0.0677584633231163, -0.11654907464981079, 0.08897127956151962, -0.003340131603181362, 0.027199622243642807, -0.11095861345529556, 0.17016537487506866, -0.020170677453279495, 0.015818452462553978, 0.1251966655254364, -0.003151539945974946, 0.12161795049905777, 0.11973674595355988, 0.04111172631382942, -0.057296790182590485, 0.0262326430529356, 0.0723014622926712, -0.13157202303409576, 1.0854893932421143e-32, -0.012681814841926098, 0.05895531177520752, -0.004166648723185062, 0.018442979082465172, 0.027826109901070595, 0.11891553550958633, 0.0035138060338795185, -0.04547834023833275, -0.19460706412792206, -0.080725759267807, -0.12617605924606323, 0.15900518000125885, 0.011626314371824265, 0.05329623445868492, -0.010168826207518578, 0.05513531714677811, -0.023026904091238976, 0.12747754156589508, 0.03999485448002815, -0.08160989731550217, 0.0250155720859766, -0.06643053144216537, -0.12109401822090149, -0.02382678911089897, -0.13996487855911255, -0.04455803334712982, -0.09819692373275757, -0.021850205957889557, -0.0367591418325901, 0.02747398614883423, -0.012333436869084835, 0.1087423786520958, 0.03974093869328499, -0.042115066200494766, 0.038101594895124435, -0.051891736686229706, -0.04306672140955925, -0.059354525059461594, 0.08494553714990616, -0.03745928034186363, -0.0127153554931283, 0.22890901565551758, -0.09928975999355316, -0.12673000991344452, -0.010197392664849758, 0.056343141943216324, -0.07237349450588226, 0.02438630908727646, -0.02837149053812027, -0.0032717676367610693, 0.014033879153430462, 0.026685897260904312, -0.08334047347307205, -0.06113021448254585, -0.004434453323483467, -0.015338240191340446, -0.017131919041275978, -0.17450833320617676, 0.023076847195625305, 0.08790625631809235, -0.0534089095890522, 0.0977858453989029, 0.023727621883153915, -0.053361888974905014, -0.21052664518356323, 0.19935061037540436, -0.01400700956583023, 0.055020567029714584, -0.1447407305240631, 0.05144769325852394, -0.007056802976876497, -0.06104141101241112, 0.06301184743642807, -0.07137715816497803, 0.014025473967194557, -0.1044268012046814, -0.03480479121208191, 0.044270362704992294, 0.0907067209482193, 0.014551687054336071, 0.09171777218580246, -0.10433200001716614, 0.12364909797906876, 0.08551813662052155, 0.004789530765265226, -0.0678776204586029, 0.0048295739106833935, 0.026403427124023438, 0.0029087092261761427, -0.0026540516410022974, 0.0236769188195467, -0.022391362115740776, -0.0842093676328659, 0.07617548853158951, -0.011741353198885918, -1.0200087743031465e-32, -0.1313871443271637, -0.02987070009112358, -0.0031761014834046364, -0.029265092685818672, -0.12824027240276337, 0.06873769313097, 0.0652269721031189, 0.020364554598927498, 0.09322913736104965, 0.029972871765494347, -0.017807617783546448, 0.049504343420267105, -0.03927869349718094, -0.014294954016804695, -0.019484078511595726, -0.023514963686466217, 0.05924100801348686, -0.09779764711856842, 0.01945679262280464, -0.15593895316123962, 0.06401778757572174, 0.1163676455616951, -0.06572036445140839, 0.24035534262657166, 0.03339453041553497, 0.1156163364648819, 0.046524252742528915, 0.06127774342894554, 0.05574658513069153, -0.01245544757694006, -0.09433519840240479, -0.042083803564310074, -0.16239063441753387, 0.12158819288015366, 0.022050242871046066, 0.02529240772128105, 0.07113181799650192, -0.17186357080936432, -0.06675135344266891, 0.03736279159784317, 0.042595695704221725, 0.06413844227790833, 0.03503693267703056, -0.01814907044172287, 0.020159898325800896, -0.043305329978466034, 0.07979646325111389, -0.01603483036160469, 0.11668796092271805, 0.05350825563073158, 0.08143197000026703, -0.022915199398994446, 0.061996281147003174, 0.1245921179652214, -0.11884935200214386, -0.047581128776073456, -0.0033795475028455257, -0.03556336462497711, -0.10681997239589691, 0.10831794142723083, 0.10007354617118835, 0.20138640701770782, -0.10101369768381119, -0.02554849162697792, -0.08147472143173218, -0.054366230964660645, 0.01091783307492733, -0.06783861666917801, 0.03623005747795105, -0.19307388365268707, 0.0018145102076232433, -0.2240571826696396, 0.09726820886135101, -0.15834350883960724, -0.0005069631151854992, 0.20955270528793335, -0.02611212059855461, -0.1595824807882309, -0.08447463065385818, 0.01998634822666645, -0.027564145624637604, 0.011775879189372063, 0.028352340683341026, 0.024963196367025375, -0.009457876905798912, 0.044619884341955185, -0.04240231215953827, -0.002344084670767188, -0.031562693417072296, 0.06346825510263443, -0.05672712251543999, -0.11152493208646774, -0.02722756564617157, 0.1727379858493805, 0.09105387330055237, -9.967062197802079e-08, -0.006123448722064495, -0.09131129831075668, 0.09697584807872772, 0.06843724101781845, 0.009347854182124138, -0.09418302774429321, 0.07383640855550766, -0.01636485569179058, 0.17668870091438293, 0.12372767180204391, 0.12949001789093018, 0.03170955926179886, -0.19850093126296997, 0.08440963178873062, -0.0792747288942337, 0.00015578475722577423, -0.045574840158224106, 0.05080485716462135, -0.059029046446084976, -0.014716025441884995, 0.0014720635954290628, 0.012437860481441021, 0.1040230318903923, -0.09597378224134445, 0.05481517314910889, -0.07224339246749878, 0.0271461084485054, 0.07203574478626251, 0.06570716202259064, 0.07194747775793076, -0.028032269328832626, -0.11005262285470963, 0.19742940366268158, 0.06771736592054367, -0.09543066471815109, -0.04543038457632065, 0.07983764261007309, 0.08022678643465042, -0.017999514937400818, 0.10336324572563171, -0.06601766496896744, -0.10884592682123184, -0.012834200635552406, 0.037279438227415085, -0.0010537049965932965, -0.04862469434738159, -0.17125897109508514, 0.030269451439380646, 0.04695809632539749, -0.19458213448524475, 0.062317680567502975, -0.017105471342802048, 0.09602990001440048, 0.09961163997650146, -0.007498038932681084, 0.10852999985218048, -0.14724673330783844, 0.05413665622472763, -0.03182573989033699, -0.06461524218320847, 0.09871464222669601, -0.20150679349899292, -0.09877147525548935, 0.13964392244815826], "changes": {"1wk": -6.860466586247529, "1mo": -30.11627950817909}}, {"text": "Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year-Ended September 30, 2024 Business Wire Tue, Nov 26, 2024, 12:01 AM 13 min read In This Article: ENTA +1.17% On Track to Report Topline Results for RSVPEDs, a Phase 2 Study of Zelicapavir in Infants and Children Infected with Respiratory Syncytial Virus (RSV), in December Announced Positive Topline Results for EDP-323 in a Phase 2a Human Challenge Study of Healthy Adults Infected with RSV Expands Immunology Portfolio with the Introduction of a New Discovery Program Focused on STAT6 Inhibition and the Nomination of EPS-1421, a Potent and Selective KIT Inhibitor Development Candidate Operations Supported by Cash and Marketable Securities Totaling $248.2 Million at September 30, 2024, as well as Continuing Retained Royalties WATERTOWN, Mass., November 25, 2024 --( BUSINESS WIRE )-- Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for virology and immunology indications, today reported financial results for its fiscal fourth quarter and year-ended September 30, 2024. \"Our fiscal fourth quarter was an exciting time for Enanta as we announced positive data from a Phase 2a human challenge study of EDP-323, our RSV L-inhibitor. We believe these results are among the strongest ever reported for an antiviral in an RSV challenge study, and significantly unlock further promise of our RSV program, in addition to advancing our leadership role in the RSV treatment landscape,\" said Jay R. Luly, Ph.D., President and Chief Executive Officer at Enanta Pharmaceuticals. \"With results from our RSVPEDs study of zelicapavir, our RSV N-inhibitor, expected in December, we could potentially have two of the leading clinical candidates for the treatment of RSV with different mechanisms of action, providing us with important optionality. The results of these studies will guide our decisions as we work to develop first-in-disease and best-in-class treatments for patients suffering from RSV.\" Dr. Luly added, \"We also made notable progress in advancing and expanding our immunology portfolio with the nomination of EPS-1421 as our lead development candidate for our KIT inhibition program. We are excited about the potential for potent and selective, oral, small molecule inhibitors for the treatment of chronic spontaneous urticaria and possibly other mast cell driven diseases. We are also pleased to introduce our second discovery stage program to develop oral STAT6 inhibitors for the treatment of type 2 immune driven diseases, with an initial focus on the treatment of atopic dermatitis, and future expansion opportunities in asthma and other indications. With multiple ongoing programs in both virology and immunology, we are committed to advancing our pipeline to help patients and to create value for shareholders.\" Story Continues Fiscal Fourth Quarter and Year-Ended September 30, 2024 Financial Results Total revenue was $14.6 million for the three months ended September 30, 2024, which consisted of royalty revenue derived from worldwide net sales of AbbVie\u2019s hepatitis C virus (HCV) regimen MAVYRET \u00ae /MAVIRET \u00ae , compared to royalty revenue of $18.9 million for the three months ended September 30, 2023. For the twelve months ended September 30, 2024, total revenue was $67.6 million compared to $79.2 million for the same period in 2023. The decrease in the quarter and in year-over-year revenue is due to a decline in AbbVie\u2019s sales of MAVYRET \u00ae /MAVIRET \u00ae . A portion (54.5%) of Enanta\u2019s ongoing royalty revenue from AbbVie\u2019s net sales of MAVYRET \u00ae /MAVIRET \u00ae is paid to OMERS, one of Canada\u2019s largest defined benefit pension plans, pursuant to a royalty sale transaction affecting royalties earned after June 2023. For financial reporting purposes, the transaction was treated as debt, with the upfront purchase payment of $200.0 million recorded as a liability. Each quarter, Enanta records 100% of the royalty earned as revenue and then amortizes the debt liability proportionally as 54.5% of the cash royalty payments are paid to OMERS through June 30, 2032, subject to a cap of 1.42 times the purchase payment, after which point 100% of the cash royalty payments will be retained by Enanta. Interest expense was $2.6 million for the three months ended September 30, 2024 and $10.9 million for the twelve months ended September 30, 2024. This compares to interest expense of $3.2 million for the three months ended September 30, 2023 and $5.1 million for the twelve months ended September 30, 2023. Research and development expenses were $30.8 million for the three months ended September 30, 2024, compared to $36.2 million for the three months ended September 30, 2023. For the twelve months ended September 30, 2024, research and development expenses were $131.5 million compared to $163.5 million for the same period in 2023. The decrease in the quarter and in year-over-year research and development expenses is primarily due to a decrease in costs associated with Enanta\u2019s COVID-19 program as the company announced previously that plans to pursue any further COVID-19 efforts would be in the context of collaborations. These decreases were partially offset by increased costs associated with Enanta\u2019s immunology programs. General and administrative expenses totaled $13.7 million for the three months ended September 30, 2024, compared to $13.8 million for the three months ended September 30, 2023. For the twelve months ended September 30, 2024, general and administrative expenses were $57.9 million compared to $52.9 million in 2023. The increase in year-over-year general and administrative expenses was due to an increase in legal fees related to the company\u2019s patent infringement suit against Pfizer. Interest and investment income, net, totaled $3.2 million for the three months ended September 30, 2024, compared to $4.7 million for the three months ended September 30, 2023. The decrease was due to lower cash and investment balances year-over-year. For the twelve months ended September 30, 2024, interest and investment income, net, totaled $14.8 million compared to $11.4 million in 2023. The increase was due to an increase in average invested cash due to receipt of $200.0 million from OMERS in April 2023 as well as changes in interest rates year-over-year. Enanta recorded an income tax benefit of $0.4 million for the three months ended September 30, 2024, compared to an income tax benefit of $1.4 million for the three months ended September 30, 2023. Enanta recorded an income tax benefit of $1.7 million for the twelve months ended September 30, 2024, compared to an income tax expense of $2.8 million for the twelve months ended September 30, 2023. The income tax benefit during 2024 was due to interest earned on a pending $28.7 million federal income tax refund. Despite recording a loss before taxes during the twelve months ended September 30, 2023, Enanta recorded tax expense driven by the receipt of the $200.0 million from OMERS, which is treated as income for Federal and State income tax purposes. Net loss for the three months ended September 30, 2024, was $28.8 million, or a loss of $1.36 per diluted common share, compared to a net loss of $28.1 million, or a loss of $1.33 per diluted common share, for the corresponding period in 2023. For the twelve months ended September 30, 2024, net loss was $116.0 million, or a loss of $5.48 per diluted common share, compared to a net loss of $133.8 million, or loss of $6.38 per diluted common share for the corresponding period in 2023. Enanta\u2019s cash, cash equivalents and marketable securities totaled $248.2 million at September 30, 2024. Enanta expects that its current cash, cash equivalents and short-term marketable securities, as well as its continuing retained portion of royalty revenue, will continue to be sufficient to meet the anticipated cash requirements of its existing business and development programs into fiscal 2027. Virology RSV Enanta is progressing multiple clinical programs comprising a robust antiviral portfolio aimed at treating populations at high-risk for serious outcomes from RSV infection. This includes zelicapavir, Enanta\u2019s lead, oral N-protein inhibitor, and EDP-323, its oral L-protein inhibitor, both of which received Fast Track designation from the U.S. Food and Drug Administration (FDA). Zelicapavir is being evaluated in two Phase 2 clinical trials in high-risk pediatric and adult populations. Enrollment is complete in RSVPEDs, a first-in-pediatrics Phase 2, randomized, double-blind, placebo-controlled study of zelicapavir in hospitalized and non-hospitalized RSV patients that are 28 days to three years of age. The company is on track to report topline data in December 2024. RSVHR is a Phase 2b, randomized, double-blind, placebo-controlled study of zelicapavir in adults with RSV infection who are at high risk of complications, including age over 65 years and/or those with congestive heart failure, chronic obstructive pulmonary disease or asthma. Enrollment in RSVHR is progressing, and the company is targeting enrollment completion in the current Northern Hemisphere RSV season. Enanta\u2019s second clinical RSV candidate, EDP-323, is a novel oral, direct-acting antiviral selectively targeting the RSV L-protein. In September 2024, Enanta announced positive topline results for EDP-323 in a Phase 2a challenge study of healthy adults infected with RSV. Treatment with EDP-323 achieved statistically significant (p=<0.0001) reductions in both viral load and clinical symptoms compared to placebo. Overall, EDP-323 was generally well-tolerated and demonstrated a favorable safety profile that was comparable to placebo over 5 days of dosing through Day 28 of follow-up. There were no serious adverse events and no discontinuations of EDP-323. With these positive results the company has a potential second approach for treating RSV that may offer a best-in-disease opportunity. Pending RSVPEDs data results, Enanta will provide next steps for EDP-323 and its RSV program. Immunology Today, Enanta announced the expansion of its immunology portfolio which is focused on designing and developing highly potent and selective, oral small molecule inhibitors for the treatment of inflammatory diseases, by targeting key drivers of the type 2 immune response. KIT Inhibitor EPS-1421: Enanta nominated EPS-1421 as its lead development candidate. EPS-1421 is a novel, potent and selective oral inhibitor of KIT, designed to treat chronic spontaneous urticaria and potentially other indications by depleting mast cells, thereby addressing a primary driver of these diseases. EPS-1421 inhibits KIT with nanomolar potency in both binding and cellular assays and is highly selective for KIT versus other kinases. Further, EPS-1421 has demonstrated good in vitro and in vivo ADME properties preclinically. The company expects to conduct scale-up activities and IND enabling studies in 2025. STAT6 Inhibitors: The company\u2019s second discovery program is aimed at developing oral STAT6 inhibitors for the treatment of type 2 immune driven diseases and will initially focus on atopic dermatitis and potentially other indications by blocking the IL-4/IL-13 signaling pathway, thereby addressing a primary driver of these diseases. Currently, Enanta is advancing novel, potent and selective oral inhibitors of STAT6. The company\u2019s prototype inhibitors demonstrate potent activity and high selectivity for STAT6 over other STATs in both biochemical and cellular assays. Enanta continues to evaluate multiple compounds in preclinical studies and expects to conduct lead optimization activities for this program in 2025. Corporate Enanta will not be holding a conference call with today\u2019s fiscal fourth quarter and year-end update. The company will provide its next update with the release of the RSVPEDs study results, expected in December 2024. About Enanta Pharmaceuticals, Inc. Enanta is using its robust, chemistry-driven approach and drug discovery capabilities to become a leader in the discovery and development of small molecule drugs with an emphasis on indications in virology and immunology. Enanta\u2019s clinical programs are currently focused on respiratory syncytial virus (RSV) and its earlier-stage immunology pipeline aims to develop treatments for inflammatory diseases by targeting key drivers of the type 2 immune response, including KIT and STAT6 inhibition. Glecaprevir, a protease inhibitor discovered by Enanta, is part of one of the leading treatment regimens for curing chronic hepatitis c virus (HCV) infection and is sold by AbbVie in numerous countries under the tradenames MAVYRET \u00ae (U.S.) and MAVIRET \u00ae (ex-U.S.) (glecaprevir/pibrentasvir). A portion of Enanta\u2019s royalties from HCV products developed under its collaboration with AbbVie contribute ongoing funding to Enanta\u2019s operations. Please visit www.enanta.com for more information. Forward Looking Statements This press release contains forward-looking statements, including statements with respect to the prospects for advancement of Enanta\u2019s clinical programs in RSV and its preclinical programs targeting KIT and STAT6 inhibition. Statements that are not historical facts are based on management\u2019s current expectations, estimates, forecasts and projections about Enanta\u2019s business and the industry in which it operates and management\u2019s beliefs and assumptions. The statements contained in this release are not guarantees of future performance and involve certain risks, uncertainties and assumptions, which are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed in such forward-looking statements. Important factors and risks that may affect actual results include: the impact of development, regulatory and marketing efforts of others with respect to vaccines and competitive treatments for RSV; the discovery and development risks of Enanta\u2019s programs in virology and immunology; Enanta\u2019s lack of clinical development experience; Enanta\u2019s need to attract and retain senior management and key research and development personnel; Enanta\u2019s need to obtain and maintain patent protection for its product candidates and avoid potential infringement of the intellectual property rights of others; and other risk factors described or referred to in \"Risk Factors\" in Enanta\u2019s Form 10-K for the fiscal year-ended September 30, 2023, and any other periodic reports filed more recently with the Securities and Exchange Commission. Enanta cautions investors not to place undue reliance on the forward-looking statements contained in this release. These statements speak only as of the date of this release, and Enanta undertakes no obligation to update or revise these statements, except as may be required by law. Tables to Follow ENANTA PHARMACEUTICALS, INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS UNAUDITED (in thousands, except per share amounts) Three Months Ended Twelve Months Ended September 30, September 30, 2024 2023 2024 2023 Revenue $ 14,607 $ 18,932 $ 67,635 $ 79,204 Operating expenses Research and development 30,778 36,167 131,476 163,524 General and administrative 13,683 13,795 57,850 52,887 Total operating expenses 44,461 49,962 189,326 216,411 Loss from operations (29,854 ) (31,030 ) (121,691 ) (137,207 ) Interest expense (2,581 ) (3,151 ) (10,940 ) (5,148 ) Interest and investment income, net 3,249 4,664 14,843 11,360 Loss before income taxes (29,186 ) (29,517 ) (117,788 ) (130,995 ) Income tax benefit (expense) 363 1,410 1,743 (2,821 ) Net loss $ (28,823 ) $ (28,107 ) $ (116,045 ) $ (133,816 ) Net loss per share Basic $ (1.36 ) $ (1.33 ) $ (5.48 ) $ (6.38 ) Diluted $ (1.36 ) $ (1.33 ) $ (5.48 ) $ (6.38 ) Weighted average common shares outstanding Basic 21,190 21,057 21,157 20,969 Diluted 21,190 21,057 21,157 20,969 ENANTA PHARMACEUTICALS, INC. CONDENSED CONSOLIDATED BALANCE SHEETS UNAUDITED (in thousands) September 30, September 30, 2024 2023 Assets Current assets Cash and cash equivalents $ 37,233 $ 85,388 Short-term marketable securities 210,953 284,522 Accounts receivable 6,646 8,614 Prepaid expenses and other current assets 12,413 13,263 Income tax receivable 31,999 31,004 Short-term restricted cash 608 \u2014 Total current assets 299,852 422,791 Property and equipment, net 32,688 11,919 Operating lease, right-of-use assets 40,658 22,794 Long-term restricted cash 3,360 3,968 Other long-term assets 94 803 Total assets $ 376,652 $ 462,275 Liabilities and Stockholders' Equity Current liabilities Accounts payable $ 8,002 $ 4,097 Accrued expenses and other current liabilities 13,547 18,339 Liability related to the sale of future royalties 34,462 35,076 Operating lease liabilities 1,524 5,275 Total current liabilities 57,535 62,787 Liability related to the sale of future royalties, net of current portion 134,779 159,429 Operating lease liabilities, net of current portion 53,943 21,238 Series 1 nonconvertible preferred stock 1,350 1,423 Other long-term liabilities 231 663 Total liabilities 247,838 245,540 Total stockholders' equity 128,814 216,735 Total liabilities and stockholders' equity $ 376,652 $ 462,275 View source version on businesswire.com: https://www.businesswire.com/news/home/20241125650982/en/ Contacts Media and Investors: Jennifer Viera jviera@enanta.com View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "ENTA", "date": "2024-11-25T21:01:00+00:00", "sentiment": {"score": 0.8801650390960276, "confidence": 0.887813150882721, "probabilities": {"positive": 0.887813150882721, "negative": 0.007648111786693335, "neutral": 0.10453879088163376}}, "embedding": [-0.12890765070915222, -0.03124184161424637, -0.07747621089220047, -0.0846889391541481, 0.03300679847598076, 0.010130589827895164, -0.021205972880125046, 0.20552460849285126, 0.053839944303035736, 0.20696723461151123, -0.056093424558639526, 0.09553200006484985, 0.04442868381738663, 0.11458152532577515, -0.03141936659812927, 0.06392829120159149, 0.015267833136022091, 0.04630892351269722, -0.08691422641277313, 0.044548384845256805, 0.005732692778110504, 0.10597887635231018, 0.11178639531135559, -0.07240317761898041, 0.03061726875603199, 0.06427989900112152, -0.09501755237579346, 0.07812853902578354, -0.11599820107221603, -0.09712588787078857, 0.03553985804319382, 0.11024315655231476, 0.051769278943538666, -0.12419525533914566, -0.03880714997649193, -0.006150588393211365, -0.1609041690826416, 0.07394007593393326, -0.00930330902338028, -0.08009669929742813, -0.021903086453676224, -0.01003657840192318, -0.2061898112297058, -0.06759461760520935, 0.02089860662817955, -0.2581886053085327, -0.12013280391693115, 0.007596071809530258, -0.011873947456479073, 0.07682289928197861, -0.03789360821247101, -0.09892183542251587, -0.0004127025604248047, 0.17671290040016174, -0.14366428554058075, -0.05394146591424942, -0.1959051787853241, -0.10693486034870148, -0.03655761480331421, 0.0015841084532439709, 0.04113869369029999, 0.016449008136987686, -0.03733526170253754, -0.06644774973392487, 0.0784476101398468, -0.0711892694234848, 0.13853485882282257, 0.053013794124126434, -0.030260426923632622, -0.03800693899393082, 0.015633653849363327, 0.016115374863147736, -0.09258584678173065, 0.21634231507778168, -0.0659751147031784, 0.14480102062225342, 0.2044285237789154, 0.09651035070419312, 0.14543794095516205, -0.10831144452095032, 0.14708520472049713, 0.001058946829289198, 0.04143332690000534, 0.06284193694591522, -0.034600358456373215, 0.05624587461352348, 0.02321622148156166, 0.14458248019218445, 0.09376398473978043, 0.00981418788433075, 0.13194063305854797, -0.07244955003261566, 0.11530780047178268, -0.02648891508579254, 0.07667865604162216, 0.02093363367021084, -0.177222341299057, 0.012105626054108143, 0.030192578211426735, 0.012196697294712067, 0.029707785695791245, -0.08584802597761154, -0.13310649991035461, -0.13395965099334717, 0.022593144327402115, -0.06838013231754303, 0.14912277460098267, -0.07479163259267807, 0.002745436504483223, -0.010753169655799866, -0.1373295783996582, -0.035628385841846466, 0.07574765384197235, 0.0527273453772068, -0.03805757313966751, 0.23968815803527832, -0.07864397019147873, 0.11361303925514221, 0.10794264823198318, -0.006652708165347576, 0.17041563987731934, 0.020699990913271904, 0.051568545401096344, -0.12802380323410034, 0.02353387139737606, 0.044284094125032425, -0.03422577679157257, 9.125846067485194e-33, -0.005927243269979954, 0.014101894572377205, 0.08072859793901443, 0.13542190194129944, 0.08723969012498856, 0.09673396497964859, 0.1224646270275116, 0.038915663957595825, -0.25526902079582214, -0.08972421288490295, -0.2234915792942047, 0.05897677689790726, 0.04326432943344116, 0.13314951956272125, -0.12751276791095734, -0.021594464778900146, -0.030359843745827675, 0.015000270679593086, -0.05479113385081291, 0.007687773555517197, 0.04732126742601395, -0.03147733211517334, 0.049473702907562256, 0.03561971336603165, 0.009177346713840961, 0.018052052706480026, -0.13180698454380035, 0.00335727259516716, 0.08358624577522278, 0.008587428368628025, -0.04552429914474487, 0.15048837661743164, -0.019068917259573936, 0.005750600248575211, -0.062300026416778564, -0.12729528546333313, -0.015285699628293514, -0.1320272833108902, 0.015179326757788658, 0.033563122153282166, 0.06723694503307343, 0.21667689085006714, -0.11863532662391663, -0.013220027089118958, -0.03507944568991661, -0.03057062439620495, -0.08769728243350983, 0.025892993435263634, -0.017943207174539566, -0.0005806423723697662, 0.02948325127363205, 0.01643122173845768, -0.05971252918243408, -0.20755770802497864, -0.050854891538619995, 0.00788441114127636, -0.08081956207752228, 0.06224515661597252, -0.005808436777442694, 0.04092609882354736, -0.027740858495235443, 0.08186419308185577, 0.005732112564146519, 0.045341283082962036, -0.1494060456752777, 0.009142826311290264, 0.04643026739358902, -0.11331593245267868, -0.10210657119750977, 0.10682801157236099, -0.05296841263771057, -0.07131204754114151, 0.10305808484554291, -0.04324614629149437, 0.1944764256477356, -0.18692199885845184, 0.09152919054031372, 0.03225482255220413, 0.008727692067623138, -0.009000826627016068, -0.07750353217124939, -0.007697136141359806, -0.05868338793516159, 0.11975023150444031, 0.017121192067861557, -0.17133398354053497, -0.06977356225252151, -0.041733112186193466, -0.05403132736682892, -0.07461726665496826, 0.1467999517917633, 0.016279911622405052, -0.06274992227554321, 0.0948248952627182, 0.0025583310052752495, -1.0147607797739004e-32, -0.009358664974570274, 0.05664600431919098, 0.003210612805560231, -0.01936032995581627, -0.02648579701781273, 0.1572754681110382, 0.11143074929714203, -0.12582342326641083, 0.1791832596063614, -0.03920033201575279, 0.1608567237854004, -0.0025226206053048372, 0.059478774666786194, -0.03238694369792938, 0.00295702344737947, -0.024981539696455002, 0.045896440744400024, -0.12130805104970932, -0.057865921407938004, 0.0014233142137527466, 0.055651258677244186, 0.1592278927564621, -0.028381096199154854, 0.029594872146844864, 0.11107008159160614, -0.015051334165036678, 0.16020731627941132, 0.07374116778373718, 0.0538393072783947, -0.0731600746512413, -0.0391596257686615, -0.00836954452097416, -0.2813161611557007, 0.035622961819171906, -0.06477312743663788, 0.018875326961278915, 0.18418502807617188, -0.2476794719696045, -0.07860559225082397, -0.13038001954555511, 0.0569642037153244, 0.03827591985464096, -0.04905596375465393, 0.09056562185287476, 0.014582605101168156, -0.05579975247383118, 0.06238856166601181, 0.05143149197101593, 0.09589628875255585, -0.02953820675611496, 0.0459308996796608, -0.004905762616544962, -0.12947194278240204, 0.05126927047967911, -0.022311395034193993, -0.0077971238642930984, -0.06006893515586853, -0.05635186284780502, -0.02817780151963234, 0.08660174161195755, 0.06279486417770386, 0.11989634484052658, -0.062408752739429474, -0.03225427865982056, -0.006406351923942566, 0.13888846337795258, 0.18429218232631683, 0.0539754256606102, 0.06394394487142563, -0.2917293906211853, -0.015221799723803997, -0.11236097663640976, 0.022767020389437675, -0.12821918725967407, -0.05571494251489639, 0.10559312254190445, -0.08147567510604858, -0.24235858023166656, -0.0043389564380049706, -0.0762203112244606, -0.06962956488132477, -0.04901538044214249, -0.0681867003440857, -0.017466949298977852, 0.06301763653755188, 0.033763542771339417, 0.03519284725189209, 0.047809332609176636, 0.03480833023786545, 0.09129585325717926, -0.048092104494571686, -0.14324145019054413, -0.03363106772303581, 0.1816723346710205, 0.07232935726642609, -1.0075913081664112e-07, 0.23802624642848969, -0.12635666131973267, -0.007631806656718254, -0.025588281452655792, 0.03644094988703728, -0.05297692492604256, -0.002001199871301651, 0.12074608355760574, 0.09313133358955383, 0.21505378186702728, 0.06329500675201416, 0.16411493718624115, -0.061273444443941116, 0.05093330889940262, 0.06052238866686821, 0.009044271893799305, -0.05662960186600685, 0.13825508952140808, -0.1414332389831543, -0.08955246210098267, 3.3663585782051086e-05, 0.05096662789583206, -0.08420555293560028, -0.04905205965042114, 0.033549413084983826, -0.20902985334396362, -0.05546559765934944, -0.011235162615776062, 0.07665883004665375, -0.2208583652973175, -0.08040095865726471, -0.05615495145320892, 0.0915040671825409, 0.00020645279437303543, -0.11694160103797913, -0.08318199217319489, 0.10048782825469971, 0.019216328859329224, 0.049404554069042206, 0.14499688148498535, 0.12290129065513611, -0.056219682097435, -0.03583063185214996, -0.04877837002277374, -0.10196568071842194, -0.03168913722038269, -0.14660866558551788, -0.06874479353427887, 0.0012236631009727716, -0.19097459316253662, -0.0060478090308606625, -0.030807241797447205, 0.02595493011176586, -0.08798130601644516, -0.02787175215780735, 0.16950461268424988, -0.1184358298778534, -0.08874236047267914, 0.0573129877448082, -0.0789196714758873, 0.048401281237602234, -0.179376482963562, -0.0008111028000712395, 0.024637576192617416], "changes": {"1wk": -4.8834686224222486, "1mo": -32.29745005911511}}, {"text": "Enanta Pharmaceuticals Announces Positive Topline Results from First-in-Pediatrics Phase 2 Study Evaluating Zelicapavir for the Treatment of Respiratory Syncytial Virus (RSV) Business Wire Mon, Dec 9, 2024, 2:30 PM 11 min read In This Article: ENTA +1.17% Observed an antiviral effect for the primary and secondary virology endpoints in the overall population, with a viral load decline of 1.4 log at the end of treatment in Part 2 Demonstrated a viral load decline of 1.2 log compared to placebo at the end of treatment in prespecified analysis of patients randomized within 3 days of symptom onset Zelicapavir was well-tolerated with a favorable safety profile Conference call and webcast to discuss data at 8:30 a.m. ET today WATERTOWN, Mass., December 09, 2024 --( BUSINESS WIRE )-- Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for virology and immunology indications, today announced positive topline results from the first-in-pediatrics Phase 2 study evaluating zelicapavir in hospitalized and non-hospitalized children aged 28 days to 36 months with respiratory syncytial virus (RSV). An antiviral effect was observed for the primary and secondary virology endpoints in the overall pooled efficacy population. The primary endpoint in Part 2 of the study, which focused on virology, showed a pronounced antiviral effect with a 1.4 log decline in viral load at Day 5 compared to placebo. Additionally, a rapid and robust virologic effect was observed in a prespecified subset of patients who were randomized within 3 days of symptom onset, with a 1.2 log decline in viral load at Day 5 compared to placebo. The study also showed that zelicapavir demonstrated a favorable safety profile and was well-tolerated in this pediatric population. Zelicapavir, which received Fast Track designation from the U.S. Food and Drug Administration (FDA), is a novel N-protein inhibitor in development as a once-daily oral treatment for RSV. \"We are excited to share these positive results from our first-in-pediatric Phase 2 study of zelicapavir, which we believe confirm a strong profile for our lead RSV antiviral and strengthen Enanta\u2019s position as a leader in developing treatments for RSV. Zelicapavir demonstrated an antiviral effect on both primary endpoints, as well as secondary virology endpoints. Furthermore, patients who joined the study within 3 days of symptom onset showed a robust 1.2 log reduction in viral load at Day 5. These data provide us with continued confidence in zelicapavir and valuable insights to inform the design of a potential registration enabling trial,\" said Scott T. Rottinghaus, M.D., Chief Medical Officer of Enanta Pharmaceuticals. \"There is a substantial need for safe and effective oral treatments for RSV, and we believe that these important antiviral data along with the favorable safety profile observed in this young, vulnerable population support further clinical evaluation of zelicapavir.\" Story Continues \"In my practice, I see many children requiring hospitalization for severe RSV infection during the RSV season. The impact of RSV is felt not only by patients and caregivers, but also broadly by public health. I believe that a safe and effective antiviral therapeutic is critical in addressing this significant and unmet need,\" said Jaime Deville, MD, FAAP, a Principal Investigator in the Phase 2 pediatric clinical trial of zelicapavir and Professor of Clinical Infectious Diseases in the Department of Pediatrics at the David Geffen School of Medicine, University of California, Los Angeles and UCLA Mattel Children\u2019s Hospital. \"These results support further evaluation of zelicapavir and suggest the potential for zelicapavir to improve patient outcomes. I\u2019m excited to see this compound move forward, to possibly deliver the first safe and effective antiviral to treat children with RSV infection.\" Zelicapavir Phase 2 Study Topline Results This Phase 2 study was a randomized, double-blind, dose ranging, placebo-controlled study in hospitalized and non-hospitalized pediatric patients with RSV aged 28 days to 36 months. The primary objective of Part 1 of the study was to evaluate the safety and pharmacokinetics of zelicapavir and to determine the optimal dosing for Part 2 of the study. The primary objective of Part 2 of the study was to evaluate the antiviral activity of zelicapavir, with assessment of symptom severity as an exploratory objective. Because exposure was similar across all cohorts and doses, and all patients received a therapeutic dose, primary efficacy analyses were able to be performed across all dosed patients from Parts 1 and 2. A total of 96 patients received zelicapavir (n=70) or placebo (n=26). Part 1 evaluated multiple doses and patients were treated with zelicapavir (n=36) or placebo (n=16) once-daily (QD) for 5 days. In Part 2, patients received the selected dose of zelicapavir (n=34) or placebo (n=10) QD for 5 days. Demographics and baseline characteristics were balanced across treatment groups, with the majority of patients being hospitalized at enrollment, and a mean duration of RSV symptoms prior to randomization of 4 days. Zelicapavir demonstrated a favorable safety profile over the initial 5-day dosing period and through 23 days of follow-up. Adverse events (AEs) were similar between zelicapavir and placebo and there were no AEs leading to treatment discontinuation or study withdrawal. Furthermore, zelicapavir achieved target drug exposure levels across all age groups and dosing cohorts. Exposure was similar across cohorts and doses, and all patients received a therapeutic dose. A dose of 5 mg/kg was selected for age \u2265 28 days to <12 months, and a dose of 7.5 mg/kg was selected for age \u226512 months to \u226436 months. An antiviral effect was observed for the primary and secondary virology endpoints in the overall pooled efficacy population, with the viral load decline peaking at 0.7 log on Day 9 compared to placebo. The primary endpoint for Part 2 of the study showed a more pronounced effect, with a viral load decline of 1.0 log at Day 3 and 1.4 log at Day 5 compared to placebo. Additionally, a rapid and robust antiviral effect was observed in the prespecified subset of patients who were randomized within 3 days of symptom onset, which represents about 40% of patients in the study (n=38/96). In these patients, a viral load decline of 0.9 log at Day 3 and 1.2 log at Day 5 was observed compared to placebo. Furthermore, zelicapavir treatment resulted in a greater proportion of patients having undetectable viral load at Days 5 and 9 compared to placebo and improvements in AUC of change from baseline for viral load at all timepoints. Qualitative improvement in time to undetectable viral load was observed at early timepoints, although median time to undetectable was similar between groups. Overall, virology results were similar regardless of age or whether patients were enrolled from a hospitalized or outpatient setting. As there are no validated symptom tools approved by regulatory agencies for pediatric RSV, multiple methods were used to assess symptoms. ReSViNET (REspiratory Syncytial VIrus NETwork), a publicly available pediatric tool with caregiver assessments, was used as an exploratory endpoint in all patients. This tool was originally designed primarily for prophylaxis studies to assess disease severity at a single timepoint. There was no difference in symptoms between zelicapavir and placebo using ReSViNET. RESOLVE-P (RESpiratory ObservabLE Reported Outcome-Pediatric), a proprietary tool being developed by Enanta in alignment with regulatory agency input, was specifically designed to assess the severity of pediatric RSV infection change over time based on observations by the child\u2019s caregiver. As this tool was finalized and introduced late in the study, data are only available from a small number of patients (n=15). In this dataset, a trend toward greater symptom reduction in patients treated with zelicapavir was observed. Full data from the study will be presented at a future medical conference or in a peer-reviewed publication. Conference Call and Webcast Information Enanta will host a conference call and webcast today at 8:30 a.m. ET. The live webcast can be accessed at \" Events & Presentations \" in the investors section of Enanta\u2019s website. To participate by phone, please register for the call here . It is recommended that participants register a minimum of 15 minutes before the call. Once registered, participants will receive an email with the dial-in information. The archived webcast will be available on Enanta\u2019s website for approximately 30 days following the event. About Zelicapavir Zelicapavir, Enanta\u2019s lead N-protein inhibitor, is being developed for the treatment of RSV infection, and has been granted Fast Track designation by the U.S. Food and Drug Administration. Zelicapavir is a nanomolar inhibitor of both RSV-A and RSV-B activity. Zelicapavir is differentiated from RSV fusion inhibitors as the N-protein inhibitor targets the virus\u2019 replication machinery and has demonstrated a high barrier to resistance in vitro. In preclinical studies, Zelicapavir maintained antiviral potency across all clinical isolates tested and was active against viral variants resistant to other mechanisms. Zelicapavir demonstrated a favorable safety, pharmacokinetic and drug-drug interaction profile in an extensive Phase 1 program. In a Phase 2 challenge study, zelicapavir achieved highly statistically significant (p<0.001) reductions in RSV viral load and clinical symptoms compared to placebo, and demonstrated a favorable safety profile and was well-tolerated, with infrequent adverse events. Zelicapavir is currently being evaluated in RSVHR, a Phase 2b study in the elderly and/or those with congestive heart failure, chronic obstructive pulmonary disease (COPD) or asthma. About Respiratory Syncytial Virus RSV is the most common cause of bronchiolitis (inflammation of the small airways in the lung) and pneumonia in children under one year of age in the United States and a significant cause of respiratory illness in older adults and immunocompromised individuals. 1 According to the Centers for Disease Control and Prevention, virtually all children in the United States get an RSV infection by the time they are two years old and one to two out of every 100 children younger than six months of age with an RSV infection may need to be hospitalized. 2 Globally, there are an estimated 33 million cases of RSV annually in children less than five years of age, with about 3 million hospitalized and up to approximately 100,000 dying each year from complications associated with the infection. 3 RSV represents a significant health threat for adults older than 65 years of age, with an estimated 177,000 hospitalizations and 14,000 deaths associated with RSV infections annually in the United States. 4 About Enanta Pharmaceuticals, Inc. Enanta is using its robust, chemistry-driven approach and drug discovery capabilities to become a leader in the discovery and development of small molecule drugs with an emphasis on indications in virology and immunology. Enanta\u2019s clinical programs are currently focused on respiratory syncytial virus (RSV) and its earlier-stage immunology pipeline aims to develop treatments for inflammatory diseases by targeting key drivers of the type 2 immune response, including KIT and STAT6 inhibition. Glecaprevir, a protease inhibitor discovered by Enanta, is part of one of the leading treatment regimens for curing chronic hepatitis c virus (HCV) infection and is sold by AbbVie in numerous countries under the tradenames MAVYRET\u00ae (U.S.) and MAVIRET\u00ae (ex-U.S.) (glecaprevir/pibrentasvir). A portion of Enanta\u2019s royalties from HCV products developed under its collaboration with AbbVie contribute ongoing funding to Enanta\u2019s operations. Please visit www.enanta.com for more information. Forward Looking Statements Disclaimer This press release contains forward-looking statements, including with respect to the prospects for further development and advancement of zelicapavir for the treatment of RSV. Statements that are not historical facts are based on management\u2019s current expectations, estimates, forecasts and projections about Enanta\u2019s business and the industry in which it operates and management\u2019s beliefs and assumptions. The statements contained in this release are not guarantees of future performance and involve certain risks, uncertainties and assumptions, which are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed in such forward-looking statements. Important factors and risks that may affect actual results include: the development risks of early stage discovery efforts in the disease areas in Enanta\u2019s research and development pipeline, such as RSV; the impact of development, regulatory and marketing efforts of others with respect to competitive treatments for RSV; Enanta\u2019s limited clinical development experience; Enanta\u2019s need to attract and retain senior management and key scientific personnel; Enanta\u2019s need to obtain and maintain patent protection for its product candidates and avoid potential infringement of the intellectual property rights of others; and other risk factors described or referred to in \"Risk Factors\" in Enanta\u2019s most recent Annual Report on Form 10-K for the fiscal year ended September 30, 2024 and other periodic reports filed more recently with the Securities and Exchange Commission. Enanta cautions investors not to place undue reliance on the forward-looking statements contained in this release. All forward-looking statements contained in this release speak only as of the date on which they were made and are based on management\u2019s assumptions and estimates as of such date. Enanta undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made, except as required by law. 1. Centers for Disease Control & Prevention \u2013 Respiratory Syncytial Virus Last accessed: December 2024. 2. Centers for Disease Control & Prevention \u2013 RSV in Infants and Young Children Last accessed: December 2024. 3. Shi, Ting et al. \" Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study .\" Lancet (London, England) vol. 390,10098 (2017): 946-958. doi:10.1016/S0140-6736(17)30938-8 4. Falsey, Ann R et al. \" Respiratory syncytial virus infection in elderly and high-risk adults .\" The New England Journal of Medicine vol. 352,17 (2005): 1749-59. doi:10.1056/NEJMoa043951 View source version on businesswire.com: https://www.businesswire.com/news/home/20241209611449/en/ Contacts Media and Investors: Jennifer Viera 617-744-3848 jviera@enanta.com View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "ENTA", "date": "2024-12-09T11:30:00+00:00", "sentiment": {"score": 0.09795072674751282, "confidence": 0.4851961135864258, "probabilities": {"positive": 0.4851961135864258, "negative": 0.38724538683891296, "neutral": 0.12755849957466125}}, "embedding": [0.015815623104572296, -0.045824628323316574, -0.07650227099657059, -0.09635207802057266, -0.016247767955064774, -0.045392297208309174, -0.0978989228606224, 0.2883514165878296, 0.09594716876745224, 0.12990941107273102, -0.04439573734998703, 0.1450449526309967, 0.157341867685318, 0.16427579522132874, -0.05846017971634865, 0.06493739783763885, 0.13561737537384033, 0.0586758553981781, -0.06422636657953262, 0.03650108724832535, 0.10587061196565628, 0.030033087357878685, 0.07982791215181351, -0.05660705640912056, -0.11906208097934723, 0.10844369232654572, -0.20306572318077087, 0.1203077882528305, -0.037079982459545135, 0.03137773275375366, -0.019839592278003693, 0.0948309674859047, 0.08127506077289581, -0.03873695060610771, -0.06433743983507156, 0.03095201402902603, -0.21056614816188812, 0.08400867879390717, -0.09557019919157028, -0.06719425320625305, -0.096097931265831, 0.06198665499687195, -0.22638213634490967, -0.05227391794323921, 0.0014725462533533573, -0.1740301251411438, -0.12354348599910736, 0.06888962537050247, 0.012159870937466621, 0.06750594079494476, -0.05891929194331169, -0.07869239151477814, -0.021852251142263412, 0.238680899143219, -0.18019695580005646, 0.04306116700172424, -0.15723764896392822, -0.1420074850320816, 0.004874597303569317, 0.008177673444151878, -0.1002151221036911, 0.07320450991392136, -0.05452381446957588, -0.13697640597820282, 0.035068534314632416, -0.009276515804231167, 0.06635855883359909, 0.09751490503549576, 0.03897695988416672, 0.060956232249736786, -0.0370936393737793, 0.0006663110107183456, -0.012864602729678154, 0.1960245966911316, -0.15107743442058563, 0.10759516805410385, 0.24261948466300964, 0.038863152265548706, 0.08619523048400879, -0.06487074494361877, 0.08928544074296951, 0.06969888508319855, 0.08084319531917572, 0.11412893235683441, -0.01961006596684456, 0.01591234654188156, 0.016295606270432472, 0.1033337190747261, 0.02449442446231842, -0.013474497944116592, 0.12053760886192322, 0.027919240295886993, 0.10423199832439423, 0.02849043719470501, 0.1763853281736374, -0.007139231078326702, -0.158157616853714, 0.003493987023830414, -0.0064014857634902, -0.0754927322268486, 0.07413358986377716, -0.2231096774339676, -0.033659230917692184, -0.0021506198681890965, -0.0008448446169495583, -0.026620792225003242, 0.15481238067150116, -0.05387955158948898, -0.062233537435531616, 0.04193507134914398, -0.03520674630999565, 0.02333727478981018, 0.10257527977228165, 0.0037461724132299423, -0.027473364025354385, 0.24457064270973206, 0.03159191459417343, 0.13201671838760376, -0.03389110788702965, -0.05451612174510956, 0.2282455563545227, -0.0547051802277565, 0.2019915133714676, -0.1954185962677002, 0.030635034665465355, 0.0523187592625618, 0.12040158361196518, 7.657481707259349e-33, -0.039378441870212555, -0.037331078201532364, 0.08338451385498047, 0.15834654867649078, 0.13526266813278198, 0.11772206425666809, 0.12793833017349243, 0.10009780526161194, -0.07468006014823914, -0.08021989464759827, -0.1354491114616394, -0.02829904854297638, 0.08192072063684464, 0.12524408102035522, -0.10960614681243896, 0.0547998808324337, -0.029884543269872665, 0.017753606662154198, -0.08303165435791016, 0.072746142745018, 0.058525390923023224, -0.11075526475906372, 0.09535533934831619, 0.0649460032582283, -0.008293863385915756, -0.05257919430732727, -0.18368440866470337, 0.06617330014705658, -0.04382740706205368, -0.07149102538824081, 0.001088111661374569, 0.037727635353803635, -0.05770612508058548, -0.02383633702993393, -0.07714729011058807, -0.12185061722993851, 0.022033952176570892, -0.08050233125686646, 0.0041379365138709545, 0.02673380821943283, 0.06999967247247696, 0.1028549000620842, -0.05156106501817703, 0.10122354328632355, 0.09885738790035248, 0.0019575394690036774, -0.1793859302997589, 0.014842240139842033, -0.04585001990199089, -0.007530374452471733, 0.06427229195833206, -0.0640605241060257, -0.11633389443159103, -0.21432903409004211, -0.19200843572616577, 0.12033115327358246, 0.04981544613838196, 0.09394091367721558, 0.003859488293528557, -0.026441287249326706, -0.032554712146520615, 0.04672761633992195, 0.03863280266523361, 0.01244782842695713, -0.12346821278333664, -0.08858730643987656, 0.08552178740501404, -0.10073742270469666, -0.09613429009914398, 0.09900146722793579, -0.05201476812362671, -0.047446999698877335, 0.02030373550951481, 0.05642586201429367, 0.12890183925628662, -0.12805137038230896, -0.03948809206485748, 0.04438623785972595, 0.03885882720351219, -0.03676935285329819, -0.10600630939006805, -0.002921279286965728, -0.006745460443198681, 0.1283400058746338, -0.02633313275873661, -0.21477879583835602, -0.1301962435245514, -0.02210194244980812, -0.08188298344612122, -0.039733342826366425, 0.12247727811336517, 0.042889755219221115, 0.01685703732073307, 0.09779907763004303, -0.00379023514688015, -9.81758482000977e-33, -0.047816842794418335, 0.059814803302288055, -0.008317919448018074, -0.0035976124927401543, 0.04997055605053902, 0.24492883682250977, 0.05174107104539871, -0.1664811372756958, 0.1509685218334198, -0.1488383710384369, 0.08678984642028809, 0.006471456028521061, -0.027242405340075493, 0.029884394258260727, -0.07627131044864655, 0.14536021649837494, -0.009105410426855087, -0.04789149388670921, -0.1311909258365631, -0.00022002868354320526, 0.04787411913275719, -0.015664104372262955, -0.0014356314204633236, -0.017958711832761765, 0.1405162513256073, -0.1104816272854805, 0.15000174939632416, -0.0005626920610666275, 0.09330612421035767, -0.05695541948080063, 0.05882462486624718, -0.013464385643601418, -0.12928850948810577, 0.07947824895381927, -0.01845095306634903, 0.06259723007678986, 0.10663343966007233, -0.25931471586227417, -0.07573187351226807, -0.11641507595777512, 0.035797182470560074, 0.08344046771526337, 0.012275449931621552, -0.027546411380171776, -0.09276837110519409, 0.03013594262301922, 0.042401593178510666, -0.08678851276636124, -0.006437879987061024, -0.024885069578886032, 0.051915645599365234, 0.05891071632504463, -0.10617948323488235, 0.10841986536979675, -0.005081126932054758, 0.01869870349764824, -0.026082437485456467, -0.03801290690898895, -0.06729759275913239, 0.1068815365433693, 0.1459784358739853, -0.026555538177490234, -0.06927944719791412, -0.15836194157600403, 0.020393595099449158, 0.09828098118305206, 0.1509062498807907, 0.08451154828071594, 0.11298997700214386, -0.31162703037261963, -0.10250885784626007, -0.1231163889169693, -0.0101753706112504, -0.15314406156539917, -0.08349445462226868, 0.035299159586429596, -0.028576981276273727, -0.2254190742969513, -0.040025003254413605, -0.17040657997131348, -0.1047806590795517, -0.09711411595344543, -0.1061764657497406, -0.08763714879751205, -0.08839957416057587, -0.027566540986299515, 0.07265552878379822, 0.06744736433029175, 0.08216779679059982, 0.11221727728843689, -0.01959131844341755, -0.13353827595710754, -0.11816324293613434, 0.06415516138076782, 0.028097162023186684, -1.0044972498235438e-07, 0.1598580777645111, -0.0976143479347229, 0.06900498270988464, 0.0429348424077034, 0.017896635457873344, -0.03386349231004715, 0.066679447889328, 0.06939852237701416, 0.03823312371969223, 0.22121813893318176, -0.024200592190027237, 0.10039566457271576, -0.08521582186222076, 0.08017800748348236, 0.052329178899526596, 0.0038768022786825895, -0.06460590660572052, 0.1263035386800766, -0.08030179142951965, -0.009855167008936405, 0.018586808815598488, 0.07804363965988159, -0.152450293302536, -0.10009530931711197, 0.08427775651216507, -0.23167920112609863, 0.02719002030789852, 0.014764601364731789, 0.04102738946676254, -0.2676182985305786, -0.08640848100185394, 0.021749548614025116, 0.08015093207359314, -0.0695415511727333, -0.20038536190986633, -0.05015639215707779, 0.09685925394296646, 0.028093557804822922, 0.09459283202886581, 0.15690737962722778, 0.1422460973262787, -0.00995376706123352, 0.039765968918800354, -0.07113102823495865, -0.01890835538506508, -0.040088407695293427, -0.10898372530937195, 0.01095411367714405, 0.10233891010284424, -0.11455021798610687, -0.00899294763803482, 0.01362132653594017, 0.034410517662763596, -0.09060504287481308, -0.06080462038516998, 0.14115116000175476, -0.1186733990907669, -0.12795601785182953, 0.16343265771865845, -0.08457875996828079, -0.08971509337425232, -0.10868183523416519, 0.04641804099082947, -0.01537320762872696], "changes": {"1wk": -32.5503300577357, "1mo": -39.70917092308744}}, {"text": "PREMIUM Enanta Pharmaceuticals Fiscal Q4 Net Loss Widens, Revenue Declines MT Newswires Tue, Nov 26, 2024, 1:26 AM In This Article: ENTA +1.17% Enanta Pharmaceuticals (ENTA) late Monday reported a fiscal Q4 net loss of $1. PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? Sign in Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "ENTA", "date": "2024-11-25T22:26:23+00:00", "sentiment": {"score": 0.016972750425338745, "confidence": 0.04908338561654091, "probabilities": {"positive": 0.04908338561654091, "negative": 0.032110635191202164, "neutral": 0.9188060164451599}}, "embedding": [-0.003049517748877406, -0.03495700657367706, 0.06968434154987335, -0.037340197712183, 0.06680325418710709, 0.0529303252696991, 0.06905770301818848, 0.13925090432167053, 0.04394561052322388, 0.25520214438438416, 0.05532677099108696, 0.010942552238702774, -0.008375735022127628, 0.16561999917030334, 0.16484500467777252, 0.04654185473918915, -0.0004795139539055526, -0.15775726735591888, -0.16460926830768585, 0.03806259483098984, -0.0026684575714170933, -0.005045868456363678, -0.0903468132019043, 0.10874610394239426, 0.2671690583229065, -0.009605461731553078, -0.1912781149148941, 0.014187192544341087, -0.05847792327404022, -0.1826380342245102, -0.12026585638523102, 0.17858199775218964, -0.008341239765286446, -0.16170631349086761, 0.20584362745285034, -0.158524751663208, -0.14991995692253113, 0.03056180104613304, 0.07384998351335526, -0.09879893064498901, 0.08202257752418518, -0.014059335924685001, -0.3338058590888977, 0.0060761962085962296, 0.016256926581263542, -0.2661256194114685, -0.006615986116230488, 0.057521019130945206, 0.13147537410259247, 0.03404178097844124, 0.004499353002756834, -0.05865729600191116, 0.08140164613723755, 0.013935074210166931, -0.02631712518632412, -0.2003857046365738, -0.1478281170129776, -0.12123250216245651, -0.15076622366905212, 0.11616595089435577, 0.2036411315202713, -0.09697698801755905, -0.11957036703824997, 0.006088134832680225, 0.010673108510673046, 0.0515902154147625, 0.17868921160697937, 0.002277421997860074, -0.25058379769325256, -0.08461510390043259, -0.007856552489101887, -0.101669080555439, -0.0676790103316307, 0.11463545262813568, -0.016000647097826004, -0.010077829472720623, 0.302693247795105, 0.03562101349234581, -0.03318166732788086, -0.04661260172724724, 0.2043302357196808, -0.04041197896003723, -0.16004814207553864, -0.0368979349732399, 0.12385992705821991, 0.01381464023143053, 0.09374012798070908, -0.0909881591796875, 0.09694063663482666, -0.15076994895935059, 0.059850554913282394, 0.020900636911392212, 0.16196483373641968, -0.03289075195789337, 0.020393557846546173, -0.020037608221173286, -0.292082816362381, -0.11592688411474228, -0.030349085107445717, 0.10640938580036163, 0.17034420371055603, 0.09167385846376419, -0.17885737121105194, -0.11517862975597382, 0.012063330970704556, -0.07173336297273636, 0.26853641867637634, 0.15995419025421143, 0.015090624801814556, 0.11650852113962173, -0.173725888133049, 0.009092778898775578, 0.09823640435934067, 0.10767576843500137, -0.10107045620679855, 0.2941460609436035, -0.00149724876973778, 0.15059570968151093, 0.07059603184461594, -0.09044884890317917, 0.021793339401483536, 0.06429410725831985, 0.007314932998269796, 0.01759941317141056, 0.004589702468365431, 0.0942760705947876, -0.10966905951499939, 1.4540380228251982e-32, 0.061558905988931656, 0.0754869282245636, 0.1980658918619156, -0.08384901285171509, 0.15985053777694702, 0.1111067607998848, 0.10204525291919708, -0.06730090081691742, -0.2635379731655121, -0.23532545566558838, -0.25170066952705383, 0.1747865229845047, -0.06926766037940979, 0.03457622602581978, -0.08543384075164795, -0.08841471374034882, -0.18369655311107635, 0.09173418581485748, 0.167555034160614, 0.04989727959036827, -0.1667761653661728, -0.14866337180137634, -0.09535529464483261, 0.06292065978050232, -0.12350231409072876, 0.17514866590499878, -0.016352301463484764, 0.013124643824994564, 0.10188350826501846, 0.061530690640211105, -0.1361789107322693, 0.20136623084545135, -0.003488687565550208, -0.1683436781167984, -0.024461867287755013, -0.010420632548630238, 0.06751763820648193, 0.16969366371631622, 0.01843668706715107, -0.06878484040498734, -0.04113952815532684, 0.21793320775032043, -0.11610708385705948, -0.17794470489025116, -0.1305464506149292, -0.050946690142154694, 0.07156043499708176, 0.036175668239593506, 0.029407260939478874, -0.003954102285206318, -0.0002291793207405135, 0.011898437514901161, -0.2233874648809433, -0.1014159545302391, 0.09155096858739853, -0.003739406354725361, 0.06084078550338745, -0.03488764539361, 0.06460875272750854, -0.012205475009977818, 0.12590275704860687, -0.060301341116428375, -0.04983147978782654, -0.03200120851397514, -0.16940699517726898, 0.10055408626794815, 0.012018965557217598, -0.08974859863519669, -0.20540323853492737, 0.2025759071111679, 0.07109051942825317, -0.0680554062128067, 0.08144097775220871, 0.08649475127458572, 0.088272325694561, -0.182981476187706, -0.1433783620595932, 0.07472895085811615, 0.10619698464870453, 0.062286876142024994, -0.025318140164017677, -0.03934439644217491, 0.1205732524394989, 0.04676080122590065, 0.04698314145207405, -0.10604944080114365, 0.225800558924675, -0.010612917132675648, 0.07692886143922806, 0.0838039293885231, 0.06394670158624649, -0.007700970396399498, -0.05160853639245033, 0.11132191866636276, 0.03611232712864876, -1.3376045726922814e-32, -0.1044483557343483, 0.14737020432949066, -0.15847748517990112, -0.07605961710214615, -0.22290578484535217, 0.026836436241865158, 0.051006581634283066, 0.2200886607170105, 0.16938430070877075, 0.15465819835662842, 0.1842346489429474, 0.10662192106246948, -0.1330532729625702, 0.06479897350072861, 0.055711910128593445, -0.10277774930000305, 0.20801198482513428, -0.2454284131526947, -0.030585721135139465, -0.18467576801776886, 0.08614078909158707, 0.12905097007751465, -0.1262751966714859, 0.18903103470802307, 0.1610659807920456, 0.07344017177820206, 0.08331695944070816, 0.2455344796180725, -0.03288964927196503, -0.1838262379169464, -0.2356346696615219, -0.2847769558429718, -0.3132082223892212, 0.07276655733585358, -0.07883987575769424, -0.0250229611992836, 0.14493156969547272, -0.10679861158132553, -0.14102862775325775, 0.013993588276207447, -0.059701982885599136, 0.0555310882627964, 0.010347424075007439, 0.09736346453428268, 0.05009806901216507, -0.16523627936840057, -0.04937959834933281, -0.06987465173006058, 0.0944298580288887, 0.028430460020899773, 0.20849983394145966, -0.014681263826787472, -0.052130840718746185, 0.09373831003904343, -0.19506913423538208, 0.163614422082901, 0.09694422036409378, 0.11224382370710373, -0.14608712494373322, 0.042628213763237, -0.026946818456053734, 0.08847388625144958, -0.23860327899456024, 0.007987616583704948, 0.019606932997703552, -0.01166426669806242, 0.16591006517410278, -0.06589219719171524, 0.15457376837730408, -0.23253655433654785, 0.024810487404465675, -0.13982370495796204, -0.016113650053739548, -0.16123831272125244, -0.03706108778715134, 0.224308043718338, -0.2217562198638916, -0.06256383657455444, 0.028939655050635338, -0.03892209753394127, 0.02386392280459404, -0.08841867744922638, -0.04350179433822632, 0.028108198195695877, -0.0924525260925293, -0.05727637931704521, 0.14265088737010956, 0.014119177125394344, -0.049832068383693695, 0.13610149919986725, -0.12578600645065308, -0.07339388132095337, -0.030994754284620285, 0.31171944737434387, 0.11446603387594223, -9.957445712416302e-08, 0.030725011602044106, -0.06368617713451385, -0.05091603845357895, 0.17228816449642181, -0.08921035379171371, -0.1569288820028305, 0.07073245197534561, 0.17373360693454742, 0.18774087727069855, 0.12059902399778366, -0.026189787313342094, 0.12082080543041229, -0.0499529130756855, 0.1930168867111206, -0.0012418839614838362, 0.04597277566790581, -0.020783578976988792, 0.10720346122980118, 0.0026483689434826374, -0.23766006529331207, -0.04086272045969963, 0.1002628430724144, -0.034621890634298325, -0.16704848408699036, -0.07150407135486603, -0.1314169466495514, 0.04913301393389702, 0.14204207062721252, 0.10610755532979965, -0.1335810124874115, -0.119192935526371, -0.10338570177555084, 0.11311914026737213, -0.03488640487194061, -0.2135973870754242, -0.021826772019267082, 0.0020062110852450132, -0.10019592195749283, 0.036453597247600555, 0.11634168773889542, 0.032669201493263245, -0.17234006524085999, -0.1307011991739273, -0.05696459859609604, -0.02898358926177025, 0.033240288496017456, -0.1288451850414276, -0.053817905485630035, 0.09746503829956055, -0.29139822721481323, 0.13291318714618683, -0.07138408720493317, 0.16801437735557556, -0.023911725729703903, 0.01696551963686943, -0.06838960200548172, -0.05250834301114082, 0.004539883695542812, 0.016722625121474266, -0.0021568709053099155, 0.07043217122554779, -0.1795274317264557, -0.00046712972107343376, 0.14929194748401642], "changes": {"1wk": -4.8834686224222486, "1mo": -32.29745005911511}}, {"text": "PREMIUM Oppenheimer Adjusts Enanta Pharmaceuticals Price Target to $14 From $16, Maintains Perform Rating MT Newswires Wed, Nov 27, 2024, 4:29 PM In This Article: ENTA +1.17% Enanta Pharmaceuticals (ENTA) has an average rating of overweight and mean price target of $18.13, a PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? Sign in Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "ENTA", "date": "2024-11-27T13:29:45+00:00", "sentiment": {"score": 0.06149978842586279, "confidence": 0.07450145483016968, "probabilities": {"positive": 0.07450145483016968, "negative": 0.013001666404306889, "neutral": 0.9124969244003296}}, "embedding": [0.01117720827460289, -0.0864434540271759, -0.07161180675029755, 0.062397874891757965, 0.045948274433612823, -0.09979472309350967, 0.11203344911336899, 0.22382427752017975, 0.007983298040926456, 0.20635734498500824, 0.08385881781578064, -0.14105132222175598, -0.004793097265064716, 0.10735256969928741, 0.1642153114080429, 0.02092999592423439, 0.22207200527191162, -0.14977803826332092, -0.035661060363054276, 0.10058683902025223, -0.030327364802360535, 0.04917427897453308, -0.05560579523444176, 0.18650688230991364, 0.11979614943265915, -0.0005571699584834278, -0.023703938350081444, -0.019983312115073204, -0.15287907421588898, -0.08032622933387756, -0.13185016810894012, -0.042115554213523865, -0.008280416950583458, -0.1276000589132309, 0.11576668173074722, -0.09910435229539871, -0.1764388382434845, 0.05822693929076195, 0.025110021233558655, -0.058030351996421814, -0.004826159682124853, 0.07502587884664536, -0.268964946269989, -0.020882582291960716, 0.002445467747747898, -0.3539833724498749, 0.002739888383075595, 0.10990404337644577, 0.13436053693294525, 0.1708022803068161, -0.02723546139895916, -0.10229542851448059, 0.0796964019536972, -0.11698877066373825, 0.07276222854852676, -0.14195984601974487, -0.10814264416694641, -0.210436150431633, -0.04905356466770172, -0.05289173871278763, 0.0668368935585022, -0.09263555705547333, -0.15043164789676666, -0.021855028346180916, 0.11919816583395004, -0.14329762756824493, 0.21994927525520325, -0.11990942806005478, -0.0944657102227211, 0.011354402638971806, 0.10567006468772888, -0.04125065729022026, 0.12625251710414886, 0.06974674761295319, -0.06246369332075119, 0.041268058121204376, 0.21682186424732208, -0.0700686126947403, 0.0113736717030406, 0.041869889944791794, 0.19467410445213318, -0.19634610414505005, -0.08735249936580658, -0.00763723673298955, 0.2049524039030075, -0.039719805121421814, 0.22367051243782043, 0.15457475185394287, 0.1909063756465912, 0.030912717804312706, 0.05416148528456688, -0.06615506112575531, 0.005032001528888941, -0.08030664920806885, 0.00171156064607203, 0.05277813598513603, -0.39140579104423523, 0.019529659301042557, -0.1859215348958969, -0.02369104139506817, 0.1626623570919037, 0.08888725191354752, -0.12380944192409515, -0.003459351370111108, -0.16324271261692047, -0.12559789419174194, 0.2623133063316345, 0.11339898407459259, -0.06220826134085655, 0.12809211015701294, -0.19558198750019073, -0.12650638818740845, 0.15364104509353638, 0.13400577008724213, -0.11694391816854477, 0.12017875909805298, 0.011815124191343784, -0.06789632886648178, 0.11554457247257233, -0.13452228903770447, 0.06458140909671783, -0.03586551547050476, 0.15058961510658264, 0.11210466176271439, -0.12740151584148407, 0.024085301905870438, -0.1571526825428009, 1.1321617352259409e-32, 0.08012666553258896, 0.06027888134121895, 0.04555646702647209, -0.20221363008022308, -0.0069437711499631405, 0.17232823371887207, 0.017357220873236656, 0.012490185908973217, -0.3099185526371002, -0.16771343350410461, -0.20106209814548492, 0.16045881807804108, -0.014659948647022247, 0.17342710494995117, -0.1545829474925995, -0.0875808522105217, -0.05494103580713272, 0.1545879989862442, 0.07600267231464386, 0.06864746659994125, -0.24817410111427307, -0.042936328798532486, -0.1796751767396927, -0.042351119220256805, -0.170164093375206, 0.11757288873195648, -0.13877719640731812, 0.045202914625406265, 0.060928355902433395, -0.00984418299049139, -0.04253365844488144, 0.13270467519760132, -0.016555629670619965, -0.02038760669529438, 0.07592485100030899, -0.1325598657131195, 0.04190509021282196, 0.09701943397521973, 0.05197926610708237, -0.1094263345003128, 0.09629585593938828, 0.35559046268463135, -0.08336347341537476, -0.11837396025657654, -0.07754962146282196, 0.1478527933359146, -0.055162593722343445, 0.01777326874434948, -0.046701133251190186, -0.05843854323029518, -0.04055917635560036, 0.067973293364048, -0.17051471769809723, -0.1302572786808014, -0.047147106379270554, -0.06772006303071976, -0.00629785330966115, -0.08912649750709534, 0.2039356529712677, 0.10483387857675552, -0.1090981736779213, 0.0720786526799202, 0.03637312725186348, -0.06964217126369476, -0.11892687529325485, 0.1390322744846344, -0.15737581253051758, -0.03746972605586052, -0.12566383183002472, 0.20980174839496613, 0.11088648438453674, -0.017682284116744995, 0.11609362065792084, -0.03860194981098175, 0.01983056031167507, -0.1507919430732727, -0.13152410089969635, -0.0051787239499390125, 0.041814252734184265, 0.14360886812210083, -0.023918014019727707, -0.08197977393865585, 0.04841664060950279, 0.06155022606253624, 0.01524102408438921, -0.10880434513092041, -0.17615000903606415, 0.10496476292610168, -0.02536693774163723, 0.1500369757413864, 0.2322905957698822, -0.0736999437212944, -0.1488477736711502, 0.02155778743326664, 0.056209493428468704, -1.1539863306852921e-32, -0.0027706949040293694, 0.014656136743724346, 0.11056559532880783, -0.04030897095799446, -0.05964946746826172, 0.07790005207061768, -0.00022299046395346522, 0.09694457799196243, 0.3037017285823822, 0.17838656902313232, 0.0849202424287796, 0.19825859367847443, -0.03368232399225235, 0.0479266457259655, 0.07960087060928345, -0.06651928275823593, 0.04791010543704033, -0.12131652981042862, 0.07360107451677322, -0.31471875309944153, 0.005725550465285778, 0.06672555953264236, -0.04131367430090904, 0.2706690728664398, 0.08117307722568512, 0.10639825463294983, 0.14125679433345795, 0.10166215151548386, -0.053336091339588165, -0.18406108021736145, -0.19552840292453766, -0.09991846233606339, -0.13845036923885345, 0.15697941184043884, -0.17418499290943146, 0.10134875774383545, 0.14977039396762848, -0.13040851056575775, -0.0638607069849968, 0.004524078220129013, -0.08721213042736053, 0.16717103123664856, -0.007252388633787632, -0.00764533830806613, 0.12238778173923492, -0.17313170433044434, -0.008026322349905968, -0.04813738539814949, 0.016063040122389793, -0.054708126932382584, 0.09153728187084198, -0.07689781486988068, 0.013971486128866673, -0.04049716144800186, -0.18956643342971802, -0.061700817197561264, 0.0008326828246936202, 0.13602840900421143, 0.08581797033548355, 0.03401617705821991, 0.14857669174671173, 0.2086680680513382, -0.15956935286521912, -0.05650273337960243, -0.1758328527212143, 0.08386176824569702, 0.15040050446987152, -0.06135346740484238, 0.007857004180550575, -0.13109363615512848, -0.09757582098245621, -0.195601686835289, 0.13835042715072632, -0.05675329267978668, -0.019505329430103302, 0.04080890864133835, -0.02690383419394493, -0.14383061230182648, 0.07887748628854752, -0.09438522160053253, 0.0002056626253761351, -0.1321934163570404, -0.055583491921424866, 0.06489699333906174, -0.024641290307044983, -0.04499705508351326, 0.014650831930339336, 0.04537144675850868, -0.18287740647792816, 0.17161047458648682, -0.10512673854827881, -0.08423274010419846, 0.10032165795564651, 0.21615715324878693, 0.040710512548685074, -9.941179968109282e-08, -0.025154391303658485, -0.18960198760032654, 0.06969275325536728, 0.15292750298976898, -0.12774936854839325, 0.05882973223924637, 0.15035103261470795, 0.09737055748701096, 0.27924349904060364, 0.06778162717819214, 0.21340107917785645, 0.04453318566083908, 0.056102219969034195, 0.18352842330932617, -0.1478354036808014, -0.043909329921007156, 0.03644843399524689, 0.1312815099954605, 0.033290520310401917, -0.15483692288398743, -0.020749889314174652, 0.1421070247888565, 0.00378902698867023, -0.06775487214326859, -0.022160975262522697, 0.0064766379073262215, -0.13468648493289948, 0.08348806947469711, 0.03806408867239952, -0.038740914314985275, -0.15102580189704895, -0.21311599016189575, 0.15001101791858673, 0.14351128041744232, -0.027975181117653847, -0.07326996326446533, -0.07954323291778564, -0.04018383100628853, -0.06968173384666443, 0.06518092751502991, 0.11701049655675888, -0.05538574606180191, -0.16673970222473145, -0.05314134806394577, 0.027707034721970558, 0.043892208486795425, -0.2427349090576172, -0.005528544541448355, 0.01704115979373455, -0.14451590180397034, 0.2069202959537506, 0.07986067980527878, 0.07500235736370087, 0.013610650785267353, -0.01104441937059164, -0.08976481109857559, -0.14798256754875183, -0.008355974219739437, -0.02666371874511242, 0.10382392257452011, 0.2205437272787094, -0.2463575303554535, -0.022339165210723877, 0.1712651401758194], "changes": {"1wk": -0.7927485326051855, "1mo": -32.04982953746472}}]